The use of mobile health in the management of Chronic Obstructive Pulmonary Disease by Alwashmi, Meshari Fahad
 
 
 The use of Mobile Health in the management of Chronic 
Obstructive Pulmonary Disease  
 
by  
© Meshari Fahad Alwashmi  
A Thesis submitted to the School of Graduate Studies in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy  
 
 
 
 
 
 
School of Pharmacy  
Memorial University of Newfoundland  
 
 
 
 
 
 
May 2020  
 
St. John’s                  Newfoundland 
 
  
2 
 
Abstract 
 
The prevalence and mortality rates of chronic obstructive pulmonary disease (COPD) are 
increasing worldwide. Therefore, COPD remains a major public health problem. Using an 
mobile health (mHealth) intervention has the potential to enhance COPD treatment outcomes 
while mitigating healthcare costs. However, the complexity of the process of developing an 
mHealth intervention for COPD management is poorly understood, and in-depth assessment of 
the development process of mHealth interventions for COPD management is currently lacking.  
This thesis advances our understanding of how to apply the human-centered design 
process when developing an mHealth intervention for COPD management. The thesis is 
composed of the following five interconnected journal articles:    
1. A systematic review and meta-analysis to summarize and quantify the effect of mHealth 
interventions on patients with COPD;  
2. A qualitative study to explore the perceptions of healthcare providers regarding an 
mHealth intervention for COPD management;  
3. A mixed methods study to explore the perceptions of patients with COPD regarding an 
mHealth intervention for COPD management;  
4. A qualitative study to identify the features of an mHealth intervention for COPD 
management; and,  
5. A mixed methods approach, the iterative convergent design, to guide the usability testing 
process for mHealth interventions.   
 
The outcomes of this research contribute to knowledge about the use of mHealth in 
COPD management. Firstly, this thesis provides an overview of the effectiveness of mHealth in 
COPD management. Secondly, it provides an understanding of how to actively and efficiently 
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involve users in the design and development of health information technology. Thirdly, it 
provides recommendations regarding the features of an mHealth intervention to enhance COPD 
management. Lastly, it proposes a mixed methods framework for mHealth usability testing. The 
application of the proposed methods is demonstrated using different case studies. This program 
of research highlights the process of developing an mHealth intervention for COPD 
management. Application of the findings could help others in the field to further investigate the 
development of mHealth interventions in this area. 
 
	  
4 
 
Dedication 
 
This thesis is dedicated to my beloved family for their endless love and continuous 
support in my journey. You know I couldn’t have done this without you. To my mother, for 
encouraging me to be a pioneer in my field and always reminding me to revisit the purpose of 
my work. To my father, who inspires me to be a kind human and to think outside the box. To my 
siblings, for always being there to answer my calls and reminding me that I am not alone. I am 
nothing without you. 
 
 
 
  
5 
 
Acknowledgements 
 
I would like to express my deepest appreciation to everyone who has supported me 
throughout the completion of this graduate program. I would like to sincerely thank my primary 
supervisors Dr. John Hawboldt and Erin Davis for their support and encouragement. You have 
allowed me to have a truly unique learning experience in thought this program of research. I 
would like to acknowledge the support of Dr. Hawboldt that led me to an interesting academic 
topic. He works so efficiently and I can always get his timely and valuable responses.  
I would also like to acknowledge the assistance of my supervisory committee members, 
Dr. Beverly Fitzpatrick, Dr. Jamie Farrell, Dr. John-Michael Gamble, Dr. Hai Nguyen, and Dr. 
Gerard Farrell for your feedback and direction throughout this project. I will never forget Dr. 
Fitzpatrick’s encouragement during the process. We had extensive meetings to guide me through 
the design, analysis, and write-up of the thesis and manuscripts. This research would not be 
possible without the help of Dr. J. Farrell that has made recruiting research participants possible. 
Thank you to all the participants in the survey and interviews, your input and insights were 
invaluable to my research. 
My gratitude to my friends for their continued support during my Ph.D. life journey. 
They shared joy, curiosity, and passion from the first day. Specifically, Dr. Mugford for his 
support, encouragement, and fostering that allowed me to become a better scholar and person. 
Finally, I would like to acknowledge the funding from the Saudi Arabian Cultural Bureau and 
Mitacs that made it possible for me to pursue studies as a full-time graduate student. 
 
 
  
6 
 
Table of Contents 
  
List of Tables 8 
List of Figures 10 
List of Abbreviations 11 
List of Appendices 13 
Chapter 1: Introduction 15 
1.1 Overview 14 
1.2 Knowledge gap and research questions 35 
1.3 Thesis organization 38 
1.4 References 41 
Chapter 2: The Effect of Smartphone Interventions on Patients with Chronic Obstructive Pulmonary 
Disease Exacerbations: A Systematic Review and Meta-Analysis. 51 
Preface 51 
Abstract 51 
2.1 Introduction 54 
2.2 Methods 56 
2.3 Results 59 
2.4 Discussion 68 
2.5 Conclusion 72 
2.6 References 73 
Chapter 3: Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage 
Chronic Obstructive Pulmonary Disease: Qualitative Study 76 
Preface 76 
Abstract 76 
3.1 Introduction 78 
3.2 Methods 82 
3.3 Results 86 
3.4 Discussion 103 
3.5 Conclusions 107 
3.6 References 108 
Chapter 4: Perceptions of Chronic Obstructive Pulmonary Disease patients regarding a Mobile Health 
intervention to manage COPD: a Mixed Methods Study 113 
Preface 113 
7 
 
Abstract 113 
4.1 Introduction 115 
4.2 Methods 116 
4.3 Results 124 
4.4 Discussion 138 
4.5 Conclusion 145 
4.6 References 147 
Chapter 5: Features of a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: 
Qualitative Study 153 
Preface 153 
Abstract 153 
5.1 Introduction 155 
5.2 Methods 159 
5.3 Results 164 
5.4 Discussion 191 
5.5 Conclusions 197 
5.6 References 198 
Chapter 6: The Iterative Convergent Design for Mobile Health Usability Testing: Mixed Methods 
Approach 206 
Preface 206 
Abstract 206 
6.1 Introduction 208 
6.2 Methodology 221 
6.3 Discussion 239 
6.4 Conclusions 241 
6.6 References 243 
Chapter 7: Summary 250 
7.1 General Discussion 250 
7.2 Applying human-centered design activity phases to mHealth development 254 
7.3 Study implications 255 
7.4 Areas for future research 256 
7. 5 Conclusion 259 
7.6 References 259	
8 
 
List of Tables 
 
Table 1.1 Relevant dimensions of the mixed methods research integration. 32 
Table 1.2: Journal articles and objectives of each chapter. 39 
Table 2.1: Search terms for the systematic review. 58 
Table 2.2: Characteristics of studies using smartphone interventions with COPD patients. 63 
Table 2.3: Summary of the methodology in studies using smartphone interventions with COPD patients.
 64 
Table 2.4: Assessment of potential bias of studies selected for inclusion using USPSTF Quality Rating 
Criteria. 67 
Table 3.1 Participant demographics. 87 
Table 3.2: Themes with specific examples regarding the facilitators of mHealth adoption. 88 
Table 3.3: Themes with specific examples regarding the barriers of mHealth adoption. 95 
Table 4.1: Participant demographics and health information.  124 
Table 4.2: mHealth technology ownership. 128 
Table 4.3: Logistic regression predicting the likelihood of smartphone ownership. 130 
Table 4.4: mHealth technology use. 132 
Table 4.5: Joint display about barriers to mHealth adoption. 140 
Table 5.1: Participant demographics. 165 
Table 5.2: Themes with specific examples regarding the features of the patient's interface.  166 
9 
 
Table 5.3: Themes with specific examples regarding the features of the Healthcare professional's 
interface. 186 
Table 6.1 Usability constructs and descriptions. 214 
Table 6.2: Relevant dimensions of the mixed methods research integration. 216 
Table 6.3: Matching of the construct’s quantitative variables and qualitative questions in a joint display 
depicting mixed methods of data collection. 223 
Table 6.4: A joint display adapted from Kron et al’s MPathic-VR mixed methods trial comparing a 
virtual human simulation and a computer-based communications module that illustrates medical 
students’ attitudes and experiences in both trial arms. 233  
10 
 
List of Figures 
 
Figure 1.1: Incidence rates of diagnosed COPD among Canadians aged 35 years and older, by age group 
and sex, Canada, 2011–2012. 17 
Figure 1.2: Map of Newfoundland and Labrador. 25 
Figure 1.3: Human-centered design activity phases. 28 
Figure 1.4: Human-centered design activity phases and the associated thesis chapters. 40 
Figure 2.1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of 
search results and study selection. COPD: chronic obstructive pulmonary disease. 60 
Figure 2.2: Effects of smartphone interventions on the number of patients having a COPD exacerbation. 
 66 
Figure 6.1: Human-centered design activity phases. 211 
Figure 6.2: Evolution in an iterative convergent mixed methods design from qualitatively driven to 
quantitatively driven. 221 
Figure 6.3: The iterative convergent mixed methods research design. 238 
  
11 
 
List of Abbreviations 
Apps: Applications 
CCHS: Canadian Community Health Survey 
CG: Control Group 
CIHI: Canadian Institute for Health Information 
COPD: Chronic Obstructive Pulmonary Disease  
GOLD: Global Initiative for Chronic Lung Disease  
HCD: Human-Centered Design  
HCP: Health Care Provider 
IG: Intervention Group  
ISO: International Organization for Standardization 
JMIR: Journal of Medical Internet Research  
mHealth: Mobile Health 
MMR: Mixed Methods Research 
N/R: Not Reported 
NL: Newfoundland and Labrador  
NRCT: Nonrandomized Controlled Trial 
PHAC: Public Health Agency of Canada  
PI: Primary Investigator  
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
RCT: Randomized Controlled Trial 
SD: Standard Deviation 
SOB: Shortness of Breath  
SUS: System Usability Scale 
12 
 
UCD: User-Centered Design  
USPSTF: US Preventive Services Task Force  
WHO: World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
13 
 
List of Appendices 
 
Appendix 1- HCP Interview prompts 
Appendix 2 - Patient questionnaire  
Appendix 3 - Patient Interview prompts 
 
 
 
 
 
 
 
 
 
14 
 
Chapter	1:	Introduction	
1.1 Overview 
This dissertation aims to investigate how to apply the human-centered design (HCD) 
process when developing an mobile health (mHealth) intervention for Chronic Obstructive 
Pulmonary Disease (COPD) management. It will investigate various topics including the current 
state of COPD management using mHealth, the perceptions of patients with COPD and their 
healthcare providers regarding the use of mHealth in COPD management, and the perceived 
features of an mHealth intervention that could aid in managing COPD. Lastly, we provide a 
novel mixed methods framework on how to test the usability of an mHealth intervention.   
This chapter presents the background of my Ph.D. program of research. It provides an 
overview of the focus and design: COPD, mHealth, HCD, and Mixed Methods Research 
(MMR). The knowledge gap and research questions will be discussed. The last section outlines 
the structure of the thesis.   
1.1.1 Chronic Obstructive Pulmonary Disease  
1.1.1.1 Definition and Etiology 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines COPD as 
follows: 
a common preventable and treatable disease that is characterized by persistent respiratory 
symptoms and airflow limitation that is due to airway and/or alveolar abnormalities 
caused by significant exposure to noxious particles or gases (GOLD, 2019, p. 4). 
 
COPD encompasses a spectrum of diseases, including chronic bronchitis and 
emphysema, with most individuals having some characteristics of both (Kim & Criner, 2013). 
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Chronic bronchitis affects the epithelium of the central airways (Hogg, 2004). It is diagnosed by 
a persistent cough that produces sputum and mucus for at least three months in two consecutive 
years (GOLD, 2019). In chronic bronchitis, airway obstruction occurs because inflammatory 
cells drive the exaggerated mucus production, which causes the airways to narrow (Kim & 
Criner, 2013). The narrowing of airways keeps air from reaching the alveoli and prevents the 
lungs from emptying fully (O’Donnell et al., 2008). Mucus hypersecretion develops as a 
consequence of several factors, including cigarette smoke exposure, viral infection, and bacterial 
infection (Kim & Criner, 2013). Emphysema is characterized by the destruction of the gas-
exchanging surfaces of the lung (alveoli) (GOLD, 2019). This reduces the total surface area 
available for gas exchange, which leads to poor oxygenation of the blood (Phal & Sharma, 
2019).   
Various risk factors have led to the increased prevalence of COPD. The primary cause is 
tobacco smoke, including second-hand or passive exposure. Another risk factor is exposure to air 
pollution, such as in the use of biomass fuels. Occupational exposure to dust causes shortness of 
breath (SOB), thus avoiding dust may reduce COPD exacerbations (GOLD, 2019). Also, genetic 
factors may play a role in increasing the risk of COPD. This includes the deficiency of alpha-1-
antitrypsin, an anti-protease that protects the lung tissue from damage and predisposes patients to 
COPD (GOLD, 2019).  
1.1.1.2 Prevalence and Incidence Rates 
Worldwide:  The prevalence and mortality rates of COPD are increasing worldwide. 
Therefore, COPD continues to be a relevant public health problem. The COPD prevalence rate is 
rising due to the increasing prevalence of smoking in developing countries and the ageing 
population in high-income countries (GOLD, 2019). In 2008, the World Health Organization 
16 
 
(WHO) predicted that COPD will become the third leading cause of death by 2030 globally. 
COPD affected approximately 329 million people (4.8% of the global population) in 2010, 
which is much higher than the earlier figure of 64 million in 2004 (Vos et al., 2012).  
Canada: Although COPD is a preventable and treatable condition, it is the fourth leading 
cause of death in Canada (Statistics Canada, 2011). In 2008, approximately 4.6% of the 
Canadian population (aged 35 and over) reported that they had been diagnosed with COPD 
(Statistics Canada, 2011). This rate almost doubled to 8.3% in 2017 (Statistics Canada, 2019). 
Direct measurements of lung function from the Canadian Health Measures Survey ([CHMS], 
2013) indicated that 13% of Canadians had a lung function score indicative of COPD, which is 
three times higher than the reported rate (Statistics Canada, 2013). This disparity between 
reported and measured COPD in the CHMS suggests the underdiagnosis of the disease in Canada 
(Evans et al., 2014). The incidence rates of COPD in Canada for 2011–2012 increased steadily 
for both males and females across the lifespan (Figure 1.1). Overall, the incidence rates ranged 
from 317.7 per 100,000 people in the 35–39 age group, to 2309.6 per 100,000 people in the 85 
and older age group (Public Health Agency of Canada [PHAC], 2018). Among men, COPD rates 
increased steadily from age 35 and remained high; on the other hand, women’s COPD rates 
increased from age 35 but it was lower than men at age 65 and above. 
The current study was conducted in Newfoundland and Labrador (NL). In 2013, the NL 
population aged 35 and over who reported being diagnosed with chronic bronchitis, emphysema, 
or COPD by a health professional was 4.9% (Statistics Canada, CCHS, 2013).   
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Figure 1.1: Incidence rates of diagnosed COPD among Canadians aged 35 years and older, by 
age group and sex, Canada, 2011–2012. 
Estimates of the prevalence and incidence of COPD are dependent upon the definition 
and diagnostic guidelines of COPD. For example, some studies rely on pre-bronchodilator 
spirometry for diagnosing COPD; alternatively, other studies recommend post-bronchodilator 
spirometry, which implies that the best possible lung function of an individual should be used to 
classify the disease (Evans et al., 2014). This variability limits the comparability of the 
prevalence and incidence between studies. 
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1.1.1.4 Prognosis 
An acute exacerbation of COPD is defined as an acute worsening of respiratory 
symptoms that results in additional therapy (GOLD, 2019). It has detrimental effects on lung 
function, health-related quality of life (HRQL), and exercise capacity (Suh, Mandal, & Hart, 
2013). Exacerbations cause an increase in hospitalizations, relapses, and hospital readmissions 
(Matkovic et al., 2012). Although COPD exacerbations are responsible for the majority of the 
morbidity and mortality of COPD, little is understood about their cause, prevention and 
treatment (Criner et al., 2015; Miravitlles et al., 2013). COPD exacerbations negatively impact 
health status, rates of hospitalizations, and disease progression (GOLD, 2019).  
COPD is associated with multiple comorbidities, including ischemic heart disease, 
osteoporosis, glaucoma, malnutrition, anemia, peripheral muscle dysfunction, cancer, metabolic 
syndrome, and mental disorders (O’Donnell, 2008). Patients have a greater morbidity and 
mortality when COPD is present as a comorbid condition compared to when its absent (GOLD, 
2019).  
Smoking is directly responsible for approximately 80% of deaths from COPD (US 
Department of Health and Human Services, 2014). Quitting smoking has been associated with 
improved lung function, reduced chronic cough and airway mucus production, and decreased 
mortality from COPD (PHAC, 2012). All-cause mortality rates were higher among Canadians 
living with COPD than those without COPD across all age groups; the rate ratios ranged from 
4.7 in the 35–39 age group to 1.7 in the 85 and older age group (Statistics Canada, 2018). By 
2030, there may be over 4.5 million deaths annually from COPD-related conditions (Lopez et al., 
2006; WHO, 2019). In China, which has one-third of the world’s smokers, the current 
predictions of the annual COPD mortality rate will be over 2 million by 2033 (Lin et al., 2008).  
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1.1.1.4 Economic burden 
COPD imposes a significant economic burden on healthcare systems. The Conference 
Board of Canada stated that the combined direct and indirect costs of COPD would increase 
from just under $4 billion in 2010 to about 9.5 billion by 2030, an increase of 140 percent 
(Thériault, et al., 2012). In 2010, the three major chronic lung diseases: asthma, COPD, and lung 
cancer, are costing Canada’s economy $12 billion with the annual economic burden predicted to 
double by 2030 if strategies to manage the respiratory disease are not developed (The 
Conference Board of Canada, 2012).  
In 2011, Statistics Canada conducted a “Survey on Living with Chronic Diseases in 
Canada” (SLCDC). The survey included a nationally representative sample of 1,133 Canadians 
aged 35 years and older who reported being diagnosed with COPD by a health professional. 
They stated that COPD is devastating in nature and negatively impacts an individual’s quality of 
life. Among Canadians with COPD, 45% reported their overall health as “fair or poor” (PHAC, 
2012). COPD affected their activities of daily living and occupational status by reducing the 
number of hours worked or changing the type of work. As COPD progresses, it limits the quality 
of life and activity levels due to SOB. According to the Canadian Institute for Health Information 
[(CIHI), 2008], COPD now accounts for the highest rate of hospital admissions among major 
chronic illnesses in Canada. In addition, it has a much higher readmission rate than other chronic 
illnesses (CIHI, 2008).  
Respiratory diseases pose a significant economic burden to the Canadian healthcare 
system due to both direct and indirect costs. Currently, almost 6.5% of total healthcare costs are 
related to respiratory diseases (not including lung cancer) (PHAC, 2007). The direct costs are a 
result of outpatient and inpatient care expenses; alternatively, the indirect costs arise due to the 
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loss of productivity. Mittman et al. stated that hospital admissions for COPD lung exacerbations 
averaged a 10-day length of stay at a cost of $10,000 per stay (Mittman et al., 2008). They 
estimated the total cost of COPD hospitalization in Canada to be $1.5 billion a year (Mittman et 
al., 2008). Dynamic modeling has shown that any intervention that can reduce the number of 
exacerbations in a population will have a substantial impact on the morbidity and costs of COPD 
(Najafzadeh et al., 2012; Theriault et al., 2012). 
1.1.1.5 Diagnosis  
Unfortunately, about 60–85% of patients with COPD, especially in its mild to moderate 
stages, remain undiagnosed (Decramer et al., 2012). GOLD (2019) stated that a clinical 
diagnosis of COPD should be considered in any patient who has SOB, chronic cough or sputum 
production, a family history of COPD, and a history of exposure to risk factors of the disease, 
such as tobacco smoke, smoke from home cooking and heating fuels, and occupational dusts and 
chemicals (GOLD, 2019). Spirometry is the primary diagnostic tool for COPD. Forced 
expiratory volume in one second (FEV1) is the volume exhaled during the first second of a 
forced expiratory maneuver started from the level of total lung capacity. Forced vital capacity 
(FVC) is the amount of air that can be forcibly exhaled from the lungs after taking the deepest 
breath possible. The presence of a post-bronchodilator FEV1/ FVC < 0.70 confirms the presence 
of persistent airflow limitation (GOLD, 2019). Elbehairy, Webb, Neder, & O’Donnell (2013) 
recommend screening by spirometry in smokers at risk. Other strategies that may be considered 
as part of the diagnosis and assessment of COPD include chest radiographs, lung volumes and 
diffusing capacity, oximetry and arterial blood gas analysis, alpha-1 antitrypsin deficiency 
screening, exercise testing, and composite scores (GOLD, 2019). 
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The degree of airflow limitation is classified based on post-bronchodilator FEV1. Patients 
with COPD are classified into four grades: GOLD 1 has a mild airflow obstruction with FEV₁ ≥ 
80% of predicted; GOLD 2 has a moderate airflow obstruction with FEV₁ 50–80% of predicted; 
GOLD 3 has a severe airflow obstruction with FEV₁ 30–50% of predicted; and GOLD 4 has a 
very severe airflow obstruction with FEV₁ < 30% of predicted. This definition provides an 
objective method for classifying the severity of airflow limitation in COPD. Due to the weak 
correlation between FEV1, symptoms, and a patient’s health, a formal symptomatic assessment 
is required to classify the severity of the airflow (GOLD, 2019; Han et al., 2013; Jones et al., 
2009). These symptomatic assessments include the modified British Medical Research Council 
(mMRC) Questionnaire, the COPD Assessment Test (CAD), and a history of moderate or severe 
exacerbations and hospitalizations (GOLD, 2019).    
1.1.1.6 Treatment and Management 
Effective COPD management can delay disease progression and reduce acute 
exacerbations, thereby improving the quality of life and reducing healthcare costs (Nguyen et al., 
2009). Both pharmacological and non-pharmacological management strategies are crucial in 
COPD management. Non-pharmacological strategies improve health status and quality of life 
and reduce healthcare utilization by preventing the frequency and severity of COPD 
exacerbations (Suh, Mandal, & Hart, 2013). Various non-pharmacological interventions can be 
used to enhance COPD management. Smoking cessation is the most important factor that 
influences the natural history of COPD (GOLD, 2019). Pulmonary rehabilitation improves 
shortness of breath, health status, and exercise tolerance (GOLD, 2019). In addition, physical 
activity is beneficial for patients with COPD, and patients should repeatedly be encouraged to 
remain active (GOLD, 2019). The synergistic effects of multiple COPD interventions, such as 
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pulmonary rehabilitation, oxygen supplementation, and physical activity can enhance COPD 
management.  
Pharmacologic therapy is used to reduce symptoms, reduce the frequency and severity of 
exacerbations, and improve health status and exercise tolerance (GOLD, 2019). Although there 
are effective and inexpensive treatments for COPD, adherence rates are amongst the lowest of all 
chronic diseases, leading to avoidable adverse medical outcomes, costs, and reduced quality of 
life. Nonadherence in COPD is documented in the uptake of all therapies, including oxygen 
supplementation, physical rehabilitation, and medications; it contributes to rising rates of 
hospitalizations, deaths, and healthcare costs (Bender, 2016). Despite the fact that 24 million 
Americans have COPD, it has received considerably less attention in the adherence literature 
than asthma, diabetes, cardiovascular disease, and other chronic health conditions (Bender, 
2016). Advances in technology have the potential to enhance both pharmacological and non-
pharmacological interventions for COPD management.  
1.1.2 Mobile Health (mHealth) 
1.1.2.1 Definition and context  
Decades ago, it would have cost tens of millions of dollars and required instruments that 
filled an entire room to produce the computational power of a smartphone (Markoff, 2011). This 
surge in computing power and mobile connectivity has led to the emergence of mHealth, which 
can transform the mode and quality of clinical research and healthcare (Steinhubl et al., 2015). 
mHealth is defined by the World Health Organization as the use of mobile wireless technologies 
for health (WHO, 2019). It also involves the use of the mobile phone’s complex functionalities, 
including global positioning system (GPS) and Bluetooth technology. By using these 
technologies, smartphones can pair with medical devices, such as blood pressure monitors and 
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pulse oximeters, to acquire and process health-related data. mHealth strategies hold great 
promise for enhancing treatment outcomes while mitigating healthcare costs (Hayes 2014; 
Vashist et al, 2016; WHO, 2019).  
Researchers are now proposing mHealth applications for many health conditions such as 
dementia, autism, dysarthria, and Parkinson's disease (Zapata et al., 2015). Hayes et al. (2014) 
stated that mHealth could reduce physician visits, resource consumption, and emergency room 
visits. It is also suggested that smartphones can deliver effective interventions among various age 
groups and diseases (Joe et al., 2013; Juen et al., 2015; Zhang et al., 2013). mHealth offers an 
economy of scale by providing potential solutions for many problems and many types of 
patients. Moreover, researchers and clinicians will be able to obtain data from patients in real 
time. This information has the potential to enable enhanced healthcare delivery, improve quality 
of life, and reduce the burden on the healthcare system (Mutebi & Devroey, 2018). 
1.1.2.2 Access and Use of mHealth 
Before implementing mHealth solutions, it is important to understand the use of and 
access to mHealth. Duplaga et al. (2013) recruited 200 patients suffering from asthma and other 
chronic respiratory conditions to assess the acceptance of the use of mHealth applications. 
Participants responded to a questionnaire using a 5-point Likert scale. It was concluded that 
patients suffering from chronic respiratory conditions demonstrate higher levels of acceptance of 
mHealth applications such as appointment booking, prescription renewal, and access to 
information (laboratory test results, educational resources) than obtaining similar information via 
the traditional system of directly interacting with the medical system (communication with 
HCPs, disease monitoring) (Duplaga, 2013). This acceptance was associated with internet users, 
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young age, high levels of education, and suffering from a disease for fewer than five years or 
suffering from a disease for 16 years or more (Duplaga, 2013). 
Ramirez et al. (2016) found different results. They conducted a study to assess mobile 
phone and app usage among a culturally diverse patient population (244 participants), and to 
determine whether patients would be interested in using mHealth technology to manage their 
chronic diseases. The authors found that 91% percent of patients owned a mobile phone, with 
76% of mobile phone owners reporting having a mobile phone with Internet capability. They 
also stated that although the majority of their primary care patients were of lower socioeconomic 
status, they used mobile phones with Internet and mobile app capabilities to a great extent. 
To gain insight into the level of knowledge and experiences with mHealth of people with 
chronic lung diseases, Hofstede et al. (2014) completed a telephone survey of 400 people. The 
authors stated that although most asthma and COPD patients know of one or more mHealth 
applications, the actual use of these applications remains low (Hofstede et al., 2014). They 
recommended future studies to investigate patients’ perceptions of facilitators and barriers to 
mHealth use in chronic lung diseases.   
1.1.2.3	mHealth	in	Newfoundland	and	Labrador	
mHealth interventions are particularly suitable in geographic locations with a relatively 
large proportion of rural residents, such as Newfoundland and Labrador (NL). Of the Atlantic 
Provinces, NL has the highest proportion of its population (60%) living in rural areas (Figure 
1.2) (Simms & Greenwood, 2015). NL has unique challenges for effective and efficient 
healthcare delivery. It has been suggested that among patients with COPD, living in rural areas is 
associated with worse health status (Jackson et al., 2013; Abrams et al., 2013). Further, the 
authors suggest that the higher prevalence of COPD in rural areas could be linked to an increased 
proportion of older residents, shortage of healthcare providers (HCPs), underutilization of 
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spirometry and pulmonary rehabilitation, and problems with access to medical care (Jackson et 
al., 2013; Abrams et al., 2013). However, Deitenbeck et al. (2018) promoted mHealth as being 
able to support equitable access to healthcare for rural residents (Deitenbeck et al., 2018). With 
its substantial remote and rural population, as well as a high proportion of commuters, NL may 
benefit from a model that increases patient outcomes using technology in the absence of 
convenient and regular access to healthcare.    
 
Figure 1.2: Map of Newfoundland and Labrador. 
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1.1.2.4 mHealth for COPD management  
 The current literature suggests the potential for smartphone integration in the 
management of COPD (Alwashmi et al., 2016; Noah et al., 2018), allowing mHealth to play a 
significant role in the management of modifiable risk factors. The application of a multifactorial 
mHealth intervention (e.g., COPD information, dose reminders, audio-visual material, 
motivational aspects, and training in inhalation techniques) resulted in an improvement in 
therapeutic adherence in patients with COPD (Leiva-Fernandez et al., 2014). Studies reported 
that pulmonary rehabilitation (Burkow et al., 2015) and physical activity interventions can be 
delivered remotely (Nguyen et al., 2009). Wang et al. (2014), stated that a mobile-phone-based 
system could provide an efficient home endurance exercise training program with improved 
exercise capacity, strengthened limb muscles, and a decrease in systemic inflammation in 
patients with COPD. Johnston et al. (2013) indicated that the smartphone-based collection of 
COPD symptom diaries allowed patients to identify exacerbation symptoms early on in the 
exacerbation, allowing for the opportunity for early intervention. And, Bender (2016) stated that 
COPD adherence may benefit from communication and advice delivered through mobile 
technology, along with a larger program of education, monitoring, and support.  Telepharmacy, 
the delivery of pharmaceutical care via telecommunications to patients, can also be applied to 
educate patients suffering from COPD on how to improve medication use and adherence to 
treatment (Margolis et al., 2013). 
Medical devices, such as spirometers and pulse oximeters, can obtain objective data that 
cannot be collected by smartphones alone. Recent advancements in technology allow for 
seamless integration between smartphones and medical devices. Various studies have paired 
medical devices with smartphone technology to assist in COPD management and detect 
exacerbations, such as electronic vests, heart rate monitors, pulse oximeters, and accelerometers 
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(Barberan-Garcia et al.., 2014; Beattie et al., 2014; Kelly et al., 2015; Kocsis et al., 2015; 
Nabhani-Gebara et al., 2014; Spina et al., 2015; Taylor et al., 2015; Tabak et al., 2014). 
However, these studies were focused on the technical effectiveness of these methods with limited 
involvement of patients during the design of these interventions. In addition, the studies gave 
limited attention to patient perceptions, usability, and satisfaction. 
1.1.3 Human-Centered Design (HCD) of mHealth 
1.1.3.1 Definition and context   
The International Organization for Standardization (ISO) 9241-210 standard defines 
HCD as “an approach to systems design and development that aims to make interactive systems 
more usable by focusing on the use of the system and applying human factors/ergonomics and 
usability knowledge and techniques” (ISO, 2010). The ISO uses the term HCD instead of user-
centered design (UCD) to “address impacts on a number of stakeholders, not just those typically 
considered as users” (ISO, 2010). However, in practice, these terms are often used 
synonymously.   
HCD has four defined activity phases: (1) identify the user and specify the context of use, 
(2) specify the user requirements, (3) produce design solutions to meet user requirements, and (4) 
evaluate design solutions against requirements. The process model of HCD as defined in ISO 
9241-210 is illustrated in Figure 1.3. 
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Figure 1.3: Human-centered design activity phases (ISO, 2010). 
 
Understanding and specifying the context of mHealth along with specifying the user 
requirements can be accomplished by involving the users at the preliminary stages of 
development. Both quantitative and qualitative data are vital to understanding the user’s needs 
and goals. Quantitative data can be used to assess the demographics, access, and use of mHealth, 
while qualitative data can be used to understand the patient’s perceptions regarding mHealth. 
After the first iteration of the mHealth intervention is produced, usability testing can be 
employed to evaluate the designs against requirements.   
1.1.3.2 Importance of patient perspectives   
Researchers advocate developing an mHealth intervention with patients to meet their 
needs and facilitate successful uptake. When developing an mHealth intervention, Hopkins et al. 
(2016) encourage including insights from key users to potentially improve the process and the 
outcome of the intervention. And, testing mHealth interventions with patients revealed 
preferences and concerns unique to the tested population (Gray et al., 2016; Nelson et al., 2016; 
Sarkar et al., 2016). Triantafyllidis et al. (2015) stated that the limited uptake of mHealth 
adoption for remote monitoring is related to usage difficulties and low levels of patient 
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satisfaction. They recommend focusing on the patient to assure the sustainable delivery of 
remote health monitoring services for heart failure. Developing a COPD mHealth intervention 
with insights from individuals with COPD will potentially improve the process and outcome of 
the mHealth intervention.  
1.1.3.3 Importance of healthcare provider perspectives   
Including patients and their healthcare providers (HCPs) is a fundamental step in the 
development of human-centered mHealth interventions (Korpershoek et al., 2018; Simpson et 
al., 2017). It ensures that the interface requirements of both users — patients and HCPs — are 
considered during mHealth development. Further, Bender (2014) suggests a collaborative care 
approach within teams composed of physicians, nurses, pharmacists, and patient advocates to 
lead to better care and higher patient adherence for complex and comorbid conditions. Also, 
other researchers recommend the involvement of a multidisciplinary team in mHealth 
interventions to develop tailored messages (Heffernan et al., 2016), address patient medication 
needs (DiDonato et al., 2015), enhance physical activity in patients with COPD (Vorrink et al, 
2016), and to manage heart failure (Triantafyllidis et al., 2015), diabetes (Jo & Park, 2016), and 
cancer (Smith et al., 2015). 
1.1.3.4 Importance of usability testing   
The ISO defines usability as the extent to which a product can be used by specified users 
to achieve specified goals with effectiveness, efficiency, and satisfaction in a specified context of 
use (ISO, 2018). Although this definition was published in 1998, it was updated in 2018 without 
any changes to the core concepts. The definition is broad and generalizable (Bevan et al., 2015; 
Goldberg et al., 2011).  
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mHealth involves the interaction between multiple user groups through a system, making 
the usability aspect of such systems crucial for the continuous, efficient, and satisfactory use of 
the application. Although patients have expressed interest in using technologies for self-
management, current tools are not easy to use (Horton 2008; Sarkar et al., 2016). Difficulty in 
using an mHealth intervention may limit the user retention rate. A high dropout rate is one of the 
most significant barriers to mHealth adoption (Dorsey et al., 2017; Mayberry et al., 2017). The 
majority of mHealth app publishers (83%) have fewer than 10,000 users who have used their app 
at least once a month (Research2guidance, 2018). These numbers are discouraging, as according 
to a 2018 estimate, the average mHealth app costs $425,000 to develop (Research2guidance, 
2018). By putting a more significant emphasis on usability, iterative improvements can reduce 
costs and enhance the long-term use and adoption of mHealth interventions (Ribeiro et al., 2016; 
Smith et al., 2016; Usability, n.d.a). 
Researchers recommend frequent and iterative usability testing to respond to users’ 
preferences and technical issues (Hattink et al., 2016; Nelson et al., 2016; Triantafyllidis et al., 
2015). It is also important to ensure that errors in understanding or using the intervention are 
addressed before testing the intervention in an efficacy trial (Lyles et al., 2014). A systematic 
review investigated the usability evaluation processes described in 22 studies related to mHealth 
applications (Zapata et al., 2015). The results stress the importance of adapting health 
applications to users’ needs (Zapata et al., 2015). Including insights from key users of mHealth 
has the potential to improve the process and the outcome of the intervention (Hopkins et al., 
2016). 
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1.1.4 Mixed Methods Research (MMR) 
1.1.4.1 Definition and context  
MMR is gaining popularity and acceptance as a research methodology across disciplines 
around the world (Curry & Nunez-Smith, 2015). It draws from multiple scientific traditions and 
disciplinary backgrounds. MMR is defined as “the type of research in which a researcher or team 
of researchers combines elements of qualitative and quantitative research approaches for the 
broad purposes of breadth and depth of understanding and corroboration” (Johnson, 
Onwuegbuzie, 2007, p.123). MMR combines two different perspectives: one drawn from closed-
ended response data (quantitative) and one drawn from open-ended personal data (qualitative) 
(Creswell, 2015).  
Although quantitative research has historically been the primary approach in health 
sciences research, many contemporary phenomena in health and healthcare are difficult, if not 
impossible, to measure using quantitative methods alone (Curry & Nunez-Smith, 2015). The 
goal of qualitative research is to produce a deep understanding of a phenomenon. It can also be 
used to generate a hypothesis regarding a phenomenon, its precursors, and its consequences 
(Curry et al., 2009). When the study phenomenon of interest is multifaceted and complex, a 
mixed methods approach is appropriate (Curry & Nunez-Smith, 2015). The National Institutes of 
Health best practices guideline and mixed methods researchers advise distinguishing the 
quantitative purpose, the qualitative research questions, and the mixed methods questions 
(Creswell et al., 2011). Consequently, MMR can capitalize on the strengths of both methods — 
the depth of qualitative and breadth of quantitative research. The resulting mixed data can be 
integrated to balance the strengths and limitations of either method to provide a more 
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comprehensive understanding under potentially complementary sources of evidence (Curry & 
Nunez-Smith, 2015). 
Understanding the principles and practices of integration is essential for leveraging the 
strengths of MMR. Fetters and Molina-Azorin (2017) defined integration as the linking of 
qualitative and quantitative approaches and dimensions to create a new whole or a more holistic 
understanding than can be achieved by either alone. Fetters et al. examined vital integration 
principles and practices in MMR (Fetters, Curry & Creswell, 2013). They provide approaches to 
integrating both research procedures and data in the design, methods, interpretation, and 
reporting dimensions of research. Table 1.1 provides the relevant dimensions of MMR 
integration and illustrates how researchers can integrate those dimensions. Additional 
information about MMR dimensions is provided elsewhere (Fetters & Molina-Azorin, 2017). 
Through increasingly sophisticated approaches, MMR is viewed as an opportunity to address the 
highly complex and compelling research problems facing researchers in the health and social 
sciences (Mertens, 2015). Investigation of novel mHealth technologies is an important example 
of a highly complex research challenge that can benefit from a systematic mixed methods 
approach. 
Table 1.1 Relevant dimensions of the mixed methods research integration, adapted from Fetters 
& Molina-Azorin, 2017. 
Integration 
dimensions 
Mixed methods researchers integrate by: 
Rationale 
dimension 
Citing a rationale for conducting an integrated mixed methods research 
study (e.g., offsetting strengths and weaknesses, comparing, 
complementing or expanding, developing or building, and promoting 
social justice). 
Study purpose, 
aims, and 
research 
questions 
Composing an overarching mixed methods research purpose and stating 
qualitative, quantitative, and mixed methods aims or multiple mixed 
methods aims with quantitative aims and qualitative questions. 
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dimension  
Research design 
dimension 
Scaffolding the work in core (e.g., convergent, exploratory sequential, and 
explanatory sequential), advanced (e.g., intervention, case study, 
evaluation, and participatory), or emergent designs. 
Sampling 
dimension 
Sampling through the type, through the relationship of the sources of the 
qualitative and quantitative data (e.g., identical sample, nested sample, 
separate samples, and multilevel samples), and through the timing (e.g., 
same or different periods for collection of the qualitative and quantitative 
data). 
Data collection 
dimension 
Collecting both types of data with an intent relative to the mixed methods 
research procedures (e.g., comparing, matching, diffracting, expanding, 
constructing a case, connecting, building, generating and validating a 
model, or embedding). 
Data analysis 
dimension 
Analyzing both types of data using intramethod analytics (e.g., analyzing 
each type of data within the respective qualitative and quantitative methods 
and core integration analytics), using one or more core mixed methods 
analysis approaches (e.g., by following a thread, spiraling, and back-and-
forth exchanges), or employing advanced mixed methods analysis (e.g., 
qualitative to quantitative data transformation, quantitative to qualitative 
data transformation, creating joint displays, social network analysis, 
qualitative comparative analysis, repertory grid/other scale development 
techniques, geographic information systems mapping techniques, and 
iterative and longitudinal queries of the data). 
Interpretation 
dimension 
Interpreting the meaning of mixed findings (e.g., where there are related 
data and drawing metainferences or conclusions based on interpreting the 
qualitative and quantitative findings) and examining for the fit of the two 
types of data (e.g., confirmation, complementarity, expansion, or 
discordance). When the results conflict with each other, using procedures 
for handling the latter including reconciliation, initiation, bracketing, and 
exclusion. 
1.1.4.2 Importance of Mixed Methods Research in Human-Centered Design  
Human-centered design is a complex phenomenon. It is challenging to investigate 
comprehensively using only quantitative methods or qualitative methods in isolation, so-called 
monomethod approaches (Carayon et al., 2015). The alternative to using a monomethod 
approach is using diverse methods to generate a complete picture and reveal hidden patterns and 
novel relationships between variables and concepts (Curry & Nunez-Smith, 2015). To identify 
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and resolve design and usability issues, various researchers emphasize the importance of using 
multiple methods and sources of data (Nelson et al., 2016; Nitsch et al., 2016).  
One application of MMR in HCD is the explanatory sequential design (Creswell, 2015). 
The intent of the explanatory sequential design is to begin with a quantitative strand and then 
conduct a second qualitative strand to explain the quantitative results (Creswell, 2015). An 
explanatory design is typically chosen when the team anticipates the quantitative measures will 
not be sufficient to address the research question. It may also be used when quantitative 
information is required to develop the sample for the qualitative phase (Curry & Nunez-Smith, 
2015). Obtaining information from a diverse group may generate a more complete picture, reveal 
patterns that would otherwise go unnoticed, and may also cover novel relationships between 
variables and concepts (Curry & Nunez-Smith, 2015).  
Despite the recognized and intuitive value of using mixed methods for mHealth usability 
testing, mixed methodologists have yet to articulate specific designs that guide the development 
and testing of mHealth interventions. Although many studies collect both quantitative and 
qualitative data to test usability (Alnasser et al., 2018; Beatty et al., 2018; and Sage et al., 2017), 
mHealth researchers could benefit from advances being made for integration in mixed methods 
studies (Fetters, Curry & Creswell, 2013; Creswell & Clark, 2017). A core MMR study design 
that is attractive for usability testing is the convergent design (Creswell & Clark, 2017). This is 
also called by some authors a concurrent parallel study (Tashakkori, Teddlie, & Teddlie, 1998) 
or, historically, a concurrent triangulation design (Creswell et al., 2003). The convergent mixed 
methods design features the collection and analysis of both types of data and then the merging of 
the data for the final interpretation (Creswell, 2015).  
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1.2 Knowledge gap and research questions 
1.2.1 Knowledge gap in the effectiveness of mHealth in COPD management  
Little is understood about the effectiveness of mHealth in COPD management. Initially, I 
was going to create an mHealth intervention and test it to understand the effectiveness of 
mHealth in COPD management. But before developing the mHealth intervention, I started with a 
systematic review and meta-analysis of existing mHealth interventions for COPD management 
(Chapter 2). The effectiveness of mHealth interventions has receiving increased scholarly 
attention in recent years; however, the vast majority of this research is focused on the 
effectiveness of specific mHealth interventions. A thorough review of the literature is necessary 
to understand the gaps and challenges in the current use of mHealth in COPD management. It 
will inform the design of future smartphone apps that aim to limit COPD exacerbations. 
Instead of developing an mHealth intervention and pilot testing it, which is similar to 
existing studies, I decided to explore the barriers and facilitators of adopting mHealth for COPD 
management. In addition, I wanted to understand the requirements of an mHealth intervention 
for COPD management by taking into account the needs and requirements of patients with 
COPD as well as similar or different thoughts of their HCPs 
 
1.2.2 Knowledge gap in understanding the perceptions of users of mHealth in 
COPD management  
The findings of the systematic review shifted my focus from developing and testing an 
mHealth intervention to understanding the process of developing an mHealth intervention. 
Studies paid limited attention to patient perceptions, usability, and satisfaction. Therefore, gaps 
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may exist in terms of development and usability testing for mHealth interventions for COPD 
management.  
At the time of the study initiation, I could not find any study that assessed the perceptions 
of individuals with COPD and their HCPs regarding the use of mHealth for COPD management. 
Patient and HCP perspectives towards using mHealth for COPD management are relatively 
unexplored (Dennison at el. 2013; Korpershoek et al., 2018). Korpershoek et al., however, did 
provide some insight into the perceptions of patients with COPD and their HCPs towards using 
mHealth for COPD management, such as the importance of personalizing the mHealth 
intervention and making it usable. They also recommended including a larger sample of HCPs 
with more mHealth experience in future studies (Korpershoek et al., 2018). A recent meta-
analysis on the remote monitoring of patients with COPD concluded that some interventions may 
prove to be promising in changing clinical outcomes in the future, but there are still large gaps in 
the evidence base (Noah et al., 2018). Noah et al. (2018) suggest that adding a qualitative 
component would give researchers insight into which elements best engage and motivate patients 
and HCPs. 
For my study, with the intent to improve the success of mHealth interventions in COPD 
management, I included patients with COPD and their HCPs to better understand the role of 
mHealth in COPD management. I used international guidelines, such as ISO, and MMR design 
to better understand why a particular mHealth component might be successful and how patients 
use mHealth interventions in the long term. Lessons learned will bridge the knowledge gap of 
barriers and facilitators for mHealth uptake in COPD management. The study will also highlight 
the important features of mHealth that have the potential to meet the needs of patients with 
COPD and their HCPs.  
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1.2.3 Knowledge gap in a Mixed Methods Research framework suitable for 
usability testing of mHealth  
Despite the recognized and intuitive value of using mixed methods for mHealth usability 
testing, mixed methods researchers have yet to articulate specific designs that guide the 
development and testing of mHealth interventions. Although many studies collect both 
quantitative and qualitative data to test usability (Alnasser et al., 2018; Beatty et al., 2018; and 
Sage et al., 2017), mHealth researchers could benefit from advances being made for integration 
in mixed methods studies (Creswell & Clark, 2017; Fetters, Curry & Creswell, 2013). A 
systematic review of published MMR health services studies found that only one-third of articles 
provided justifications for an MMR design (Wisdom et al., 2012). In chapter 6, I provide a novel 
MMR framework suitable for usability testing of mHealth interventions.   
1.2.4 Research questions   
There are several areas in which this research adds to the current state of knowledge. The 
overarching question of this thesis is: 
● How to apply the human-centered design process when developing an mHealth 
intervention for COPD management? 
A combination of quantitative, qualitative, and mixed methods research approaches was used to 
answer the following research questions:  
● Based on the existing literature, what is the association between mHealth interventions 
and the management of COPD exacerbations? (chapter 2) 
● What are the potential facilitators and barriers that might influence healthcare providers 
of patients with COPD regarding the use of mHealth in COPD management? (chapter 3) 
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● What are the potential facilitators and barriers that might influence patients with COPD 
regarding the use of mHealth in COPD management?  (chapter 4) 
● What are the demographics of patients with COPD, and how do they use and access 
smartphones? (chapter 4) 
● How can an mHealth intervention for COPD management be developed that takes into 
account the needs and requirements of patients with COPD and their HCPs? (chapter 5) 
● What is the most suitable MMR framework for generating unique insights into the 
usability of mHealth? (chapter 6)  
This research, while focused on individuals with COPD, adds to the current 
understanding of how mHealth can be used to manage chronic diseases in general. The outcome 
of this thesis is expected to provide insight into how patient and HCP involvement in design and 
evaluation can practicably be performed and inform the development of mHealth interventions 
that are effective, efficient, easy to use, and provide a high level of user satisfaction.   
1.3 Thesis organization  
 This thesis is organized in a manuscript format, including five journal articles as chapters. 
Each chapter of the thesis text was prepared as a “stand alone” document describing the 
published work or work prepared for publication. All components were integrated 
into a logical progression from chapter to chapter, forming a unified and consistent report 
of the research undertaking. Due to the inherent nature of the manuscript-based dissertation style, 
there is some unavoidable repetition in some of the literature review and methods sections. Table 
1.2 shows the journal papers completed during the research and also demonstrates the objectives 
of each chapter.  
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Table 1.2: Journal articles and objectives of each chapter 
Papers as chapters Objectives 
Chapter 2: The Effect of Smartphone 
Interventions on Patients with Chronic 
Obstructive Pulmonary Disease 
Exacerbations: A Systematic Review and 
Meta-Analysis 
To summarize and quantify the association 
between mHealth interventions and 
management of COPD exacerbations through 
a comprehensive systematic review and meta-
analysis. 
Chapter 3: Perceptions of Healthcare 
Providers Regarding a Mobile Health 
Intervention to Manage Chronic Obstructive 
Pulmonary Disease: a Qualitative Study 
To explore the potential facilitators and 
barriers among HCPs regarding the use of 
mHealth interventions for COPD 
management. 
Chapter 4: Perceptions of patients with COPD 
regarding a Mobile Health intervention to 
manage COPD: a Mixed Methods Study 
To describe the demographics, use, and access 
to smartphones.  
To explore and develop an understanding of 
potential facilitators and barriers that might 
influence patients with COPD using mHealth 
interventions for COPD management. 
Chapter 5: Features of a Mobile Health 
Intervention to Manage Chronic Obstructive 
Pulmonary Disease: a Qualitative Study 
To explore the potential features that can be 
included in an mHealth intervention for 
COPD management. 
Chapter 6: The Iterative Convergent Design 
for Mobile Health Usability Testing: Mixed 
Methods Approach 
To provide a novel framework for generating 
unique insights into multifaceted phenomena 
impacting mHealth usability.  
 
To answer these questions, this research follows the ISO HCD activity phases that were 
discussed in section 1.1.2.1 (illustrated in Figure 1.4). Chapter 2 provides a systematic review of 
the literature. This review is necessary to understand the gaps and challenges in the current use 
of smartphones in COPD management. Chapters 3 and 4 explore the perceptions of patients with 
COPD and their HCPs regarding the use of mHealth for COPD management. These perceptions 
include the facilitators and barriers of using an mHealth intervention for COPD management. 
After interviewing HCPs (chapter 3), the findings informed the development of the interview 
prompts for patients (chapter 4). Chapter 5 includes potential features that can be included in an 
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mHealth intervention for COPD management. It elaborates on features required by patients and 
their HCPs. Both HCPs and patients stressed the importance of usability to improve the uptake of 
mHealth interventions. As a result, chapter 6 provides a novel mixed methods framework that 
can be used to enhance the usability of potential mHealth interventions. The proposed framework 
is demonstrated using different case studies.    
 
 
Figure 1.4: Human-centered design activity phases and the associated thesis chapters. 
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Chapter 2: The Effect of Smartphone Interventions on Patients with Chronic 
Obstructive Pulmonary Disease Exacerbations: A Systematic Review and 
Meta-Analysis. 
Preface 
A version of this chapter has been published in the Journal of Medical Internet Research 
(JMIR) - mHealth and uHealth: Alwashmi, M., Hawboldt, J., Davis, E., Marra, C., Gamble, J. 
M., & Ashour, W. A. (2016). The effect of smartphone interventions on patients with chronic 
obstructive pulmonary disease exacerbations: a systematic review and meta-analysis. JMIR 
mHealth and uHealth, 4(3), e105. This publication has been cited by several authors and 
organizations, including the World Health Organization and the European Respiratory Society. 
As the primary author, I reviewed the literature and analyzed the data. I completed the first 
version of the manuscript and further revised according to the suggestions of co-authors and 
reviewers. Dr. Hawboldt and Dr. Davis helped to identify the research topic and scope. Dr. Carlo 
Marra and Dr. John-Michael Gamble reviewed the manuscript and provided revision 
suggestions. Dr. Waseem AbuAshour helped to screen the articles and extract data for analysis.  
Abstract 
Background: The prevalence and mortality rates of chronic obstructive pulmonary disease 
(COPD) are increasing worldwide. Therefore, COPD remains a major public health problem. 
There is a growing interest in the use of smartphone technology for health promotion and disease 
management interventions. However, the effectiveness of smartphones in reducing the number of 
patients having a COPD exacerbation is poorly understood. 
Objective: To summarize and quantify the association between smartphone interventions and 
COPD exacerbations through a comprehensive systematic review and meta-analysis. 
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Methods: A comprehensive search strategy was conducted across relevant databases (PubMed, 
Embase, Cochrane, CINHA, PsycINFO, and the Cochrane Library Medline) from inception to 
October 2015. We included studies that assessed the use of smartphone interventions in the 
reduction of COPD exacerbations compared with usual care. Full-text studies were excluded if 
the investigators did not use a smartphone device or did not report on COPD exacerbations. 
Observational studies, abstracts, and reviews were also excluded. Two reviewers extracted the 
data and conducted a risk of bias assessment using the US Preventive Services Task Force 
quality rating criteria. A random effects model was used to meta-analyze the results from 
included studies. Pooled odds ratios were used to measure the effectiveness of smartphone 
interventions on COPD exacerbations. Heterogeneity was measured using the I2 statistic. 
Results: Of the 245 unique citations screened, 6 studies were included in the qualitative 
synthesis. Studies were relatively small with less than 100 participants in each study (range 30 to 
99) and follow-up ranged from 4-9 months. The mean age was 70.5 years (SD 5.6) and 74% 
(281/380) were male. The studies varied in terms of country, type of smartphone intervention, 
frequency of data collection from the participants, and the feedback strategy. Three studies were 
included in the meta-analysis. The overall assessment of potential bias of the studies that were 
included in the meta-analysis was “Good” for one study and “Fair” for 2 studies. The pooled 
random effects odds ratio of patients having an exacerbation was 0.20 in patients using a 
smartphone intervention (95% CI 0.07-0.62), a reduction of 80% for smartphone interventions 
compared with usual care. However, there was moderate heterogeneity across the included 
studies (I2=59%). 
Conclusion: Although current literature on the role of smartphones in reducing COPD 
exacerbations is limited, findings from our review suggest that smartphones are useful in 
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reducing the number of patients having a COPD exacerbation. Nevertheless, using smartphones 
require synergistic strategies to achieve the desired outcome. These results should be interpreted 
with caution due to the heterogeneity among the studies. Researchers should focus on conducting 
rigorous studies with adequately powered sample sizes to determine the validity and clinical 
utility of smartphone interventions in the management of COPD. 
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2.1 Introduction  
Chronic obstructive pulmonary disease (COPD) refers to a group of lung diseases that 
includes chronic bronchitis and emphysema. Often, the occurrence of COPD is associated with 
smoking (GOLD, 2015). The Global initiative for chronic Obstructive Lung Disease (GOLD) 
defines COPD as follows: 
Chronic obstructive pulmonary disease (COPD), a common preventable and treatable 
disease, is characterized by persistent airflow limitation that is usually progressive and 
associated with an enhanced chronic inflammatory response in the airways and the lung 
to noxious particles or gases. Exacerbations and comorbidities contribute to the overall 
severity in individual patients (GOLD, 2015). 
The prevalence and mortality rates of COPD are increasing worldwide. Therefore, COPD 
remains a major public health problem. One of the major effects of COPD is a reduced physical 
activity level in the affected patients (Watz et al., 2009). Although COPD is a preventable and 
treatable condition, it is the fourth leading cause of death in Canada (Statistics Canada, 2016). 
GOLD defines a COPD exacerbation as an acute event characterized by a worsening of 
the patient’s respiratory symptoms that is beyond normal day-to-day variations and leads to a 
change in medication (GOLD, 2015). An acute exacerbation of COPD has detrimental effects on 
lung function, health-related quality of life, and exercise capacity (Suh et al., 2013). According 
to the Canadian Institute for Health Information, COPD now accounts for the highest rate of 
hospital admission and readmission among major chronic illnesses in Canada (Canadian Institute 
for Health Information, 2008). The Conference Board of Canada has stated that the combined 
direct and indirect costs of COPD will increase from just under $4 billion in 2010 to roughly 
$9.5 billion by 2030, an increase of 140% (Najafzadeh et al., 2012). Dynamic modeling has 
shown that any intervention that can reduce the number of exacerbations in a population will 
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have a substantial impact on morbidity and costs of COPD (Najafzadeh et al., 2012, Theriault et 
al., 2012).  
Current advances in smartphones have allowed for opportunities to provide effective 
health promotion and disease management interventions. Several published studies indicate that 
smartphones can deliver effective interventions among various age groups and diseases (Joe & 
Demiris, 2013; Juen et al., 2015; Zhang et al., 2013; Thakkar et al., 2016). Moreover, 
interventions delivered via a smartphone may empower patients to play a more active role in 
managing their health (Juen et al., 2015).  
Recent improvements in smartphones suggest a potential for integration into COPD 
management. Effective COPD management could delay disease progression, reduce acute 
exacerbations, and improve quality of life (Spina et al., 2013). Wang et al stated that a mobile 
phone–based system could provide an efficient home endurance exercise training program to 
improve exercise capacity, strengthen limb muscles and decrease systemic inflammation in 
COPD patients (Wang et al., 2014). Another study indicated that smartphone-based collection of 
COPD symptom diaries allows patients to identify exacerbation symptoms at an early stage 
allowing for the opportunity for early intervention (Wang et al., 2014; Johnston et al., 2013).  
A thorough review of the literature is necessary to understand the gaps and challenges in 
the current use of smartphones in COPD management. It will inform the design of future 
smartphone apps that aim to limit COPD exacerbations. Therefore, we conducted a systematic 
review and meta-analysis to answer the following question: 
In patients diagnosed with COPD, will using smartphone interventions, compared 
with not using smartphone interventions, reduce the number of patients that have at 
least one exacerbation? 
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2.2 Methods  
2.2.1 Eligibility Criteria 
We included randomized controlled trials and quasi-randomized studies that used 
smartphone interventions in patients with COPD. A smartphone was defined as a mobile phone 
that performs many of the functions of a computer, typically having a touchscreen interface, 
Internet access, and an operating system capable of running downloaded applications. Some 
smartphone interventions can also include the use of medical devices that transfer data to the 
smartphone or a Web-based platform for monitoring and analysis. Studies define COPD 
exacerbations differently due to the lack of a universally accepted objective definition of a 
COPD exacerbation. Some investigators define COPD based on drug use, reported symptoms, or 
emergency admission. As a result, we based our definition of exacerbation according to the 
GOLD criteria: 
COPD exacerbation is an acute event characterized by a worsening of the patient’s 
respiratory symptoms that is beyond normal day-to-day variations and leads to a change 
in medication (GOLD, 2015). 
Studies that included additional medical conditions as well as COPD were retained if the 
outcomes specific to the COPD group were reported separately. All English and non-English 
language studies identified during the search were considered. Non-English language studies 
included an English abstract. The abstract was sufficient to apply the eligibility criteria. 
Observational studies, abstracts, and reviews were excluded. Studies without a control group 
were also excluded. Smartphones are carried everywhere, have constant Internet connections, 
and are used as communication devices. Therefore, studies that used only a tablet or Web-based 
intervention and not specifically a smartphone intervention were excluded. 
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2.2.2 Search Strategy  
A comprehensive literature search was conducted in consultation with a librarian with 
experience in conducting systematic reviews. The literature search was run from the inception of 
each database until October 14, 2015 using the methods recommended by the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 
2009). Five electronic databases: PubMed, Embase, Cochrane, CINHA, PsycINFO, and the 
Cochrane Library were searched for published article that studied the effect of smartphone 
interventions on COPD exacerbations. The references of all included studies were examined for 
relevant articles. The researchers used key search terms to identify potential studies (see Table 
2.1). 
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Table 2.1: Search terms for the systematic review. 
Search 
lines 
Search terms 
Line 1 ((((((((("obstructive lung disease"[Title/Abstract]) OR copd[Title/Abstract]) OR 
coad[Title/Abstract]) OR "chronic obstructive pulmonary disease"[Title/Abstract]) OR "chronic 
obstructive lung disease"[Title/Abstract]) OR "chronic obstructive airway* disease"[Title/Abstract])) 
OR ((((("Lung Diseases, Obstructive"[Mesh]) OR "Pulmonary Disease, Chronic 
Obstructive"[Mesh]) OR "COPD, Severe Early-Onset"[Supplementary Concept]) OR "Pulmonary 
Emphysema"[Mesh]) OR "Bronchitis, Chronic"[Mesh]))) 
2. AND ((((((((((((((((((((((((((((("mobile phone"[Title/Abstract]) OR "smart phone"[Title/Abstract]) OR 
smartphone[Title/Abstract]) OR "cell phone"[Title/Abstract]) OR "personal digital 
assistant"[Title/Abstract]) OR PDA[Title/Abstract]) OR microcomputer[Title/Abstract]) OR 
blackberry[Title/Abstract]) OR nokia[Title/Abstract]) OR samsung[Title/Abstract]) OR "i 
phone"[Title/Abstract]) OR iPhone[Title/Abstract]) OR symbian[Title/Abstract]) OR 
windows[Title/Abstract]) OR INQ[Title/Abstract]) OR iPad[Title/Abstract]) OR "i 
pad"[Title/Abstract]) OR ipod[Title/Abstract]) OR "i pod"[Title/Abstract]) OR 
mhealth[Title/Abstract]) OR "mobile health"[Title/Abstract]) OR "m health"[Title/Abstract]) OR "m-
health"[Title/Abstract]) OR app[Title/Abstract]) OR HTC[Title/Abstract]) OR 
samsung[Title/Abstract]) OR apps[Title/Abstract])) OR (((("Cell Phones"[Mesh]) OR "Computers, 
Handheld"[Mesh]) OR "Text Messaging"[Mesh]) OR "Telemedicine"[Mesh])))) 
3. AND (("Disease Progression"[Mesh]) OR exacerbation[Title/Abstract]) 
2.2.3 Study Screening 
Two authors (MA and WA) screened titles and abstracts for each unique citation. The 
screening process included removing duplicates and excluding studies that were not related to 
COPD or telemonitoring. The remaining full-text studies were then assessed for eligibility. Full-
text studies were excluded if the investigators did not use a smartphone device or did not report 
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on COPD exacerbations. The reviewers also included studies that reported the rate of COPD 
exacerbations in the intervention group but were not able to report the rate in the control group. 
The remaining studies were assessed for potential bias according to the US Preventive 
Services Task Force (USPSTF) quality rating criteria (Chou et al., 2010). Review of bias 
assessments were completed independently by 2 reviewers (MA and WA). Any disagreements 
arising between the reviewers were resolved by discussion until a consensus was achieved. 
2.2.4 Data Extraction and Synthesis 
Data were extracted regarding the study design, study procedure, intervention, population 
demographics, and number of patients having an exacerbation. Two reviewers (MA and WA) 
extracted data independently. Data from 3 studies were pooled using Review Manager version 
5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen). A random effects 
model was used to pool results from the included studies and calculate a summary odds ratio to 
measure the independent effect of smartphone interventions on COPD exacerbations. We tested 
for variance across studies using the chi-square test and measured the degree of heterogeneity 
using the I2 statistic. 
2.3 Results  
2.3.1 Overview 
The study selection process is outlined in Figure 2.1. The search process yielded 245 
records, providing 201 citations after duplicates were removed. Of these, 6 studies met the 
eligibility criteria (Nguyen et al., 2008; Liu et al., 2008; Halpin et al., 2011; Pedone et al., 2013; 
Jehn et al., 2013; Tabak et al., 2014).  
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Figure 2.1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram 
of search results and study selection. COPD: chronic obstructive pulmonary disease. 
2.3.2 Qualitative Analysis 
Six studies were included in the qualitative analysis. Table 2.2 provides characteristics of 
the 6 included research studies (Nguyen et al., 2008; Liu et al., 2008; Halpin et al., 2011; Pedone 
et al., 2013; Jehn et al., 2013; Tabak et al., 2014). All the articles were published after 2008. All 
of the studies were conducted on relatively small samples, less than 100 participants each. Some 
research studies specified the COPD severity stage according to the GOLD guidelines (Liu et al., 
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2008; Pedone et al., 2013; Jehn et al., 2013), whereas other studies included patients in all COPD 
stages (Nguyen et al., 2008; Halpin et al., 2011; Tabak et al., 2014). Furthermore, patients were 
required to be free from COPD exacerbations for either at least 3 weeks (Pedone et al., 2013) or 
one month (Nguyen et al., 2008; Halpin et al., 2011; Jehn et al., 2013; Tabak et al., 2014) to be 
included in the research studies. Studies included older participants; the mean age was 70.5 years 
(SD of 5.6). All studies had a large percentage of male participants (mean 74%). 
Table 2.3 provides characteristics of the methodology used in the research studies 
(Nguyen et al., 2008; Liu et al., 2008; Halpin et al., 2011; Pedone et al., 2013; Jehn et al., 2013; 
Tabak et al., 2014). The studies were conducted in various countries around the world. Five of 
the six included studies were randomized controlled trials (Nguyen et al., 2008; Liu et al., 2008; 
Halpin et al., 2011; Pedone et al., 2013; Jehn et al., 2013; Tabak et al., 2014), and one study used 
a quasi- experimental design (Liu et al., 2008). Postintervention follow-up assessment for the 
included studies ranged between 4 months and 9 months. The smartphone in each study was 
primarily used to collect data about the daily symptoms of the patient. As a complement to the 
smartphone intervention, education about self-management and exercise training (Nguyen et al., 
2008; Liu et al., 2008; Tabak et al., 2014) was also used in some studies. Participants used the 
smart phone to report physical activity level (Tabak et al., 2014), daily symptoms (Nguyen et al., 
2008; Liu et al., 2008; Halpin et al., 2011; Pedone et al., 2013; Jehn et al., 2013; Tabak et al., 
2014), and heart rate and oxygen saturation (Pedone et al., 2013). One study provided a Web 
portal to enable patients to treat exacerbations themselves (Tabak et al., 2014). All studies 
compared a smartphone intervention versus usual care as the control group, except one study. 
Tabak et al. provided both the intervention and control groups with a smartphone, but only the 
intervention group received automated phone calls to remind the participants about the treatment 
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regimen and to ensure that they had sufficient medications (Tabak et al., 2014). All studies 
provided participants with a smartphone but did not report other incentives to participate in the 
study. 
The frequency of collecting data from participants was different within each study. 
Symptoms and objective measurements such as spirometry and pulse oximetry were collected on 
a daily basis. Alternatively, physical activity data were collected weekly. The investigators 
assessed collected data on a daily basis. When an exacerbation was detected, patients were 
contacted to confirm the exacerbation. One study used an automated feedback mechanism that 
advised to start medication in case of an exacerbation (Jehn et al., 2013).  
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Table 2.2: Characteristics of studies using smartphone interventions with COPD patients. 
First 
author, 
(year) 
COPDa 
stage 
FEV1b, mean (SD), 
% predicted 
Participant age 
(years), mean 
(SD), 
Male 
sex, % 
Sample 
size 
(analyzed) 
No. of 
patients 
having an 
exacerbation 
IGc CGd IG CG IG CG IG CG IG CG 
Tabak, 
(2014) 
All 
stages 
48.7 
(16.7) 
56.4 
(10.6) 
65.2 
(9.0) 
67.9 
(5.7) 
57% 68% 15 
(10) 
15 
(2) 
33 N/Re 
Pedone, 
(2013) 
II or III 
  
52.5 
(14.9) 
55.4 
(15.8) 
74.1 
(6.4) 
75.4 
(6.7) 
72% 63% 50 
(39) 
49 
(49) 
9 15 
  
Jehn, 
(2013) 
II-IV 50.2 (15) 52.6 
(17.5) 
64.1 
(10.9) 
69.1 
(9.2) 
81% 73% 32 
(32) 
30 
(30) 
7 22 
Halpin, 
(2011) 
 
All 
stages 
48 
(4) 
54 
(3) 
68.5 
(1.5) 
70.2 
(1.6) 
74% 73% 40 
(39) 
39 
(38) 
23 26 
Nguyen, 
(2008) 
All 
stages 
49.0 
(16.8) 
50.3 
(17.6) 
68.0 
(8.3) 
70.9 
(8.6) 
61% 55% 26 
(20) 
24 
(19) 
10 N/R 
Liu, 
(2008) 
II or III 
  
45.2(3.2) 46 
(2.8) 
71.4 
(1.7) 
72.8 
(1.3) 
100% 100% 30 
(24) 
30 
(24) 
2 10 
aCOPD: Chronic Obstructive Pulmonary Disease. 
bFEV1: Forced Expiratory Volume in one second. 
cIG: Intervention Group. 
dCG: Control Group. 
eN/R: not reported. 
 
64 
 
Table 2.3: Summary of the methodology in studies using smartphone interventions with COPD 
patients. 
First 
author, 
(year) 
Design 
(Follow-up) 
Country 
Intervention (Frequency) Control 
Tabak, 
(2014) 
 
RCTa 
(9 months) 
Netherlands 
Short respiratory symptoms questionnaires, exercise 
program and self-management recommendations on the 
Web portal (Daily); 
Activity coach via an accelerometer and a smartphone 
(4days/week). 
Usual care 
Pedone, 
(2013) 
 
RCT 
(9 months) 
Italy 
Heart rate, physical activity, near-body temperature, and 
galvanic skin response via wristband coupled with a 
smartphone (Every 3 hours); 
Oxygen saturation levels via a portable pulse oximeter 
(Every 3 hours). 
A physician contacted participants to provide feedback in 
case of abnormal readings (Daily). 
Usual care 
Jehn, 
(2013) 
 
RCT 
(9 months) 
Germany 
COPD Assessment Test on the smartphone (Daily); 
Lung Function Tests via a portable spirometer (Daily). 
Six-minute walk test measured by accelerometer 
(Weekly). 
A study nurse contacted the participant to remind them 
about entering data (Daily). 
Usual care 
Halpin, 
(2011) 
 
RCT 
(4 months) 
United 
Kingdom 
The Exacerbations of Chronic Pulmonary Disease Tool 
(EXACT) questionnaire on the smartphone (Daily); 
Automated phone calls to remind patients about the 
treatment regimen and ensure they have sufficient 
medication (Weekly). 
EXACT questionnaire 
on the smartphone 
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Nguyen, 
(2008) 
 
RCT 
(6 months) 
United States 
Exercise training program via smartphone (Daily); 
Short respiratory symptoms questionnaires on the 
smartphone (Daily). 
A study nurse contacted the participant to remind them 
about entering data and provide feedback (Daily). 
Usual care 
 
Liu, 
(2008) 
 
NRCTb 
(9 months) 
Taiwan 
Home-based endurance exercise training program via 
smartphone (Daily); 
Short respiratory symptoms questionnaires on the 
smartphone (Daily). 
Usual care 
aRCT: Randomized Controlled Trial. 
bNRCT: Nonrandomized Controlled Trial. 
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2.3.3 Quantitative Analysis 
Three studies were included in the meta- analysis (Liu et al., 2008; Pedone et al., 2013; 
Jehn et al., 2013). Two studies were excluded because they did not report the number of patients 
having an exacerbation in the control group (Nguyen et al., 2008; Tabak et al., 2014), and 
another study provided a smartphone intervention to both the intervention and control groups 
(Nguyen et al., 2008). The follow-up period for all 3 studies was 9 months. All 3 studies reported 
that participants receiving smartphone interventions experienced a reduction in COPD 
exacerbations (Liu et al., 2008; Pedone et al., 2013; Jehn et al., 2013). Two studies used 
intention-to-treat analysis (Pedone et al., 2013; Jehn et al., 2013) and one study used per-protocol 
analysis (Pedone et al., 2013). The pooled odds ratio of patients having an exacerbation was 0.20 
in the patients using a smartphone intervention (95% CI 0.07-0.62) compared with those 
receiving usual care. The meta-analysis of COPD exacerbations indicates a reduction of 80% for 
smartphone interventions compared with usual care. There was moderate heterogeneity across 
the studies that were included in the meta-analysis (χ2=4.9, P=.08, I2=59%) (Tabak et al., 2014). 
The results are outlined in Figure 2.2. 
 
Figure 2.2: Effects of smartphone interventions on the number of patients having a COPD 
exacerbation.COPD: Chronic Obstructive Pulmonary Disease. 
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2.3.4 Risk of Bias 
A summary of the assessment of potential bias of studies selected for inclusion, using 
USPSTF Quality Rating Criteria, can be found in Table 2.4 The overall assessment of the studies 
that were included in the meta-analysis was Good (Jehn et al., 2013) and Fair (Liu et al., 2008; 
Pedone et al., 2013). It was not possible to assess for publication bias via funnel plot asymmetry 
due to the low number of studies included in the meta-analysis (Higgins & Green, 2011).  
Table 2.4: Assessment of potential bias of studies selected for inclusion using USPSTF Quality 
Rating Criteria (Chou & Dana, 2016).  
Study Assembly of 
comparable 
groups 
Maintenance 
of 
comparable 
groups 
No 
important 
differential 
loss to 
follow-up or 
overall high 
loss to 
follow-up 
Measurements: 
equal, reliable, 
valid (includes 
masking of 
outcome 
assessment) 
Clear 
definition of 
interventions 
All-
important 
outcome 
considered 
Analysis: 
adjustment 
for potential 
confounders 
Overall 
assessed 
quality 
Nguyen 
(2008) 
Good Fair Good Fair Good Good Poor Fair 
Halpin 
(2011) 
Good Good Fair Fair Poor Fair Fair Fair 
Pedone 
(2013) 
Fair Good Good Fair Good Fair Good Fair 
Liu 
(2008) 
Fair Good Fair Fair Good Good Fair Fair 
Jehn et 
(2013) 
Fair Good Good Fair Good Good Good Good 
Tabak 
(2014) 
Poor Fair Poor Fair Good Good Fair Poor 
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2.4 Discussion  
2.4.1 Principal Results 
The existing literature indicated that there is a potential for smartphone interventions in 
reducing the frequency of COPD exacerbations. Although most COPD patients were older than 
65 years, they were able to use smartphones to monitor their symptoms. Rates of COPD 
exacerbations among participants receiving a smartphone intervention during the trials proved to 
be less compared with the participants not receiving a smartphone intervention. The main 
objective for using a smartphone is early identification of COPD exacerbations. Early 
identification allows the patient and health care team to intervene successfully, thus improving 
the management of COPD and reducing COPD exacerbations. As stated previously, Najafzadeh 
et al. indicate that any intervention that reduces the number of exacerbations has a substantial 
impact on morbidity and costs of COPD (Najafzadeh et al., 2012).  
Our finding that smartphones could be useful in reducing COPD exacerbations replicates 
the findings of 3 cohort studies. Jarad and Sund (2011) coupled a smartphone with a portable 
spirometer and indicated that it reduced the number of hospitalizations for COPD exacerbations. 
Johnston et al (2013) showed that smartphone-based collection of COPD symptom diaries allows 
patients to identify exacerbation symptoms early on in the exacerbation allowing for early 
intervention. Furthermore, Ding et al conducted a cohort study of a mobile phone–based home 
monitoring system and demonstrated the potential of smartphones in early identification of 
COPD exacerbations (2014). Thakkar et al (2016) conducted a systematic review and stated that 
mobile phone text messaging approximately doubles the odds of medication adherence in 
patients with chronic diseases. Smartphones can incorporate text-messaging interventions in 
addition to various interventions that include, but are not limited to, surveys, reminders, and the 
ability to be paired with medical devices. 
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2.4.2 Risk of Bias 
Although the included studies reported promising results, there was moderate 
heterogeneity (I2=59%) across studies that were included in the meta-analysis. Liu et al (2008) 
did not randomize patients to the intervention while the other 2 studies conducted randomized 
controlled trials (Pedone et al., 2013; Jehn et al., 2013). The studies also varied in location, 
COPD severity, smartphone intervention, frequency of data collection from the participants, and 
the feedback strategy. 
In some studies, the smartphone intervention was combined with different variations of 
symptoms diaries, physiological monitoring, and educational elements directed at patients. 
Patients used the smartphone to report daily symptoms (Liu et al., 2008; Jehn et al., 2013) or 
deliver a home-based exercise training program (Pedone et al., 2013). In addition, investigators 
coupled the smartphone with various medical devices to measure physical activity levels (Pedone 
et al., 2013; Jehn et al., 2013), heart rate and oxygen saturation (Pedone et al., 2013), and 
pulmonary function tests (Liu et al., 2008). Each intervention, patient education or use of 
medical devices, could itself account for the differences between groups. Additionally, one 
researcher (Pedone et al., 2013) had a physician to contact participants to provide feedback 
regarding abnormal readings. Therefore, researchers should be cautious when interpreting the 
synergistic effect from the combination of these interventions. 
The frequency of data collection from participants and feedback strategy also differed 
between the studies. Liu et al collected data from participants every day (Liu et al., 2008). The 
data was reviewed weekly and feedback was given to participants during their three-month 
follow up visits. Jehn et al collected data from participants every day and physicians reviewed 
the data daily; however, the feedback strategy to patients was unclear (Jehn et al., 2013). Pedone 
et al collected data more frequently than other studies due to the use of the wristband and 
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portable pulse oximeter (Pedone et al., 2013). Unusual data were flagged and physicians assessed 
the data on a daily basis. Then, physicians contacted the participants to assess for a COPD 
exacerbation and suggest an intervention. 
Only 2 studies reported on metrics related to user experience (Nguyen et al., 2008; Tabak 
et al., 2014). Nugyen et al conducted semistructured interviews with participants at the end of the 
study (Nguyen et al., 2008). Participants were asked to provide feedback on what aspects of the 
program were most or least helpful for managing their dyspnea and how the program could have 
been done differently to support self-management. On the other hand, Tabak et al used the Client 
Satisfaction Questionnaire to measure user satisfaction (Tabak et al., 2014). Unfortunately, we 
were unable to combine the usability results due to the differences in the methods used to 
measure user experience. 
The frequency of data collection from the participant was also dependent on the type of 
data being collected. Symptoms were collected daily while exercise progress was assessed 
weekly. Collecting data from participants frequently could yield more accurate data; 
nevertheless, it must not compromise the participant’s adherence to the intervention. There are 
many factors that could have caused the reduction in COPD exacerbation. Early detection of 
symptoms and timely treatment could be possible by the use of smartphones or due to phone 
contact by the research team. Currently, we are uncertain whether the reduction in the number of 
patients having an exacerbation is caused by the smartphone intervention or merely due to bias 
among the studies. Additional investigations are required before large-scale implementation of 
smartphone interventions. 
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2.4.3 Limitations 
Aside from the methodological heterogeneity among studies, there are several limitations 
with this systematic review. There are a limited number of studies using smartphones in the 
management of COPD exacerbations, each with relatively small samples, less than 100 
participants each. A comprehensive search strategy was used, but studies utilizing smartphones 
in the management of COPD exacerbations that are still in progress or provided only an abstract 
were excluded. All investigators provided a smartphone to participants. This could have caused 
highly motivated participants who are familiar with smartphones to contribute data. Another 
limitation is that studies did not clearly define exacerbations (recognized and unrecognized) and 
how to identify it (e.g., drug use, reported symptoms, and emergency admission). Tabak used a 
self-management Web portal to measure exacerbations, which could have yielded many false 
positive results. The review favored smartphone interventions across all studies, thus overall 
findings do indicate that smartphone interventions may reduce the number of patients having 
COPD exacerbations across a wide variety of contexts. 
2.4.4 Implications for Future Research 
Implementing a mixed methods research design to investigate the validity and clinical 
utility of smartphone interventions could help to understand why a particular component is 
successful and how patients will use smartphone interventions for a long-term. There is limited 
research regarding smartphone interventions among COPD patients. Although the studies in this 
review have a small sample size and a relatively short follow-up period, current literature 
supports the potential of smartphones in reducing COPD exacerbations. There is a need for more 
studies evaluating smartphone interventions, including studies using smartphones as the main 
intervention. This will assist in determining whether smartphones can be effective in the 
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management of COPD. Investigators should include participants with different stages of COPD 
severity and age spans to minimize the risk of bias and enhance the generalizability of the study 
results. 
2.5 Conclusion  
Although the current literature on the role of smartphones in reducing COPD 
exacerbations is limited, our results suggest that smartphone interventions may reduce COPD 
exacerbations. Nevertheless, using smartphones require synergistic strategies, such as providing 
feedback based on both subjective and objective data, to achieve the desired outcome. The 
results should be interpreted with caution due to the heterogeneity among the studies, risk of 
small study bias, and limitations in study quality. Researchers should focus on conducting 
rigorous randomized controlled trial (RCT) studies with adequately powered sample sizes to 
determine the validity and clinical utility of smartphone interventions in the management of 
COPD.  
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Chapter 3: Perceptions of Health Care Providers Regarding a Mobile Health 
Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative 
Study 
Preface 
A version of this chapter has been published in the Journal of Medical Internet Research 
(JMIR) - mHealth and uHealth: Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., 
Farrell, J., & Hawboldt, J. (2019). Perceptions of Health Care Providers Regarding a Mobile 
Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study. 
JMIR mHealth and uHealth, 7(6), e13950. I defined the specific research aim, developed the 
methods and completed the analysis of case study. I completed the first draft and revised it 
according to the suggestions of co-authors and reviewers. Dr. John Hawboldt and Dr. Davis 
suggested the general research topic and provided feedback on the manuscript. Dr. Beverly 
Fitpatrick helped revise the original manuscript to make the argument clearer. Dr. Jamie Farrell 
and Dr. John-Michael Gamble reviewed the manuscript and provided revision suggestions. Dr. 
Jamie Farrell also assisted in recruiting participants.  
Abstract 
Background: Using a mobile health (mHealth) intervention, consisting of a smartphone and 
compatible medical device, has the potential to enhance chronic obstructive pulmonary disease 
(COPD) treatment outcomes while mitigating health care costs. 
Objective: The aim of this study was to explore the potential facilitators and barriers among 
health care providers (HCPs) regarding the use of mHealth interventions for COPD management. 
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Methods: This was a qualitative study. Semistructured individual interviews were conducted 
with HCPs, including nurses, pharmacists, and physicians who work directly with patients with 
COPD. A flexible prompts guide was used to facilitate discussions. Interview topics included the 
following: demographics, mHealth usage, perceptions toward challenges of mHealth adoption, 
factors facilitating mHealth adoption, and preferences regarding features of the mHealth 
intervention for COPD management. Interviews were conversational in nature, and items were 
not asked verbatim or in the order presented. The interviews were transcribed verbatim and 
compared against the digital recordings to ensure the accuracy of the content. After creating a 
codebook for analysis, two researchers independently coded the interview data using pattern 
coding. They discussed commonalities and differences in coding until a consensus was reached. 
Results: A total of 30 nurses, physicians, and pharmacists participated. The main facilitators to 
mHealth adoption are possible health benefits for patients, ease of use, educating patients and 
their HCPs, credibility, and reducing cost to the health care system. Alternatively, the barriers to 
adoption are technical issues, privacy and confidentiality issues, lack of awareness, potential 
limited uptake from the elderly, potential limited connection between patients and HCPs, and 
finances. 
Conclusions: It is important to understand the perceptions of HCPs regarding the adoption of 
innovative mHealth interventions for COPD management. This study identifies some potential 
facilitators and barriers that may inform the successful development and implementation of 
mHealth interventions for COPD management.  
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3.1 Introduction  
3.1.1 Background 
The surge in computing power and mobile connectivity has led to the emergence of 
mobile health (mHealth) that can transform the mode and quality of clinical research and health 
care (Steinhubl et al., 2015). mHealth is defined by the National Institutes of Health as the use of 
mobile and wireless devices to improve health outcomes, health care services, and health 
research. An mHealth intervention could also include the use of a medical device that is 
compatible with a smartphone. Evidence suggests that mHealth interventions may benefit 
patients with many chronic health conditions including chronic obstructive pulmonary disease 
(COPD) (Alwashmi et al., 2016, Joe & Demiris, 2013, Juen et al., 2015; Zhang et al., 2013). 
Although COPD is a preventable and treatable condition, it is estimated to be the third 
leading cause of death worldwide by 2020 (Murray & Lopez, 1997). According to the Canadian 
Institute for Health Information, COPD now accounts for the highest rate of hospital admission 
and readmission among major chronic illnesses in Canada (Canadian Institute for Health 
Information, 2008). The Conference Board of Canada has stated that the combined direct and 
indirect costs of COPD will increase from just under CAD $4 billion in 2010 to roughly $9.5 
billion by 2030, an increase of 140% (Najafzadeh et al., 2012). Dynamic modeling has shown 
that any intervention that can reduce the number of exacerbations in a population will have a 
substantial impact on morbidity and costs associated with COPD (Najafzadeh et al., 2012; 
Theriault et al., 2012). The authors previously published a systematic review and noted that the 
current literature on the role of smartphones in reducing COPD exacerbations is limited but does 
suggest that smartphone interventions may reduce COPD exacerbations (Alwashmi et al., 2016).  
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3.1.2 Importance of Human-Centered Design 
The International Organization for Standardization (ISO) 9241-210 standard defines 
human-centered design (HCD) as “an approach to systems design and development that aims to 
make interactive systems more usable by focusing on the use of the system and applying human 
factors/ergonomics and usability knowledge and techniques” (ISO, 2010). The ISO uses the term 
HCD instead of user-centered design to “address impacts on a number of stakeholders, not just 
those typically considered as users” (ISO, 2010). However, in practice, these terms are often 
used synonymously. 
There is increasing interest from academics and clinicians in harnessing smartphone apps 
as a means of delivering behavioral interventions for health; however, research on the 
development and evaluation of such apps is in the relatively early stages (Dennison et al., 2013). 
Many of the barriers to using mHealth, such as high dropout rates and development costs, can be 
avoided with better planning and collaboration (Research2Guidance, 2018, Dorsey et al., 2017; 
WHO, 2017).  
Difficulty in using an mHealth intervention may limit the user retention rate. A high 
dropout rate is one of the most significant barriers to mHealth adoption (Mayberry et al., 2017; 
Dorsey et al., 2017). The majority of mHealth app publishers (83%) have less than 10,000 users 
who have used the app at least once a month (Research2Guidance, 2018). These numbers are 
discouraging as according to a 2018 estimate, the average mHealth app costs $425,000 to 
develop (Research2Guidance, 2018). By putting a more significant emphasis on usability, 
iterative improvements can reduce costs and enhance the long-term use and adoption of mHealth 
interventions (Usability.gov, n.d. a; Ribeiro et al., 2016; Smith et al., 2015).  
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Testing mHealth interventions with patients has revealed preferences and concerns 
unique to the tested population (Nelson et al., 2016; Sarkar et al., 2016; Gray et al., 2016). When 
developing an mHealth intervention, Hopkins et al. (2016) encourage including insights from 
key users to potentially improve the process and the outcome of the intervention. 
Triantafyllidis et al. (2015) used an iterative approach to refine a tablet computer–based 
home monitoring system for heart failure patients. There was limited uptake of the system owing 
to usage difficulties and low levels of patient satisfaction. The authors recommended patient-
centered approaches for sustainable delivery of remote health monitoring services 
(Triantafyllidis et al., 2015). Patient-centered care recognizes the complex, subjective, and 
changing nature of the patient’s health status (Upshur et al., 2008); in addition, it links multiple 
episodes of care offered by diverse providers into continuous, integrated care trajectories unique 
to particular patients (Boyd & Fortin, 2010; Miller et al., 2015). Developing a COPD mHealth 
intervention with insights from health care providers (HCPs) working with patients with COPD 
will potentially improve the process and outcome of the mHealth intervention. 
3.1.3 Involvement of Health Care Providers 
HCD is particularly suited to developing mHealth interventions, which generally involve 
multiple stakeholders. Bender suggests a collaborative care approach within teams comprising 
physicians, nurses, pharmacists, and patient advocates to lead to better care and higher patient 
adherence for complex and comorbid conditions (Bender, 2014). Also, other researchers 
recommend the involvement of a multidisciplinary team in mHealth interventions to develop 
tailored messages (Heffernan et al., 2016), address patient medication needs (DiDonato et al., 
2015), enhance physical activity in patients with COPD (Vorrink et al., 2016), and support the 
management of heart failure (Triantafyllidis et al., 2015), diabetes (Jo & Park, 2016), and cancer 
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(Smith et al., 2015). Chiang et al. (2015) stated that few studies have examined the obstacles 
faced by HCPs when carrying out telehealth interventions. Similar obstacles in mHealth need to 
be addressed. 
Nursing, medicine, and pharmacy are some of the largest health professions in Canada. 
Nurses promote COPD management by supportive, preventive, therapeutic, palliative, and 
rehabilitative means to gain or maintain optimal function (Ministry of Health and Long Term 
Care, 2018). Physicians assess the condition of COPD and diagnose, treat, and prevent any 
disease, disorder, or dysfunction whereas pharmacists play a role in the promotion of health, 
prevention, and treatment of COPD through monitoring and management of medication therapy 
(Ministry of Health and Long Term Care, 2018). Furthermore, the role of pharmacists has shifted 
from drug dispensing responsibilities to the provision of direct patient care (Hepler et al., 2002). 
By obtaining the perspectives of nurses, physicians, and pharmacists, we hope to understand the 
facilitators and barriers affecting some of the largest health professions in Canada. Furthermore, 
it will enable us to understand the differences in requirements for an mHealth intervention. 
3.1.4 Involvement of Health Care Providers Human-Centered Design in 
Chronic Obstructive Pulmonary Disease 
Although mHealth is gaining popularity in recent years, patient and HCP perspectives 
toward using mHealth for COPD management are relatively unexplored (Korpershoek et al., 
2018). One study provided insight into the perceptions of COPD patients and their HCPs toward 
using mHealth for COPD management. They stated that potential barriers to use mHealth include 
the following: patients avoiding confrontation with the disease, preference for personal contact 
with an HCP, difficulties with displaying feelings in an application leading to invalid patient 
measures and lack of trust in advising characteristics of an mHealth intervention, and lack of 
enthusiasm for mHealth by HCPs (Korpershoek et al., 2018). They also recommended including 
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a larger sample of HCPs with more mHealth experience in future studies to produce a more 
diverse range of HCP perspectives (Korpershoek et al., 2018). 
To improve the success of mHealth solutions in COPD management, we suggest 
including HCPs who work with patients with COPD in the development process. Lessons 
learned will bridge the knowledge gap of barriers and facilitators for mHealth uptake in COPD 
management. It will also be offered as a guide for research and technology developers working 
with COPD patients and their HCPs. 
3.2 Methods  
3.2.1 Purpose  
This study was intended to explore and develop an understanding of potential facilitators 
and barriers that might influence HCPs using mHealth interventions for COPD management. 
3.2.2 Study Design  
We used a descriptive qualitative research design that was grounded in pragmatism 
(Merriam & Tisdell, 2015; Patton, 2015). Using a qualitative methodology allowed us to achieve 
an in-depth, contextualized picture of how a diverse sample of HCPs, in this case nurses, 
pharmacists, and physicians, think and feel about the possibilities and challenges of using 
mHealth. This has a pragmatic value as mHealth is an emerging option for delivering health care. 
3.2.3 Recruitment and Study Setting 
HCPs involved in the treatment of patients with COPD were eligible to participate. The 
primary investigator (PI) contacted the Newfoundland and Labrador Medical Association, the 
Association of Registered Nurses of Newfoundland and Labrador, and the Pharmacists' 
Association of Newfoundland and Labrador. These organizations were asked to forward a 
recruitment email to their mailing lists or post it in their websites. Interested HCPs contacted the 
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PI via email or telephone, who then scheduled appointments to complete the consent forms and 
conduct the interviews. Our sample consisted of 30 HCPs: 10 nurses, 10 pharmacists, and 10 
physicians. The study took place in St. John’s, Canada. We conducted some interviews at 
Memorial University and others at the participants’ offices or homes. 
We used purposive typical case sampling to gather information that would reflect typical 
cases of mHealth use (Patton, 2015; Creswell, 2016). We also used a criterion-based selection 
(Patton, 2015) so that we could categorize participant characteristics such as age, familiarity with 
mHealth, health care profession, and years of experience. In addition, as the interviews 
progressed, some participants were recruited by snowball or chain sampling, where participants 
suggested other possible HCPs (Patton, 2015; Emerson, 2015). Snowball or chain sampling was 
used to ask a few information-rich participants for additional contacts to provide confirming or 
different perspectives, allowing for richer data (Patton, 2015). 
Participants were recruited from April 2018 to August 2018. We first contacted nurses, 
and after interviewing 8 nurses, we reached saturation as we were not gathering new information. 
However, we continued interviewing until 10 nurses were interviewed. This was to strengthen 
the validity of inferences (Maxwell, 2013). We used the same sampling strategy for the 
remaining professions, with similar saturation points and continuing to interview the 10 
participants for each profession. Our final sample size was comparable with similar qualitative 
studies (Korpershoek et al., 2018; Damhus et al., 2018; MacDonald et al., 2018).  
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3.2.4 Ethical Considerations  
Ethical approval for this study was obtained from the Newfoundland and Labrador Health 
Research Ethics Authority (HREB -2017-194). Before agreeing to participate, all subjects were 
informed about the nature of the research project, possible risks and benefits, and their rights as 
research subjects. All participants completed a written consent form. They were also given a 
copy of the consent form. 
3.2.5 Data Collection 
We conducted individual semistructured interviews to gain an understanding of the 
everyday life-worlds of HCPs in relation to using mHealth (Brinkman & Kvale, 2015). Using 
semistructured interviews allowed the interviewer to begin with a broad question to direct the 
focus of the interview and then to provide an opportunity for the HCPs to bring forth their 
thoughts and feelings about the phenomenon that they thought were important (Brinkman & 
Kvale, 2015; Rubin & Rubin, 2012). The interview prompts are available in Appendix 1. If 
participants identified that they have not used mHealth, they were asked questions pertaining to 
why they had not used mHealth (barriers). However, we did not ask them about facilitators 
because they did not have the experience to answer these questions. To facilitate discussions, the 
interviews were conversational in nature and items were not asked verbatim or in the order 
presented. As the study progressed, emerging issues were explored with subsequent participants 
to refine the themes. The prompts were informed by findings from the literature and input from 
the authors who have diverse backgrounds including mHealth, pharmacy, nursing, medicine, 
respirology, family medicine, education, and qualitative research. 
The interviews were recorded to enable transparent and accurate transcription. Interview 
lengths ranged from 20 to 60 min. Topics included the following: demographics, mHealth usage, 
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perceptions toward challenges of mHealth adoption, factors facilitating mHealth adoption, and 
preferences regarding features of the mHealth intervention for COPD management. Owing to the 
large amount of data, preferences regarding features of the mHealth intervention will be 
published in another article. Data consisted of more than 13 hours of interview time with 
approximately 300 pages of transcription. 
3.2.6 Data Analysis  
The interviews were transcribed verbatim and compared against the digital recordings to 
ensure the accuracy of the content. Identifying information (names) was removed to protect 
anonymity. We used NVivo (version 12; QSR International) to organize the data and examine 
the words, including frequency counts, as in classical content analysis (Leech & Onwuegbuzie, 
2008). All data were analyzed, but we only coded the data that were relevant for answering the 
research questions, as recommended by Saldana (2016), Wolcott (2009), and Yin (2016). An 
audit trail was created to keep track of all analytic decisions (Guest et al., 2012). 
After using NVivo, we used first cycle coding with the nurses’ data that were both 
structural and holistic (Saldana, 2016), meaning that we used the interview prompts and the 
literature to guide some of the coding. One researcher analyzed the transcripts and developed a 
set of themes and subthemes and then obtained input from a second researcher. In the second 
cycle of coding, the 2 researchers independently coded the nurses’ data using pattern coding to 
develop themes (Saldana, 2016). They then discussed commonalities and differences in their 
coding and theme development until a consensus was reached. The analysis of the nurses’ data 
was mainly inductive and iterative throughout as we went back and forth among the data, the 
coding, and the themes (Miles et al., 2014). 
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After the nursing analysis was finished, we completed the same 2 cycles of analysis for 
the pharmacist and physician data. These 2 analyses included inductive and deductive analysis. 
However, the analysis was more deductive in nature as themes had already been developed from 
the nursing data. The iterative process continued as these analyses were conducted to find 
commonalities, differences, and new patterns in thinking in relation to the nurses’ data. Once 
these 3 sets of analysis were complete, the 2 researchers discussed common and different trends 
among the 3 HCP groups to develop final themes that encompassed all the HCPs. 
3.3 Results  
3.3.1 Demographics  
The sample included HCPs who worked with patients with COPD in various settings, 
including respirology clinics, cancer clinics, critical care, long-term care, and community health. 
Some HCPs founded a medical technology company or had a software programming 
background. About half of the HCPs had experience with an mHealth intervention to manage 
COPD. Participant demographics are outlined in Table 3.1.  
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Table 3.1 Participant demographics. 
Demographics Sample size Age (years), mean 
(SD) 
Years of experience, 
mean (SD) 
Nurses 5 47.3 (6) 19.6 (9) 
mHealth nursesa 5 40.6 (10) 15.8 (10) 
Physicians 5 37 (9) 8.4 (8.7) 
mHealth physicians 5 41.2 (12) 14.4 (11) 
Pharmacists 7 35.7 (11) 11.4 (10) 
mHealth pharmacists 3 27.5 (4) 3.6 (2) 
amHealth: Experience in using a mobile health intervention. 
  
The majority of HCPs thought that mHealth can play a role in COPD management; 
however, some HCPs had opposing views. One nurse who implements an mHealth intervention 
to manage COPD indicated that “... the majority of our patients are very sad to leave the 
programme.” However, one physician expressed his concern: 
there hasn’t been a lot of evidence to prove that this makes a difference in terms of 
patient outcomes... I think those people are just happy to have another set of eyes 
watching them, right. I think it probably gives them reassurance. 
Finally, a pharmacist said, “There’s obviously going to be some patients who don’t want 
to do it who are technology averse in which case that’s totally fine, they can use the traditional 
methods.” 
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We developed themes under 2 categories: facilitators and barriers that would influence 
the feasibility and use of mHealth. Table 3.2 summarizes the main facilitators and Table 3.3 
summarizes the main barriers. We have also included details and examples to illustrate the 
HCPs’ thoughts and beliefs.  
3.3.2 Facilitators  
Table 3.2: Themes with specific examples regarding the facilitators of mHealth adoption. 
Theme Specific examples for each theme 
There are possible health benefits 
for patients 
Patients can become more readily educated about their 
disease; In areas with limited access to health care, 
mHealtha technologies can bridge the gap between 
patients and health care providers; Patients can 
become more motivated, empowered, and accountable 
with managing their health care 
The software needs to be easy to 
use 
The technology needs to be simple; The language 
should be basic; The software should be visually 
appealing 
Health care providers and patients 
need to be educated on the use of 
mHealth 
Educational strategies are needed 
The credibility of mHealth should 
be evident 
Evidence about the effectiveness of mHealth is 
important; The credibility of the developer is 
important 
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mHealth should reduce the cost 
to the health care system 
It results in a decreased use of health care resources; It 
is affordable owing to the reduced cost of medical 
devices, and it does not include a large physical 
infrastructure; Partnering with private entities could 
facilitate uptake 
amHealth: mobile health. 
3.3.2.1 There are Possible Health Benefits for Patients  
Pharmacists, nurses, and physicians agreed that mHealth has the potential to provide 
health benefits to patients. One nurse, who was experienced with mHealth remarked, “It could 
make life for them, you know, much easier, and improve their quality of life.” Another nurse felt 
confident that patients would be “more educated about their diseases and about what things they 
should be looking for.” A physician commented on his patients who were enrolled in an mHealth 
intervention program, “... I think those people are just happy to have another set of eyes watching 
them, right. I think it probably gives them reassurance.”  
Some HCPs mentioned that mHealth could increase patient autonomy through simulating 
empowerment and motivation in patients. The following physician statement represents thoughts 
from several other HCPs, “it would give patients the power to then be a part of their management 
plan, which is better when patients are empowered, because they feel in control of their health.” 
A few pharmacists also mentioned increased motivation as part of this same vein of thought and 
talked about “access to motivation or making the patient really feel like they were more kind of 
involved in their own healthcare.” Some nurses indicated that mHealth interventions could 
provide a sense of accountability:  
There’s a sense of accountability I believe from the patients. The nurse is watching me 
this morning, I better do it because she’ll be waiting or he’ll be waiting, definitely. 
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Access to health care in rural areas was also thought to be an important facilitator. Many 
HCPs highlighted the importance of mHealth in reducing travel time and improving access to 
rural areas (Newfoundland and Labrador, Canada). A nurse observed, “you look at all these 
small communities in and around the island, those people could certainly benefit from some kind 
of remote monitoring.” This thought was reinforced by others, as in this physician statement, “I 
think that is probably the best benefit from Mobile Health in this province is that it can reach 
some of those rural communities where we can’t go and see patients.” As part of rural health 
care, it was consistently noted that mHealth would make it easier for HCPs to provide care. For 
example, a nurse pointed out that mHealth would help with management of time and perhaps 
allow for more patients to be monitored, as the following comment demonstrates, “what they can 
achieve in a video appointment is sometimes quicker, and a bit more targeted and efficient, and 
they can fit them in within their other appointments.” 
mHealth should reduce cancelled appointments and hospital visits as patients would not 
have to leave their homes, in urban as well as in rural areas. One physician expressed this 
concern about hospital visits, coupled with the advantage of mHealth:  
you can just send that from home. Not even have to go into a facility. And sometimes 
that’s really onerous for people, especially people who are suffering from COPD, so 
they’re going to have shortness of breath and exertion and find it even harder to get from 
the parking lot into the hospital, so the more you can do to make their lives easier, it’s 
great. 
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3.3.2.2 The Software Needs to Be Easy to Use 
Usability was highlighted by the majority of HCPs as an important factor in increasing 
the uptake of mHealth. One nurse with experience in conducting mHealth interventions 
cautioned that patients may stop using the intervention owing to usability issues: 
they found it hard, I’d say largely related to the technology, not being able to handle it or 
finding it too much work. Too tiring, too much trouble, not for them, that kind of thing. 
Thus, most HCPs recommended the software to be easy to use. As another nurse pointed out:  
people are overwhelmed when they are diagnosed with something that is new and 
complicated, and affects something as important as your breathing. So, this has got to be 
something that is easy for them to access and, I think, easy for them to see benefits from. 
Some pharmacists recommended using simple language to enhance usability, as in “it needs to 
be kept useful, but also simple enough for them to be able to navigate and use.” One nurse 
reinforced this notion and thought the language should be “set at a grade six reading level, so 
there’s no issues with comprehension of what they're being asked or told.” It was also thought 
that the software should be visually appealing, with color and perhaps daily progress or weekly 
tracking graphs. Font size was also raised as an issue. One nurse quipped, “people my age and 
above can’t see. A lot of it is very tiny, so the need for reading glasses.” This was apt as COPD 
generally develops in later stages of life.  
In addition, one nurse with experience in mHealth interventions said HCPs may not use 
the intervention if it was difficult to use, “where the provider is getting all this information, 
doesn’t feel that comfortable sorting through it, or using it to make clinical decisions, and then it 
just is going to no use it.” So, users and providers need software that is easy to use as well as 
comprehensive. To streamline the physician workflow, one physician suggested that data 
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collected by the mHealth intervention should be accessed via the electronic medical record: “I 
have an electronic medical record so it would be nice if it was actually in electronic format.” 
3.3.2.3 Health Care Providers and Patients Need to Be Educated on the Use of Mobile Health 
It was recognized that mHealth is a different type of learning for many HCPs as it 
includes learning about technology instead of diseases. However, as one nurse rationalized, “we 
need to make sure we are staying up and current and on top of this.” Many strategies were 
suggested for educating HCPs, such as integrating information about digital health and mHealth 
in school curricula; self-learning; Web-based learning; learning from coworkers, students, and 
sales representatives; attending educational sessions; and hiring coordinators for support.  
The necessity to educate patients was also acknowledged. As one pharmacist suggested, 
“I guess most patients with COPD are older and would probably benefit from someone walking 
through the app with them and showing them how to use it.” Hands-on learning, supplementary 
print materials, and a video tutorial were suggested as ways to teach patients how to use the 
software. Others mentioned the convenience of having family support as an enabler. 
In terms of who should teach patients, it was thought by some that HCPs should share the 
responsibility. As advocated by one pharmacist: 
I guess anyone, if you're seeing a patient or person who is in need of that service could 
introduce it. I don’t think one person should have to take all the responsibility, or one 
profession. 
However, this was not an agreed upon idea. Some thought there should be designated people to 
teach the necessary skills, but there were differing opinions about which group of HCPs should 
lead the patient education. It was also recommended by some that technical support staff be 
available as a resource for patients to call when they needed technical help. 
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3.3.2.4 The Credibility of Mobile Health Should Be Evident 
HCPs thought that the credibility of mHealth needs to be made evident to HCPs and 
patients. This would help raise awareness to facilitate uptake by HCPs. A physician worded it 
like this, “if I perceived that this is something that would help someone exercise a little bit more, 
control their weight, watch their diet, then I would recommend that.” A nurse was even more 
specific in terms of evidence:  
it would be really important to have some solid, really good evidence to show that, in 
actual fact, we receive excellent outcomes in terms of quality of life indicators, activity 
levels, medication usage at a specific time point, be it within one or two years, to decide 
that this type of monitoring, and this type of connection with your provider is making a 
difference to your outcomes. I think that type of evidence is what’s going to change my 
mind as a practitioner about whether it’s worth using it or not. 
This sentiment was reiterated by a pharmacist who thought that “knowing if there’s evidence to 
actually support its use” was essential. 
In addition, the credibility of the developer was mentioned, as in this statement from a 
pharmacist, “it’s also about the credibility of who’s putting the app together.” Added to this, 
recommendations from credible HCPs were also thought to be important. One physician 
commented:  
I mean, the power of one's network. If I view something and I think that it’s good, then me 
giving it a vote of confidence that would then get shared, and people would know that I 
am independently choosing to recommend something. 
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3.3.2.5 Mobile Health Should Reduce the Cost to the Health Care System 
It was thought that mHealth has the ability to provide the “clinical assessment and 
healthcare that was required in a more cost-effective manner”, as recommended by one of the 
nurses. It should decrease emergency visits and hospital admissions, as explained by a nurse who 
thought it would “hopefully catch things in the earlier stage before these patients who were 
mostly elderly got in enough trouble that they would end up in the emergency department.”  
Advancements in mHealth can result in a decrease in expenses, as a third nurse 
explained, “I can send a patient a whole set of devices including a blood pressure cuff, O2 sat 
machine and a weigh scale for less than 300 dollars.”  
Large physical infrastructure would not be required, and it was suggested that some of 
this could be outsourced to private entities that are already doing this type of work, thereby 
reducing expenses to taxpayers. 
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3.3.3 Barriers 
Table 3.3: Themes with specific examples regarding the barriers of mHealth adoption. 
Theme Specific examples for each theme 
There are technical issues with 
mHealtha 
It may include equipment malfunction, password 
issues, and interoperability; It requires internet access; 
Many clinics are paper based 
There may be privacy and 
confidentiality concerns 
People, other than the patients, might gain access to 
private information 
Lack of awareness is a 
challenge 
Many HCPsb and patients are not aware of the current 
advancements in mHealth 
There may be limited uptake 
from the elderly 
Some HCPs thought older age may be a barrier to 
technology adoption; Some believed the upcoming 
generation will be more familiar with technology 
mHealth may limit the personal 
connection between HCPs and 
patients 
Some thought personal connections are necessary; 
Others thought the advantages of mHealth outweigh 
personal connections; Others thought a hybrid 
approach might be optimal 
There are possible financial 
barriers; There were a few 
challenges mentioned by a 
minority of HCPs 
This includes the high cost of the mHealth 
intervention, time consumption, and lack of billing 
codes for HCPs; These included false sense of 
security, anxiety, lack of motivation, and loss to follow 
up. 
amHealth: mobile health. 
bHCP: health care provider. 
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3.3.3.1 There Are Technical Issues With Mobile Health 
Many HCPs expressed that technical issues can be barriers for mHealth adoption. 
Specifically, equipment malfunction, password issues, and interoperability were mentioned 
frequently. For example, a nurse reported, “there’s been issues with the technology not 
communicating because we have setups in four different ways.” In addition, some technical 
specifications are required, such as the smartphone being Bluetooth compatible, along with 
cellular and Wi-Fi connections being available. One nurse elaborated, “there are patients within 
little pockets of ... that don't have cellular service or Internet connection, so unfortunately those 
patients will not be able to be referred to the program.” Another limiting condition to sharing 
mHealth data via electronic medical records was mentioned by physicians, in that many clinics 
are still paper based or not up to date in technology use. 
3.3.3.2 There May Be Privacy and Confidentiality Concerns 
A few HCPs thought privacy and confidentiality could be a barrier to mHealth adoption. 
A pharmacist, echoing other HCPs, questioned, “how are patients confident that the information 
that’s in that app is only going to stay with them and that other people are not going to see that 
data?” The concern of family members viewing private information was raised, “patients, you 
know, if they’re competent they don’t want their family members to see their information and 
that could be an issue.” Also, the issue of stolen or lost phones that contained private information 
was raised. 
However, other HCPs thought these issues could be mitigated with security, as expressed 
by a pharmacist, “if it is secure and the patient gets to decide who accesses it, I don’t see it being 
an issue with confidentiality.” And, some HCPs, as noted by a nurse, were ambivalent regarding 
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privacy and confidentiality, “I wouldn’t imagine that there are any more privacy concerns than 
there are with anything else within health care.” 
3.3.3.3 Lack of Awareness Is a Challenge 
mHealth experience expressed this concern “I think if that had been a part of my training 
more and I’d seen it more then it could definitely become part of my own training.” Employers’ 
lack of knowledge was also mentioned. For example, a nurse shared:  
Our employer doesn’t want to see us having them out, people will have the impression we 
are using it for personal use. That is one big factor. Our employer tells us, keep your 
phones hidden, don’t have them out.  
3.3.3.4 There May Be Limited Uptake From the Elderly 
HCPs had conflicting opinions regarding age and mHealth adoption. All physicians and 
some nurses and pharmacists agreed that the elderly may face issues in adopting these 
technologies, as indicated by this pharmacist, “a lot of the patients with COPD being older and 
maybe not as app-savvy as the group that you’re aiming towards.” This thought was reinforced 
by one physician’s words, with a caveat of doubt, “I suppose I would assume that the elderly and 
the more frail would not be tech-savvy, though, I know smartphone use is increasing with the 
ageing population.” This caveat was supported by some of the nurses with an mHealth 
experience, as expressed by one experienced nurse:  
I had patients who are older than 90 who never owned a computer in their life and 
managed to do their sessions on their iPads and send it to me with no trouble. So, I think 
it depends on maybe education level and understanding, and maybe how things are 
explained to them. 
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A couple of pharmacists experienced in mHealth even stated that some elderly people have 
embraced technology: 
 
I’ve had a lot of kind of older generation patients that once we’ve kind of sat down 
they’ve said oh I’ve been tracking this or I have this app, and I was kind of shocked. So 
until you kind of try it out and recommend it to people you never know what they’re open 
to using or what they’re already using. 
It was also thought by some that the upcoming generation will be more familiar with technology, 
as a nurse surmised, “We have to be sensitive to the fact that technology is present in my world, 
it’s present in yours, but it wasn’t in my grandparents.” Some physicians also thought that future 
generations will value and use mHealth more than the current generation, “I think the younger 
generation will, you know, take this in very easily and very much accept it, so I think going 
forward there’s only going to be more of it, not less.” 
It was also posited that some older HCPs may face issues when adopting mHealth, as put 
forward by one pharmacist: “I’m sure there’d be some potentially older pharmacists who are less 
familiar with smartphones and apps that might have more trouble, and may benefit from a 
tutorial type thing.” This was reiterated by a physician: 
I think that probably technology maybe gets pushed to the side. I think that a lot of the 
physicians too might be, not scared but reluctant to use technology and to learn a new 
skill, especially if they’ve been in practice for thirty years or something.  
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3.3.3.5 Mobile Health May Limit the Personal Connection Between Health Care Providers 
and Patients 
As with age, HCPs had conflicting opinions about mHealth and building personal 
connections between patients and HCPs. A nurse who worried that mHealth might limit the 
personal connections said: 
I like to have a bit of actual contact and eye contact, and hear the tone of someone’s 
voice, and a gentle touch sometimes can be so reassuring, you know. I think it’s going to 
be lost with this type of technology. 
However, this same nurse added that even minimal contact could mitigate that barrier, as in “I 
think there needs to be some sort of human contact, even if it is just the face of the person who 
receives that information.”  
Some physicians also agreed that mHealth lacks this type of contact, as in “I don’t think 
you’re ever going to really replace that human element.” However, although it was emphasized 
that interacting with patients face to face is better than online, some HCPs struggled with the 
advantages of human contact versus access. One nurse who was a champion of human contact, 
recognized that mHealth is “ increasing access and to me, that would be a better benefit than the 
actual face to face, to be able to reach more people more often.” Then there were nurses 
experienced in mHealth who thought it could enhance the personal connection, as in “I think the 
bond is actually a bit more in this program than it was when I was a bedside nurse in some ways, 
because you're getting more personal with the patient about other aspects of their healthcare as 
well.” One nurse reported that she had done surveys about patient satisfaction, provider 
satisfaction, and support staff satisfaction and “the surveys, they do come back that it’s similar if 
not better than a face-to-face.” 
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The majority of physicians, and many pharmacists, thought mHealth has the potential to 
improve personal connections. This pharmacist’s statement represents a commonly expressed 
example of how this could happen:  
I think it would strengthen that relationship because you could ask them about their apps 
and go through it with them when they come other than just seeing if they’re late using 
their prescriptions or late picking them up or anything. 
Some HCPs suggested a hybrid model so that mHealth could supplement the personal 
connection, as in this physician’s comment, “Do I think that it could totally replace it, absolutely 
not... but can I see it being hand-in-and, absolutely.” This sentiment was supported by another 
physician, “I would like to see them for the initial consultation, but I think for follow-up reports, 
you know, we could save them great distances from travelling.” and supported by a nurse, as in “ 
I think having regular face-to-face contacts intermittently is still a very important part of 
healthcare, and it’s something that I think will never be completely removed.” 
3.3.3.6 There Are Possible Financial Barriers 
HCPs had conflicting opinions about financial implications. A few HCPs said some 
patients with COPD may not be able to afford mHealth and do not have access to smartphones. 
One physician expressed it this way, “generally more patients with COPD are falling in the lower 
socio-economic grouping that wouldn’t necessarily be able to afford this.” A nurse with 
experience conducting mHealth programs endorsed this concern by adding that only about 10% 
of participants may remain in the mHealth intervention if the insurance company stopped paying 
for the service. 
In addition to individual patient costs, there is the initial cost of establishing the 
infrastructure, including costs related to storing data in the cloud. In addition, costs related to the 
101 
 
maintenance and replacement of outdated technology were discussed, as reinforced by one nurse, 
“there’s a number of equipment across the province that are nine years old, and if they die then 
there’s no replacement.” In addition, some mHealth programs are limited to a certain period. 
Participants may get medical devices (e.g., blood pressure monitors and pulse oximeters) that 
have to be returned for cleaning to be used by other participants. One experienced nurse 
complained that getting medical devices back from patients can be problematic, as in:  
I have actually been at the plants, the facilities where we get them back and clean them. 
And cockroaches in the boxes that were coming back and just swilled with feces and 
blood and so on. It is just... They have been horrendous. 
Most physicians thought lack of time was a major challenge. They mentioned time to 
learn about mHealth themselves, time to teach patients, and time to review the results of the 
mHealth intervention. One physician gave this example, “when you get a 12 page report on one 
patient and you’re seeing 40 patients a day and you know time constraints with the amount of 
work that you do outside in terms of paperwork is already a burden.” 
Pharmacists had contradictory views about time. A few pharmacists thought lack of time 
could be a barrier, as in: 
Most pharmacists are quite busy as it is... I see the workload potentially going up 
because now if patients are using this they can’t forget to write things down or lose what 
they documented. It’s all there for them, so now they bring the information in. 
Alternatively, other pharmacists thought that mHealth could save time by collecting information 
required in advance “with the expanded pharmacists role we’re building more time to spend with 
our patients and in that sense we will have that time to teach them and to monitor some of these 
new technologies that are coming up.” 
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Lack of reimbursement and billing codes were also mentioned as barriers. One 
experienced pharmacist explained:  
there’s not a whole lot of reimbursement for services like this and like that’s the biggest 
barrier with most things within the pharmacy profession...doing like daily monitoring on 
patients like is time-consuming and we definitely want to do it but unfortunately like it 
does take time and resources and those resources aren’t always available. 
In addition, it was emphasized that the lack of billing codes for mHealth is another financial 
barrier, as a physician insisted:  
I mean we’re all so busy that nobody wants to do anything for free because why would I 
do that for free if I get paid for it. So that’s a barrier that has to be overcome is that how 
do you change some of the way physicians are paid. There’s no incentivizing the 
optimized care as an example. If I do a poor quality of care for my COPD patient or if I 
do an excellent quality of care, it’s the same payment. So there’s a problem with the 
system in that sense and physicians in general would be resistant to sort of evaluate how 
well they’re doing with their patients. 
3.3.3.7 There Were a Few Challenges Mentioned by a Minority of Health Care Providers 
There were additional challenges that were mentioned by small numbers of HCPs. For 
example, one physician thought patients may gain “a false sense of security” about their health 
status, owing to technology. Another physician voiced concern that “some sub-groups of patients 
with anxiety might have impaired quality of life because then they become obsessed with that 
rather than actually just saying okay that’s what they’re saying, I’m okay.” A pharmacist 
questioned validity:  
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the validity of the data would be something that some people might question. I guess a lot 
of that would depend on how straightforward the devices are to use or how much training 
might be required to make sure that they are using it correctly. 
Motivation to continue using the intervention was also a concern. A pharmacist 
wondered, “I think getting patients to use it and use it often enough might be difficult, depending 
on the patient.” A few pharmacists and physicians noted that many patients with COPD are not 
motivated to manage their disease. One pharmacist commented:  
The biggest challenge I find with COPD patients, now that’s the population that I deal 
with, is that they are smokers and continue to smoke, the majority of them. Their 
education level is probably a little bit on the lower side and that’s related to the whole 
smoking, right, that kind of thing, the socio-economic status of the patient. So they’re not 
necessarily invested in improving their health with a lot of effort, right. They’ll take an 
inhaler, take a pill to help them get better, but really changing their lifestyle and their 
smoking is not high on their list. 
 
One nurse highlighted that about 30% of patients dropped out after using an mHealth 
intervention. 
3.4 Discussion  
3.4.1 Principal Findings  
This qualitative study found that HCPs, in general, had a positive attitude toward 
mHealth adoption for COPD management, but several facilitators and barriers were identified. 
More barriers were identified than facilitators, indicating a need to address these barriers to 
optimize successful implementation of mHealth interventions. 
104 
 
To facilitate mHealth uptake, our thoughts, based on the data, are that both HCPs and 
patients need to understand the potential benefits of the mHealth intervention. The interventions 
must be easy to use for both patients and HCPs. This could reduce the time and resources 
required to teach patients and providers about the mHealth intervention. One physician stated 
that the use of mHealth interventions could provide a false sense of security, thereby keeping the 
user from seeking medical advice in a timely manner. This concern along with the lack of 
awareness concerned HCPs, an important finding is the need for HCPs to teach patients about 
mHealth interventions. Some HCPs thought there should be a designated person to teach 
patients. It is preferable that these professionals have a background in chronic disease 
management and technical support.  
There were a few barriers identified by the HCPs. Most of these barriers have the 
potential to be resolved, as suggested by many of the HCPs. Technical issues continue to be a 
challenge for mHealth adoption, especially for rural areas and developing countries that have 
poor connection network. 
3.4.2 Comparison With Previous Work  
Although the numbers of HCPs using mHealth interventions are growing, studies 
focusing solely on the frontline staff perspective on mHealth are limited (Damhus et al., 2018; 
Brunton et al., 2015). Some of the findings presented in this study confirm findings that have 
been reported previously in the context of mHealth for COPD management. As Damhus et al 
(2018) noted, HCPs reported technical issues as a major challenge for mHealth adoption. Our 
findings are in agreement with Vorrink et al. (2017), who stress the importance of training 
patients and HCPs on the proper use of mHealth. In this study, as well as other studies, we have 
noted that mHealth will not replace face-to-face interactions (Korpershoek et al., 2018; Damhus 
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et al., 2018; Vorrink et al., 2017). In agreement with Damhus et al. (2018) and Korpershoek et al. 
(2018), we suggest that the expected benefits of using mHealth contribute to the success of 
mHealth uptake, although our study provides additional insight with regard to these perceptions.  
3.4.3 Strengths and Limitations  
There are several strengths of this study. First, this research is based on a diverse sample 
of participants. It includes various perspectives by presenting the views of nurses, pharmacist, 
and physicians, including a respirologist. This human-centered approach ensures that needs and 
challenges of different people involved in the management of COPD can be considered before 
developing an mHealth intervention. Second, some HCPs had experience in using an mHealth 
intervention to manage COPD which further increases the richness of the data. Third, all of the 
interviews were conducted in a similar manner to ensure consistency during the data collection 
and analysis. Finally, mHealth is particularly important in geographic locations with relatively 
large proportions of rural residents such as Newfoundland and Labrador. mHealth may enhance 
care provider access throughout sparsely populated rural areas. Newfoundland and Labrador has 
a substantial remote and rural population, therefore our results may be more applicable to rural 
areas.  
There were also several limitations. First, not all the HCPs had experience with using 
mHealth. Thus, the perceptions of these participants were not based on actual interventions with 
patients. Second, we used only one data collection method, thus not triangulating data collection. 
Conducting focus groups with some of the participants following the individual interviews could 
have yielded richer information as participants would have been given the opportunity to 
compare their thoughts and confirm or expand upon each other’s ideas. This would be a 
recommendation for a future study.  
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3.4.4 Implications for Practice   
The findings of this study provide insights into the barriers and facilitators for using 
mHealth as a part of COPD management. This information may help a variety of stakeholders 
who are planning to use mHealth interventions for COPD management. Lessons learned include 
the importance of raising an awareness among patients with COPD and HCPs regarding the 
potential of mHealth interventions in COPD management. Professional associations and 
universities could play a significant role in raising an awareness of, and even introducing, 
mHealth in undergraduate health professional curricula. It also may be beneficial to designate an 
HCP, with a background in chronic disease management and technical support, to teach patients 
about mHealth.  
The findings emphasize the importance of developing a user-friendly mHealth 
intervention. This could reduce the time and resources required to teach patients and providers 
about the mHealth intervention. In addition, the lack of an internet connection limits access to 
mHealth interventions, so this should be taken into consideration when measuring access to 
health resources in rural communities.  
In terms of credibility, health organizations such as the Food and Drug Administration, 
Health Canada, or the Canadian Association for Drugs and Technologies should take an active 
role in regulating mHealth interventions. These organizations can develop their own app stores, 
similar to the Veteran Affairs app store, to showcase credible mHealth interventions. In addition, 
when developing mHealth interventions, it is important to follow international guidelines for the 
exchange, integration, sharing, and retrieval of electronic health information (Health Level 7, 
2018). This could help in addressing interoperability issues. Nevertheless, these regulations 
should be implemented in a manner that supports mHealth uptake.  
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3.4.5 Recommendations for Future Research  
Future studies would benefit from conducting focus groups with some of the participants 
following the individual interviews. Focus groups could yield richer information as participants 
would be given the opportunity to compare their thoughts and confirm or expand upon each 
other’s ideas. Furthermore, including the perspectives of allied HCPs, such as physiotherapists, 
social workers, and occupational therapists, would be beneficial to understand the perspectives of 
administrators (e.g., information technology managers) who may be able to identify some of the 
challenges with using mHealth for COPD management. The authors have conducted a similar 
study with a focus on the perspectives of individuals with COPD. In addition, a future article will 
focus solely on the features of the ideal mHealth intervention for COPD management. After 
developing a user-centered mHealth intervention, the authors recommend using a mixed methods 
framework for usability testing (Alwashmi et al., 2019). 
3.5 Conclusions 		
It is important to understand the perceptions of HCPs regarding the adoption of 
innovative mHealth interventions for COPD management. This study identifies the facilitators 
and barriers that may aid in the successful development and implementation of mHealth 
interventions for COPD management. Lessons from this study may also be applied to other 
chronic diseases. Additional research is needed to investigate the conflicting opinions regarding 
mHealth adoption by the elderly, the personal communication between HCPs and patients, and 
the cost-effectiveness of mHealth interventions in COPD management.   
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Chapter 4: Perceptions of Patients With Chronic Obstructive Pulmonary 
Disease regarding a Mobile Health intervention to manage COPD: a Mixed 
Methods Study 
Preface 
A version of this chapter will be submitted to a suitable journal. I defined the specific 
research aim, developed the methods, and completed the analysis of the case study. I completed 
the first draft and revised it according to the suggestions of co-authors and reviewers. Dr. John 
Hawboldt and Dr. Davis suggested the general research topic and provided feedback on the 
manuscript. Dr. Beverly Fitzpatrick helped revise the original manuscript to make the argument 
clearer. Dr. Jamie Farrell also assisted in recruiting participants. Dr. John-Michael Gamble and 
Dr. Hai Nguyen provided suggestions on how to analyze the quantitative data. The co-authors 
reviewed the manuscript and provided revision suggestions. 
Abstract 
Background: Using a mobile health (mHealth) intervention consisting of a smartphone and 
compatible medical device has the potential to enhance chronic obstructive pulmonary disease 
(COPD) treatment outcomes while mitigating health care costs. 
Objective: This study was intended to describe the demographics, use, and access to 
smartphones of patients with COPD. It also aims to explore and develop an understanding of 
potential facilitators and barriers that might influence COPD patients using mHealth 
interventions for COPD management. 
Methods: This was an explanatory sequential mixed methods study. Patients who attended three 
respirology clinics completed a questionnaire about technology access and use. Semi-structured 
individual interviews were conducted with patients. Interview topics included the following: 
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demographics, mHealth usage, perceptions toward challenges of mHealth adoption, factors 
facilitating mHealth adoption, and preferences regarding features of the mHealth intervention for 
COPD management. 
Results: A total of 100 adults completed the survey but 23 patients were excluded because they 
were not diagnosed with COPD. Of those, 10 patients with COPD participated in the interview. 
The quantitative component revealed that many COPD patients owned a mobile phone, but only 
about a quarter of the participants, 18/77 (23.4%), owned a smartphone. The likelihood of 
owning a smartphone was not associated with age, sex, marital status, or geographical location, 
but patients with high educational status are more likely to own a smartphone. The qualitative 
component found that COPD patients, in general, had a positive attitude toward mHealth 
adoption for COPD management, but several facilitators and barriers were identified. The main 
facilitators to mHealth adoption are possible health benefits for patients, ease of use, educating 
patients, and credibility. Alternatively, the barriers to adoption are technical issues, lack of 
awareness, potential limited uptake from the elderly, privacy and confidentiality issues, finances, 
and lack of interest in mHealth”. 
Conclusions: It is important to understand the perceptions of patients with COPD regarding the 
adoption of innovative mHealth interventions for COPD management. This study identifies some 
potential facilitators and barriers that may inform the successful development and 
implementation of mHealth interventions for COPD management.  
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4.1 Introduction  
 
Advancements in mobile phones and communication technologies have led to the 
inception of mobile health (mHealth), which can transform clinical research and healthcare 
(Steinhubl, Muse, & Topol, 2015). mHealth is defined by the National Institutes of Health as the 
“use of mobile and wireless devices to improve health outcomes, healthcare services, and health 
research”. An mHealth intervention could also include the use of a medical device that is 
compatible with a smartphone. Previous research suggests that mHealth interventions may 
benefit patients with many chronic health conditions, including Chronic Obstructive Pulmonary 
Disease (COPD) (Alwashmi et al., 2016; Joe & Demiris, 2013; Juen, Qian Cheng, & Schatz, 
2015; Zhang, Song, & Bai, 2013).  
Alwashmi et al. (2016) noted that the current literature on the role of smartphones in 
reducing COPD exacerbations is limited, but they suggest that mHealth interventions may reduce 
COPD exacerbations. To potentially enhance the adoption and outcome of the mHealth 
intervention, key users should be involved in the development of these interventions. 
4.1.1 Importance of Human-Centered Design 
The International Organization for Standardization (ISO) 9241-210 standard defines 
human-centered design (HCD) as “an approach to systems design and development that aims to 
make interactive systems more usable by focusing on the use of the system and applying human 
factors/ergonomics and usability knowledge and techniques” (ISO, 2010). The ISO uses the term 
HCD instead of user-centered design (UCD) to “address impacts on a number of stakeholders, 
not just those typically considered as users” (ISO, 2010). However, in practice, these terms are 
often used synonymously.  
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Many researchers use mHealth to assist in the management of chronic diseases; 
nevertheless, gaps still exist regarding the development process of these mHealth interventions 
(Dennison et al., 2013). Testing mHealth interventions with patients has revealed preferences 
and concerns unique to the tested population (Nelson et al., 2016; Sarkar et al., 2016; Steele Gray 
et al., 2016). Developing a COPD mHealth intervention with insights from COPD patients will 
potentially improve the process and outcome of the mHealth intervention.  
4.1.2 Human-Centered Design in Chronic Obstructive Pulmonary Disease 
Cruz et al. (2014) conducted a systematic review to provide a comprehensive description 
of the methodologies used in home telemonitoring interventions for COPD and to explore 
patients’ adherence and satisfaction with the use of telemonitoring systems. They recommended 
that telemonitoring interventions should be adjusted to their target population and that 
assessment of patients’ acceptance of telemonitoring technology should be considered prior to its 
implementation (Cruz et al., 2014). Similar strategies can be applied to mHealth. To improve the 
success of mHealth solutions that target COPD patients, we suggest including COPD patients in 
the development process. Key lessons about mHealth adoption will be offered as a guide for 
research and technology developers working with patients with COPD.  
4.2 Methods  
4.2.1 Purpose  
This study describes the demographics, use, and access to smartphones of patients with 
COPD. It also aims to explore and develop an understanding of potential facilitators and barriers 
that might influence COPD patients using mHealth interventions for COPD management. 
 
117 
 
4.2.2 Study Design  
We conducted an explanatory sequential mixed methods research design (Creswell, 
2015). The study began with a quantitative strand and was followed by a qualitative strand to 
explain the quantitative results (Creswell, 2015). Explanatory designs are typically chosen when 
a team anticipates that quantitative measures will not be sufficient to address the research 
question. They may also be used when quantitative information is required to develop the sample 
for the qualitative phase (Curry & Nunez-Smith, 2015). In this study, the quantitative component 
was fully completed before the design and implementation of the qualitative component. The 
results of the quantitative component were used to define the qualitative sample. 
4.2.3 Ethical Considerations 
Ethical approval for this study was obtained from the Newfoundland and Labrador Health 
Research Ethics Authority (HREB -2017-194). Before agreeing to participate, all subjects were 
informed about the nature of the research project, possible risks and benefits, and their rights as 
research subjects. All participants in the interview completed a written consent form and were 
given a copy.   
4.2.4 Quantitative phase 
The quantitative phase aimed to describe the demographics, use, and access to 
smartphones among patients with COPD. It also aimed to assess whether demographic factors 
predicted engagement with mHealth. The results were used to define the qualitative sample and 
create the questions required for the qualitative strand. 
4.2.4.1 Recruitment and Study Setting  
Participants were recruited during routine visits to their respirologists at outpatient 
respirology clinics in the Eastern Health Regional Health Authority of the province of 
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Newfoundland and Labrador (NL), Canada. Participants were eligible for the study if they met 
the following inclusion criteria:  
1. a COPD diagnosis (self-report), 
2. aged ≥30 years at study enrollment, 
3. able to answer questionnaires in English, and  
4. able to provide informed consent.  
Patients who attended three respirology clinics received a consent cover letter for 
research. The cover letter included a questionnaire about technology access and use (Appendix 
2). After reading the cover letter, interested participants completed the questionnaire and 
submitted it in a locked box (blue box) available at the respirology clinic. 
The last section of the questionnaire included a question about the participant’s interest in 
participating in an interview regarding the same topic. Interested participants provided their 
contact information and placed it in another box (red box) located at the respirology clinic.  
We separated the contact information from the questionnaire to assure that the 
questionnaire was kept anonymous. Each questionnaire had a unique identifier. Only the primary 
investigator (PI) was able to link the questionnaire with the contact information. The sample size 
(n=100) is comparable to studies conducted by Granger et al. (2018) and Kayyali et al., (2017) 
who assessed the use of technology among patients. Patients did not receive remuneration for 
completing the questionnaire. 
4.2.4.2 Data Collection  
The questionnaire was adapted from Ramirez et al. (2016) to assess how patients use 
various types of mobile technology and to what extent they use mHealth. In addition, the 
questionnaire was used to assess the need for and interest in using mobile health technology, 
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such as mobile phone apps and social media, to help manage health (Ramirez et al., 2016). 
Similar to Ramirez et al. (2016), the questionnaire was not validated due to the lack of 
standardized instruments regarding the use and access to mHealth; however, the questions were 
consistent with previously published literature in the field. 
The questionnaire also included demographic information such as age, sex, 
race/ethnicity, primary language spoken, annual household income, and education level. In 
addition, participants were asked about their mobile phone ownership and if their mobile phone 
had internet capabilities. They were also asked if they used the Internet on their mobile phones to 
learn about their health. Afterwards, the participants were asked about their knowledge of mobile 
phone apps, if they used such apps, and if they were currently using any mobile health apps. In 
addition, participants identified individuals who they might rely on to use mobile phones and/or 
mobile apps for them (e.g., partner, child, friend). 
4.2.4.3 Statistical Analysis  
A database of the questionnaire results was created using unique non-identifying 
numbers. The information was password protected. Before analysis was performed, data were 
cleaned, coded, and entered into Statistical Package for the Social Sciences (SPSS) version 25.0 
(IBM Corp., Armonk, NY). The unclear or incomplete survey items were flagged for queries. 
These were brought to the attention of the research team, then each item was discussed, and a 
decision concerning its eligibility and entry was made. 
Baseline characteristics of participants were summarized with percentages for categorical 
variables and means and standard deviations for continuous variables. Crude and adjusted odds 
ratios were measured using univariate and multivariable logistic regression analyses to determine 
if smartphone ownership was independently associated with age, sex, marital status, education 
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level, and geographical location. All statistical tests were performed with an alpha significance 
level of 0.05.  
4.2.5 Qualitative phase 
We used a descriptive qualitative research design grounded in pragmatism (Merriam & 
Tisdell, 2015; Patton, 2015). Using a qualitative methodology allowed us to achieve an in-depth, 
contextualized picture of how a diverse sample of patients with COPD think and feel about the 
possibilities and challenges of using mHealth. This has pragmatic value, as mHealth is an 
emerging option for delivering healthcare. 
4.2.5.1 Recruitment and Study Setting  
Once all the questionnaires were collected and analyzed, we only contacted participants 
who agreed to participate in an interview. Based on the demographic information collected from 
the questionnaire, a purposeful sampling strategy was used to identify key informants that could 
provide rich and diverse interview data. Specifically, we used criterion-based selection (Patton, 
2015) to categorize participant characteristics such as age, familiarity with mHealth, smartphone 
ownership, and years living with COPD.  
After interviewing 8 COPD patients, we reached saturation, as we were not gathering 
new information. However, we continued interviewing until 10 COPD patients were interviewed 
to strengthen the validity of inferences (Maxwell, 2013). Our final sample size was comparable 
to similar qualitative studies (Barken et al., 2018; Korpershoek et al., 2018). 
 The study took place in St. John’s, NL, Canada. We conducted some interviews at 
Memorial University of Newfoundland and others at the participants’ homes. Participants were 
recruited from April 2018 to August 2018. After completing the interviews, participants were 
offered a gift card (30 Canadian dollars).  
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4.2.5.2 Data Collection  
We conducted individual semi-structured interviews in-person to gain an understanding 
of the lived experiences of COPD patients in relation to using mHealth (Brinkman & Kvale, 
2015; Rubin & Rubin, 2012). Using semi-structured interviews allowed the interviewer to begin 
with a broad question to direct the focus of the interview and then to provide an opportunity for 
COPD patients to bring forth their thoughts and feelings about the phenomena they thought were 
important (Brinkman & Kvale, 2015; Rubin & Rubin, 2012). The interview prompts are 
available in supplemental Appendix 2. If participants identified that they had not used mHealth, 
they were asked questions pertaining to why they had not used mHealth (barriers). However, we 
did not ask them about facilitators because we did not think they had the experience needed to 
answer these questions. To facilitate discussions, the interviews were conversational in nature, 
and items were not asked verbatim or in the order presented. As the study progressed, emerging 
issues were explored with subsequent participants to refine the themes.  
The interview questions and prompts were informed by findings from the literature and 
input from the authors, who have diverse backgrounds including in mHealth, pharmacy, nursing, 
medicine, respirology, family medicine, education, and qualitative research. They were also 
informed by interviewing healthcare providers (HCPs) regarding the use of mHealth in COPD 
management (Alwashmi et al., 2019a). Lastly, the interview questions were informed by the 
results of the quantitative strand. For example, I was able to explore the barriers further with 
participants who did not own a smartphone and I was able to learn more about the facilitators 
from participants who used mHealth intervention to manage their COPD.  
The interviews were recorded to enable transparent and accurate transcriptions. Interview 
lengths ranged from 20 to 40 minutes. Topics included demographics, mHealth usage, 
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perceptions towards challenges of mHealth adoption, factors facilitating mHealth adoption, and 
preferences regarding features of the mHealth intervention for COPD management. Owing to the 
large amount of data, preferences regarding features of the mHealth intervention will be 
published in another article. Data consisted of about four hours of interview time with 
approximately 100 pages of transcription. 
4.2.5.3 Data Analysis  
The interviews were transcribed verbatim and compared against the digital recordings to 
ensure the accuracy of the content. Identifying information (names) was removed to ensure 
anonymity. We used NVivo (Version 12; QSR International) to organize the data and examine 
the words, including frequency counts, as in classical content analysis (Leech & Onwuegbuzie, 
2008). All data were analyzed, but we only coded the data that were relevant for answering the 
research questions, as recommended by Saldana, 2015; Wolcott, 2009; and Yin, 2011. An audit 
trail was created to keep track of all analytic decisions (Guest et al., 2012). 
After using NVivo, we used first cycle coding that was both structural and holistic 
(Saldaña, 2016), meaning that we used the interview prompts and the literature to guide some of 
the coding. One researcher analyzed the transcripts and developed a set of themes and sub-
themes and then obtained input from a second researcher regarding the validity and accuracy of 
the chosen themes. In the second cycle of coding, the two researchers independently coded the 
data using pattern coding to develop themes (Saldaña, 2016). They then discussed commonalities 
and differences in their coding and theme development until consensus was reached. The 
analysis of the data was mainly deductive in nature because themes had already been developed 
using the HCP data, which we used as a starting point (Alwashmi et al., 2019a). An inductive 
analysis was also performed for new data that did not belong to the existing themes. The iterative 
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process continued as these analyses were conducted to find commonalities, differences, and new 
patterns in thinking. 
4.2.6 Mixed methods integration 
In addition to the integration at the study design level, we implemented integration at the 
methods, interpretation, and reporting levels (Fetters et al., 2013). We implemented integration at 
the methods level in two ways: connecting and building. Connecting occurs when a researcher 
links one type of data to another type of data through sampling (Fetters et al., 2013). In the 
present study, we used data from the questionnaire to purposefully sample participants for 
follow-up interviews. Specifically, we were able to categorize participant characteristics such as 
age, familiarity with mHealth, smartphone ownership, and years living with COPD. Obtaining 
information from a diverse group may generate a more complete picture, reveal patterns that 
would otherwise go unnoticed, and may also help identify novel relationships between variables 
and concepts (Curry & Nunez-Smith, 2015). Building occurs when one database informs the data 
collection approach of the other (Fetters et al., 2013). In the present study, we used the 
questionnaire responses to develop some aspects of the interview guide. This allowed us to 
potentially gain further insights regarding mHealth use.     
Further, we implemented integration at the interpretation and reporting level. We used 
both integrations through narrative and the use of a joint display (Fetters et al., 2013; Guetterman 
et al., 2015). Integration through a narrative occurs when a researcher describes the quantitative 
and qualitative findings in a single report or series of reports (Fetters et al., 2013). In the current 
study, we describe the findings in a single report and use the contiguous approach, in which 
qualitative and quantitative findings are reported in different sections. Lastly, we use a joint 
display to provide a structure to discuss the integrated analysis (Guetterman et al., 2015). 
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4.3 Results  
4.3.1 A cross-sectional survey of COPD patients  
4.3.1.1 Demographics 
A total of 100 adults completed the survey from January 2018 to November 2018. Only 
77 participants reported that they were diagnosed with COPD and were included in the analysis. 
Table 4.1 provides an overview of the demographic and health information of the sample. Of 
these subjects, 20 (26%) were under the age of 65, 44 (59.5%) were female, and 44/74 (59.5%) 
were married. Furthermore, 14/52 (26.9%) reported an annual household income of less than 
$20,000, 52/68 (76.5%) were retired, 48/68 (70.6%) had earned at least a high school diploma, 
and 20/68 (29.5%) had earned a college or professional degree. Additionally, 18/71 (25.4%) 
participants were living in a rural area, with a population less than 1,000. The most common 
comorbidities were cancer 18 (28.1%), diabetes 15 (23.4%), cardiovascular diseases 14 (21.9%), 
and skeletal or muscular diseases 12 (18.8%). Almost half the participants (28/ 68 , 41.2%) were 
taking more than six medications. 
Table 4.1: Participant demographics and health information, n=77.   
Variable n(%) 
Age (years) (n=77) 30–34 years 2 (2.6) 
 45–54 years 3 (3.9) 
 55–64 years 15 (19.5) 
 65 or older  57 (74) 
Sex (n= 74) Female 44 (59.5) 
 Male 30 (40.5) 
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Marital status 
(n=74) 
Married 44 (59.5) 
 Common Law 6 (8.1) 
 Single (never married) 6 (8.1) 
 Widowed, Separated, or Divorced 18 (24.3) 
Income (n=52) Under $20,000 14 (26.9) 
 $20,000–$39,000 18 (34.6) 
 $40,000–$59,000 6 (11.5) 
 $60,000–79,000 4 (7.7) 
 $80,000–150,000 8 (15.4) 
 Over $150,000 2 (3.8) 
Employment (n= 
68) 
Employed full time 6 (8.8) 
 Employed part time 2 (2.9) 
 Self-employed 2 (2.9) 
 Retired 52 (76.5) 
 Unemployed 6 (8.8) 
Education level 
(n=68) 
Less than high school 14 (20.6) 
 High School Equivalency (GED) 9 (13.2) 
 High School 25 (36.8) 
 College/ trade 10 (14.7) 
 Bachelor’s degree 5 (7.4) 
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 Master’s degree 4 (5.9) 
 PhD/ MD/ JD 1 (1.5) 
Population size 
(n=71) 
Rural area (with a population less 
than 1,000) 
18 (25.4) 
 Small population centre (with a 
population between 1,000 and 
29,999) 
 
23 (32.4) 
 Medium population centre (with a 
population between 30,000 and 
99,999) 
6 (8.5) 
 Large urban population centre 
(with a population of 100,000 or 
more). 
24 (33.8) 
Self reported 
comorbidities* 
(n=65) 
Cancer 18 (28.1) 
Diabetes 15 (23.4) 
 Heart disease  14 (21.9) 
 Skeletal/ Muscular disease 12 (18.8) 
 Kidney disease 4 (6.3) 
 Mental health issues 2 (3.1) 
Medication intake 
(n=68) 
None 2 (2.9) 
 1–2 10 (14.7) 
 3–4 12 (17.6) 
 4–6 16 (23.5) 
 More than 6 28 (41.2) 
* Some patients reported several comorbidities.   
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4.3.1.2 mHealth technology ownership 
Table 4.2 illustrates the findings regarding mHealth technology ownership. Many 
participants, 56 (72.7%), owned a mobile phone, but only about a quarter of the participants, 18 
(23.4%), owned a smartphone. The number of iPad or tablet owners was slightly higher than 
smartphones at 25 (32.5%). In terms of the availability of a smartphone in the household, 21 
(27.3%) participants stated that a person in the household owns a smartphone. Although only 18 
participants reported having a smartphone, 22 (28.6%) participants were able to access the 
internet via their phone, suggesting a higher number of smartphones than initially reported. 
About a third of participants (27, 35.1%) owned a blood pressure monitor, and 17 (22.0%) 
participants owned a glucometer.   
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Table 4.2: mHealth technology ownership, n=77. 
mHealth technology ownership n(%) 
Mobile phone 56 (72.7) 
Smartphone 18 (23.4) 
iPad 25 (32.5) 
Availability of a smartphone in the household 21 (27.3) 
Internet access through a mobile phone 22 (28.6) 
Spirometer/ Peak flow meter 4 (5.2) 
Glucometer 17 (22.0) 
Blood pressure monitor 27 (35.1) 
Heart rate monitor 10 (13.0) 
Accelerometer/ activity counter 3 (3.9) 
Scale 15 (19.5) 
Thermometer 18 (23.4) 
 
Logistic regression was performed to ascertain the association of age, sex, marital status, 
education level, and geographical location with the likelihood that participants owned a 
smartphone. Due to missing observations, the true N used in the regression is 65/77.  
We measured crude odds ratios to determine if smartphone ownership was independently 
associated with the occurrence of the predictor variables. The likelihood of owning a smartphone 
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was reduced in participants earning less than a high school diploma (crude odds ratio 
[cOR]= 0.11, 95%CI 0.02–0.64, P-value = 0.014) and participants earning a high school diploma 
(cOR= 0.14, 95%CI 0.04–0.5, P-value = 0.002) compared to participants who received education 
beyond high school.  
The logistic regression model was statistically significant, χ2(7) = 15.77, p < .05. The 
model explained 30.4% (Nagelkerke R2) of the variance in smartphone ownership and correctly 
classified 76.9% of cases. Sensitivity was 50.0%, specificity was 88.9%. Of the five predictor 
variables, only two were statistically significant, and both are related to education level (as 
shown in Table 4.3). The likelihood of owning a smartphone was reduced in participants earning 
less than a high school diploma (adjusted odds ratio [aOR]= 0.12, 95%CI 0.017-0.86, P-
value = 0.034) and participants earning a high school diploma (aOR= 0.13, 95%CI 0.03–0.54, P-
value = 0.005) compared to participants who received education beyond high school. 
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Table 4.3: Logistic regression predicting the likelihood of smartphone ownership 
Variable aOR 95%CI P value cOR 95%CI P value 
Age 30–64 years 
 
65 or older 
2.24 
 
Ref 
0.57–8.77 
 
0.245 
  
1.97 
 
Ref 
0.65–6.04 
 
0.233 
Sex Female 
 
Male 
2.10 
 
Ref 
0.54–8.19 0.285 1.03 
 
Ref 
0.36–2.94 0.954 
Marital 
Status 
In a 
relationship 
 
Not in a 
relationship 
2.36 
 
 
Ref 
0.494–
11.29 
0.281 1.63 
 
 
Ref 
0.51–5.17 0.408 
Education 
level 
Less than high 
school 
 
High school 
 
More than 
high school 
0.12 
 
 
0.13 
 
Ref 
0.02–0.86 
 
 
0.03–0.54 
0.034* 
 
 
0.005* 
0.11 
 
 
0.14 
 
Ref 
0.02–0.64 
 
 
0.04–0.50 
0.014* 
 
 
0.002* 
Population 
size  
Rural area 0.50 0.09–2.76 0.43 0.35 0.08–1.47 0.149 
Small 
population 
center 
 
a medium 
population 
center or a 
large 
population 
center 
0.46 
 
 
 
Ref 
0.11–1.92 0.29 0.61 
 
 
 
Ref 
0.19–2.01 0.415 
aOR: Adjusted odds ratio; cOR: Crude odds ratio; CI: Confidence Interval 
* Significance level is less than 0.05 
Note: In a relationship includes being married or in common law; not in a relationship includes 
being single, widowed, separated, or divorced; high school includes GED. 
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4.3.1.3 mHealth technology use  
Table 4.4 highlights the findings related to mHealth technology use. Only a third of the 
participants, 20 (29%), understood the term “app”. Of these, 10 (50%) used apps. Among app 
users, only three participants used health apps and seven participants were interested in using a 
health app. Six app users were comfortable allowing their family members to access their health 
information, and seventy percent were comfortable with their HCP accessing their healthcare 
information. The most common social media platform used was Facebook (29, 51.8%). Among 
users of social media, 13/29 (44.8%) reported using social media at least once a day.  
Participants completed questions about their concerns regarding mHealth adoption. The 
first question was about concerns regarding smartphones. The following three options were 
chosen by participants: cost of smartphones (21, 24.5%), reducing face to face interactions (10, 
20.4%) and not easy to use (9, 18.4%). Of the participants who use apps (n=10), the following 
concerns about app use were chosen: worried about personal information disclosure (6), extra 
fees to use the app (3), apps use a lot of data (3), apps are not easy to use (1), and I do not know 
if they are effective (1). No participants chose “taking too much time to use” or “not 
recommended by a healthcare provider” as a concern arising from using apps.  
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Table 4.4: mHealth technology use. 
Variable N n(%) 
Understood the term “app” 77 20 (29) 
Use apps  20 10 (50) 
Use health apps 10 3 (30) 
Interested in using health apps  10 7 (70) 
Comfortable allowing a family member to access health information 10 6 (60) 
Comfortable allowing a HCP to access health information  10 7 (70) 
     
Social media use Facebook 77 29 (51.8) 
 Twitter 77 2 (3.6) 
 Instagram 77 2 (3.6) 
 Snapchat 77 1 (1.8) 
Interested in using social media to share health experience 77 9 (13.4) 
Frequency of social media use Never 29 1 (3.4) 
 A few times a month 29 5 (17.2) 
 A few times a week 29 3 (10.3) 
 About once a day 29 7 (24.1) 
 More than once a day 29 13 (44.8) 
n= 77 is the total study population.  
n= 20 is the sample who understood the term “app”. 
n= 10 is the sample that use apps. 
n= 29 is the sample that use social media.  
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4.3.2 Semi-structured Interviews with COPD patients  
We developed themes under two categories: facilitators and barriers that would influence 
the feasibility and use of mHealth. We have included details and examples to illustrate the 
patients’ thoughts and beliefs.  
4.3.2.1 Demographics 
Ten COPD patients participated in face-to-face interviews. The mean age was 67.6 
(±7.58) years and the range was from 51–80 years. There were four females and six males. 
Participants stated that the mean number of years living with COPD was 8.4 (±4.45) and the 
range was from 3–15 years.  
Six participants owned a smartphone, two owned a mobile phone, and two did not have 
either. Participants used their phones for different purposes, including communication, managing 
finances, gaming, and browsing the internet. One patient stated “I use it for everything. I never 
thought I’d see the day where I was dependant on my phone”. On the other hand, another 
participant stated that she did not use her smartphone beyond making phone calls: “I have a 
phone but I am not smart enough to use it”. Some participants used it to monitor their physical 
activity: “I have a health thing on it and I look at it every once in a while just to see how many 
steps I’ve done that day because it… Improve health activity”. One patient used his smartphone 
to “get pollen reports and anything that will trigger a COPD attack...to do research on 
nutraceutical products or on COPD-related matters”. Four participants were enrolled in an 
mHealth intervention to manage their COPD. 
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4.3.2.2 Facilitators 	
Patients reported four facilitators, which are discussed below. 
1. There are possible health benefits for patients. 
Patients agreed that mHealth has the potential to provide health benefits to patients. Some 
patients mentioned that mHealth could increase patient autonomy by providing empowerment 
and motivation to patients. One patient who used a fitness tracker remarked, “I think it’s better 
for me to track what I do every day. It is going to make me feel better...That would help me a lot 
with my pains… I know how my day was and I know how I feel like”. Another patient who kept 
track of his vitals, weight, and medication intake stated that “if I had been monitored, I might not 
have this broken arm...That should’ve been picked up on. I mean, I got the records there and you 
look back on it, I can easily look back on them now and say you had water retention, your resting 
heart rate was way too high, and your blood pressure was low. There’s something wrong”. Two 
patients described that mHealth could provide a sense of security and reduce hospitalization: 
“...it felt good to have that, you know, that security there at least that in those four months that I 
had it. So there was no guessing because you don’t know if you should or you shouldn’t go to a 
hospital.”  
2. The software needs to be easy to use.  
Usability was highlighted by many patients as an important factor in increasing the 
uptake of mHealth. One patient cautioned that he might not use an intervention if it was not easy 
to use: “I’m not getting into something that’s going to fill up my day ferreting around. But if it’s 
something that I’ve got to look at for five or ten minutes, I’m okay with that”. Participants who 
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were enrolled in an mHealth intervention mentioned that there was “no trouble setting up. It’s all 
there, so all you had to do is turn it on”. 
3. Patients need to be educated on the use of mHealth. 
Patients learned how to use mHealth interventions via different sources. The majority 
asked their family members for assistance “...I’ll go to my 14-year-old who is generationally 
more apt to be able to teach me a new technology”. This was also mentioned by another patient 
who used a fitness tracker: “My nieces. They buy it for me and they set it up for me and 
everything”. Other patients taught themselves about mHealth interventions: “If I can read it, I 
can learn it...I generally research it myself” or used the library: “Also the libraries here will help 
you in any programs”. One patient said that her “...own care worker helps with it, I don’t know 
how to do it”. It was also recommended by some that technical support staff be available as a 
resource for patients to call when they needed technical help. 
4. The credibility of mHealth needs to be evident. 
Some patients thought that the credibility of mHealth needs to be made evident. Some 
patients stated that they would use an mHealth intervention if it was recommended by their HCP: 
“if he told me that, I probably would try to do it”. This was reiterated by a patient who monitored 
his COPD regularly: “Doctor xx was the one that said to me… If you’re going to cope with this 
and keep it under control, you’re going to have to learn how to look after yourself”.   
4.3.2.3 Barriers 	
Patients reported six barriers to mHealth adoption, which are discussed below.  
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1. There are technical issues with mHealth. 
A few patients expressed that they did not have the technical expertise to use mHealth. 
One patient expressed his concern: “I wouldn’t know how to turn a computer on. I’m not very 
good… You know, I never grew up with computers but I have seen one”. This was reiterated by 
another patient: “It just looked way too complicated to download the app so I didn’t because I’m 
technology averse”. For patients that used mHealth, technical issues included limited cellular and 
Wifi connection: “we travel out to the cabin every weekend and the cabin’s out in central 
Newfoundland out in Terra Nova and now it’s getting better now because these phone services 
getting better out there”. Another issue was moving and setting up the mHealth intervention 
components, such as a blood pressure monitor or a scale, when travelling: “...  it’s not a problem. 
But when you go on vacation, sometimes you got to take this along with you and set it up 
somewhere”.  
2. Lack of awareness is a challenge. 
Many patients indicated that a lack of awareness is a barrier to mHealth adoption. One 
patient expressed this concern: “I’m not aware of everything that’s out there, but people need to 
be more aware of their COPD and know more about it.” Also, a family member stated the 
following about her mother who has COPD: “I think it’s more she probably don’t know what her 
phone can do, right. But if you say to her okay we’re going to start using this, this is going to be 
useful and it’s going to be beneficial I’m sure she’d be game for it”. 
However, patients who participated in an mHealth intervention stated that their HCP 
recommended the mHealth intervention to them when they were in the hospital or attended a 
community health event. Another patient mentioned that “it was advertised and I called in about 
it and they got in contact with me, set me up with it”. 
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3. There may be limited uptake from the elderly. 
A few patients mentioned that they face issues in adopting technology because of their 
age. One patient stated, “I’m not generationally born into technology that is prevalent and 
considered a norm of the day”. This was also mentioned by another: “I try but I’m a little bit 
nervous, sometimes I’ll ask my daughter or someone else around because we didn’t grow up 
with the phones as you do today”.  
4. There are possible financial barriers. 
A few patients said they cannot afford mHealth and did not have access to smartphones. 
One patient expressed it this way: “there’s no way I’ll pay that money”. Expenses incurred 
through the use of data were also discussed: “it’s a bit expensive for like I’ve got no data right 
now because it’s all extra”. In addition to individual patient costs, one patient raised the concern 
of additional costs required by HCPs: “doctors are not going to do that without a fee”. Also, 
some mHealth programs are limited to a certain period, so this may increase costs.  
5. There may be privacy and confidentiality concerns. 
One patient thought privacy and confidentiality could be a barrier to mHealth adoption. 
She was open to sharing the results with a HCP but not a family member: “I don’t want to make 
them worry (her family) because I told them nothing about my cancer... I don’t like to worry my 
family”. The rest of the patients were willing to share the results with their family members and 
HCPs: “I don’t care who sees it...They can put it in the Evening Telegram, doesn’t bother me.” 
This was echoed by another patient: “they (his family) watch over my shoulder like nothing else 
now”.   
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6. Some patients were not interested in using an mHealth intervention.  
Some patients indicated that a lack of interest in mHealth is a major barrier to its 
adoption. One patient expressed this concern: “I do try to help myself but when it comes to using 
the phone and that stuff and the computer, it’s not for me”. This was also mentioned by another 
patient with limited technology experience: “I know on smartphones you can dial, you can play a 
game and some they can even watch movies probably, but I got no interest”. Another patient 
mentioned that they are too busy to include an mHealth intervention in their routine: “So my day 
is pretty filled with different things. So remembering is a problem. Sometimes I just say: To hell 
with it and I am not going to do it. But remembering is probably the biggest thing”.  
When patients use mHealth, they may not share the results with their HCP. This occurs if 
the mHealth intervention is not integrated in the healthcare system. One patient posited that some 
HCPs are not interested in reviewing the records brought by patients: “And my sheet, he didn’t 
even look at it...That’s, that’s depressing”.  
4.4 Discussion  
4.4.1 Principal Findings 
We conducted an explanatory sequential mixed methods study with COPD patients and 
identified their perceptions regarding the use of mHealth for COPD management. The 
quantitative component revealed that over 70% of COPD patients owned a mobile phone, but 
only about a quarter of the participants, 18/77 (23.4%), owned a smartphone. The likelihood of 
owning a smartphone was not associated with age, sex, marital status, or geographical location. 
However, patients with high educational status were more likely to own a smartphone. The 
qualitative component found that COPD patients, in general, had a positive attitude toward 
mHealth adoption for COPD management, but several facilitators and barriers were identified. It 
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is important to promote the facilitators and address the barriers to optimize the successful 
implementation of mHealth interventions. 
Using a mixed methods approach allowed us to produce a diverse sample of COPD 
patients. The quantitative and qualitative components complemented each other to improve the 
validity of inferences and expand on why participants answered quantitative questions in a 
certain way. For example, the number of participants who stated that they had a smartphone 
(n=18) was lower than the number of participants who accessed the internet through their mobile 
phone (n=22), suggesting a lack of understanding of what a smartphone is. This was explored 
further during the interviews. Although some participants owned a smartphone, their use was 
limited to making phone calls and taking pictures. On the other hand, some participants did not 
own a smartphone, but they were able to enrol in an mHealth intervention and complete the 
program. As explained by one patient, “Eastern Health sets you up with everything. It’s so 
different, there’s nothing to it, it’s just hit the button, use your device and it’s so easy to use”. 
This finding highlights the need for education and confidence building among patients with 
COPD.   
We created a joint display (Table 4.5) to clarify some of the barriers that were reported 
quantitatively. The table is organized by survey items. It merges the related quantitative results 
and provides typical comments from COPD patients.  
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Table 4.5: Joint display about barriers to mHealth adoption  
Quantitative Results  Qualitative Results  Interpretation of mixed 
methods findings 
Variable  n/ %  Exemplar Quotes 
Concerns 
regarding 
smartphones 
(N=77)   
Cost of 
smartphones 
 
21/ 
27.3 
“I can’t afford one 
(smartphone)”;  
“I’ve got no data right now 
because it’s all extra”; “we can 
always get one (smartphone)”. 
Costs include the cost of a 
smartphone and the data to 
enable its functionalities. 
However, some patients 
could not afford to get a 
smartphone, or it could be 
provided by the healthcare 
system.     
 Not easy to 
use 
9/ 
11.7 
“I wouldn’t know how to turn 
a computer on. I’m not very 
good…”  
 
“There’s nothing to it, it’s just 
hit the button, use your device 
and it’s so easy to use”. 
Although some participants 
owned a smartphone, their 
use was limited to making 
phone calls and taking 
pictures. On the other hand, 
some participants did not 
own a smartphone, but they 
were able to enrol in an 
mHealth intervention and 
complete the program. This 
finding highlights the need 
for education and 
confidence building among 
patients with COPD. 
Concerns 
regarding app 
use 
(N=10) 
Worried about 
personal 
information 
disclosure 
 
6/  
60 
“I don’t want to make them 
worry because I told them 
nothing about my cancer... I 
just told my sister a week 
before I had my surgery... I 
don’t like to worry my 
family”.  
 
 “I don’t care who sees 
it...They can put it in the 
Evening Telegram, doesn’t 
bother me”.   
There was inconclusive 
evidence regarding 
confidentiality. Patients 
should have a choice in 
what to share and who 
should have access to their 
health information.  
n= 77 is the total study population.  
n= 10 is the sample that use apps. 
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4.4.2 Comparison with Prior Work 
Our study provides a meaningful contribution to the literature, as few prior studies have 
specifically examined the use of mHealth among COPD patients. It is important to note that the 
published literature on mHealth access and use was focused on general, and largely healthy, 
populations, with little attention to individuals with chronic illnesses, such as COPD (Robbins et 
al., 2017).  
A study investigated smartphone ownership among the general public and reported a high 
smartphone adoption rate, 76% (Kayyali et al., 2017). Ramirez et al. (2016) investigated 
smartphone ownership in primary care clinics and also found a high adoption rate of 76%; 
however, 96% of the participants were younger than 65 years old. Among COPD patients from 
several locations in the US, we found lower smartphone adoption rates, 47%, which was double 
the rate reported in our sample (Witry et al., 2018). The qualitative data expand on this finding 
by clarifying that some smartphone owners use their device in ways similar to a mobile phone 
owner. Knowing how to use the features of a smartphone, such as using apps, is necessary for 
using the mHealth intervention. This finding highlights the need for education and confidence 
building among some smartphone users to help them use their devices for COPD management.  
Our logistic regression results support the claim that a lower level of education is 
associated with limited access to mobile devices (Krebs & Duncan, 2015; Fox & Duggan, 2012; 
Illiger et al., 2014). Other researchers also found that the individuals more likely to use health 
apps tended to be younger and have higher incomes (Krebs & Duncan, 2015; Witry et al., 2018; 
Fox & Duggan, 2012; Illiger et al., 2014). Our findings echo concerns about the relationship 
between mHealth access and health disparities (Witry et al., 2018). Limiting mHealth 
interventions to smartphone or tablet owners could disproportionately benefit highly educated 
and wealthy individuals.  
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We also investigated the association between technology use and geographical location. 
Although we did not find differences between smartphone ownership among urban and rural 
patients with COPD, a report suggests that individuals living in rural areas are less likely than 
nonrural adults to have smartphones (Perrin, 2017). Previous studies suggest that among patients 
with COPD, living in rural areas was associated with worse health status (Abrams et al., 2013; 
Jackson et al., 2013). The authors suggest that the higher prevalence of COPD in rural areas 
could be linked to an increased proportion of older residents, a shortage of HCPs, the underusage 
of spirometry and pulmonary rehabilitation, and problems with access to medical care (Abrams 
et al., 2013; Jackson et al., 2013). Limited access to smartphones may further exacerbate health 
disparities for rural COPD patients (Witry et al., 2018). Policy makers and researchers should 
consider providing access to technologies for patients that cannot afford it. Additionally, some 
technology recycling programs may assist in the bridging the digital divide.  
Similar to Kayyali et al. (2017), the majority of the participants were open to data sharing 
options with a HCP through mHealth apps. Nevertheless, Kayyali et al. (2017) stated that data 
sharing can be ineffective if the participant is not honest or if data sharing is overused.  
Some of the findings presented in this study confirm previously reported findings in the 
context of mHealth for COPD management. Our findings are in agreement with Vorrink et al. 
(2017), who stress the importance of training patients and HCPs on the proper use of mHealth. 
As suggested by Korpershoek et al. (2018), we confirm that the expected benefits of using 
mHealth contribute to the success of mHealth uptake, and our study provides additional insight 
regarding these perceptions, such as on the ease of use, educating patients about mHealth, and 
the importance of credibility. Our findings echo some and add to the barriers reported by Krebs 
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& Duncan (2015), which include technical difficulties and a lack of interest. We included quotes 
from participants to expand on these insights.   
In comparison with the facilitators reported by HCPs, patients had four parallel 
facilitators: there are possible health benefits for patients, the software needs to be easy to use, 
patients need to be educated on the use of mHealth, and the credibility of mHealth should be 
evident (Alwashmi et al., 2019a). The only facilitator that was not mentioned by patients is that 
mHealth should reduce the cost to the healthcare system. On the other hand, patients had five 
parallel barriers with the HCPs: there are technical issues with mHealth, lack of awareness is a 
challenge, there may be limited uptake from the elderly, there are possible financial barriers, and 
there may be privacy and confidentiality concerns (Alwashmi et al., 2019a). The possibility of 
mHealth limiting the personal connection between HCPs and patients was not mentioned as a 
barrier by patients. Furthermore, one new barrier emerged from interviewing patients: some 
patients were not interested in using mHealth interventions. Our findings, and the limited 
literature on the matter, emphasize the need for further research into the use of mHealth in 
COPD management. 
4.4.3 Strengths and Limitations 
This study has several strengths. First, we used a mixed methods approach to produce a 
diverse sample of participants. This human-centered approach ensures that the needs and 
challenges of a diverse group of COPD patients can be considered prior to developing an 
mHealth intervention. Second, some COPD patients had experience in using an mHealth 
intervention to manage their COPD, which further increases the richness of the data. Third, all 
the interviews were conducted in a similar manner to ensure consistency during the data 
collection and analysis. Fourth, mHealth is particularly important in geographic locations with a 
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relatively large proportion of rural residents such as Newfoundland and Labrador (NL). Of the 
Atlantic Provinces, NL has the highest proportion of its population (60%) living in rural areas 
(Simms & Greenwood, 2015). mHealth may enhance care provider access throughout sparsely 
populated rural areas. NL has a substantial remote and rural population; therefore, our results 
may be more applicable to rural areas. Lastly, we recruited COPD patients from outpatient 
respirology clinics. This has led to capturing a well-characterized cohort of individuals with 
COPD.   
There were also several limitations. First, the number of COPD patients who completed 
the survey was fairly small. However, all efforts were made to recruit as many participants as 
possible and facilitate the completion of the survey. Due to the small sample size, regression 
coefficients may have been imprecisely estimated. However, the age of the sample was reflective 
of a representative sample of COPD patients in Canada that were recruited from a respirology 
clinic (Safka et al., 2017). Second, not all the patients had experience with using mHealth. Thus, 
the perceptions of these participants were not based on actual interventions with patients. Third, 
conducting focus groups with some of the participants following the individual interviews could 
have yielded richer information, as participants would have been given the opportunity to 
compare their thoughts and confirm or expand upon each other’s ideas. Fourth, there were no 
questions in the quantitative survey about facilitators of mHealth uptake. Including this topic 
would have been beneficial, as it could have been expanded upon when conducting the 
interviews. 
4.4.4 Implications for practice and for future research 
The findings of this study may help various stakeholders who are planning to use 
mHealth interventions for COPD management. Some of the barriers and facilitators have the 
145 
 
potential to be applied to other chronic diseases. It is important to consider the low rate of 
smartphone use among COPD patients when implementing an mHealth intervention for COPD 
management. Some lessons learned include the importance of raising awareness among COPD 
patients regarding the potential of mHealth interventions in COPD management. Family 
members could play a significant role in raising awareness as well as in teaching patients with 
COPD about mHealth. The findings also stress the importance of developing a user-friendly 
mHealth intervention. This could reduce the time and resources required to teach patients about 
the mHealth intervention. The lack of an internet connection could limit access to mHealth 
interventions. This should be taken into consideration when measuring access to health resources 
in rural communities.     
Future studies would benefit from conducting focus groups with some of the participants 
following the individual interviews. Focus groups could yield rich information, as participants 
would be given the opportunity to compare their thoughts and confirm or expand upon each 
other’s ideas. After developing a user-centred mHealth intervention, the authors recommend 
using a mixed methods framework for usability testing (Alwashmi et al., 2019b). Additional 
trials will be required to provide data regarding the efficacy and cost-effectiveness of mHealth 
interventions in COPD management. 
4.5 Conclusion 	
It is important to understand access to mHealth among patients with COPD and their 
perceptions regarding the adoption of mHealth for COPD management. Despite the rise in 
smartphone adoption, the rate among patients with COPD remains low. Additionally, it is 
important to consider that owning a smartphone does not mean one has the ability to use it for 
mHealth. This finding highlights the need for education and confidence building among some 
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smartphone users to be able to use their devices for COPD management. This study identifies 
some potential facilitators and barriers that may inform the successful development and 
implementation of mHealth interventions for COPD management. We recommend that those 
who develop mHealth interventions for COPD should consider the facilitators and barriers 
highlighted in this study.   
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Chapter 5: Features of a Mobile Health Intervention to Manage Chronic 
Obstructive Pulmonary Disease: Qualitative Study 
Preface 
A version of this chapter will be submitted to a suitable journal. I completed the first draft 
and revised it according to the suggestions of co-authors and reviewers. Dr. John Hawboldt and 
Dr. Erin Davis suggested the general research topic and provided feedback on the manuscript. 
Dr. Beverly Fitzpatrick helped revise the original manuscript to make the argument clearer. Dr. 
Jamie Farrell, Gerard Farrell, Hai Nguyen and Dr. John-Michael Gamble reviewed the 
manuscript and provided revision suggestions. Dr. Jamie Farrell also assisted in recruiting 
participants.  
Abstract 
Background: The use of mobile health (mHealth) interventions has the potential to enhance 
chronic obstructive pulmonary disease (COPD) treatment outcomes. Further research is needed 
to determine which mHealth features are required to potentially enhance COPD self-
management. 
Objective: The aim of this study was to explore the potential components of an mHealth 
intervention for COPD management with health care providers (HCPs) and patients with COPD. 
Methods: This was a qualitative study. We conducted semistructured individual interviews with 
HCPs, including nurses, pharmacists, and physicians who work directly with patients with 
COPD. Interviews were also conducted with a diverse sample of patients with COPD. A guide 
with prompts was used to facilitate discussions. Interview topics included demographics, 
mHealth usage, the potential use of medical devices, and recommendations for features that 
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would enhance an mHealth intervention for COPD management. Interviews were conversational 
in nature, and the items were not asked verbatim or in the order presented.  
Results: A total of 40 people — patients, nurses, physicians, and pharmacists — participated. 
The main recommendations for the proposed mHealth intervention were categorized into two 
categories: patient interface and HCP interface. The prevalent features suggested for the patient 
interface include educating patients, collecting baseline data, collecting subjective data, 
collecting objective data via compatible medical devices, providing a digital action plan, 
allowing patients to track their progress, enabling family members to access the mHealth 
intervention, tailoring the features based on the patient’s unique needs, reminding patients about 
critical management tasks, and rewarding patients for their positive behaviors. The most 
common features of the HCP interface include allowing HCPs to track their patients’ progress, 
allowing HCPs to communicate with their patients, educating HCPs and remunerating HCPs.  
Conclusions: It is important to understand the perceptions of patients and HCPs regarding the 
adoption of innovative mHealth interventions for COPD management so that the most effective, 
efficient, and feasible mHealth intervention can be developed to improve patient health. This 
study identifies important potential features that may inform the successful development and 
implementation of mHealth interventions for COPD management. 
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5.1 Introduction  
The significant rise in mobile phone ownership coupled with increased expectations of 
the user’s role in managing their own care presents a unique opportunity for Mobile Health 
(mHealth) interventions (Mendiola et al., 2015). The Global Observatory for eHealth of the 
World Health Organization defines mHealth as “medical and public health practice supported by 
mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, 
and other wireless devices” (World Health Organization, 2011). A mobile mHealth intervention 
could also include the use of a medical device that is compatible with a smartphone. The 
literature suggests that mHealth interventions could play a significant role in the management of 
chronic health conditions, including chronic obstructive pulmonary disease (COPD) (Alwashmi 
et al., 2016; Joe & Demiris, 2013; Juen et al. 2015; Zhang, Song, & Bai, 2013). Alwashmi et al.  
noted that the current literature on the role of smartphones in reducing COPD exacerbations is 
limited, but it suggests that smartphone interventions may reduce COPD exacerbations (2016). 
5.1.1 Chronic Obstructive Pulmonary Disease Treatment and Management  
Effective COPD management could delay disease progression and reduce acute 
exacerbations, thereby improving patients’ quality of life and reducing healthcare costs (Nguyen 
et al., 2009). There are various methods for enhancing COPD management. Smoking cessation is 
the most important factor that influences the natural history of COPD (GOLD, 2019). Patient 
education regarding the disease and correct use of inhalers is also vital for COPD management. 
Lareau and Hodder stress the importance of patient education for the correct use of inhalers to 
ensure the effectiveness of inhaled medications (Lareau & Hodder, 2012). In addition, the 
synergistic effects of multiple COPD interventions, such as pulmonary rehabilitation, oxygen 
supplementation, and physical activity, could enhance COPD management. Physical activity is 
beneficial for patients with COPD, and they should repeatedly be encouraged to remain active 
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(GOLD, 2019). Various studies reported that pulmonary rehabilitation (Burkow et al., 2015) and 
physical activity interventions can be delivered remotely (Nguyen et al., 2009).  
Both pharmacological and non-pharmacological management strategies are crucial in the 
management of COPD exacerbations. Pharmacologic therapy is used to reduce symptoms, 
reduce the frequency and severity of exacerbations, and improve health status and exercise 
tolerance (GOLD, 2019). Non-pharmacological strategies improve health status and quality of 
life, reduce healthcare utilization, and reduce costs by preventing the frequency and severity of 
COPD exacerbations (Suh, Mandal, & Hart, 2013). Effective self-management programs include 
written action plans that enable patients with COPD to manage exacerbations and react 
appropriately through the prompt initiation of prednisone or antibiotics (Wood-Baker et al., 
2006). Adherence to a COPD action plan can be effective in the management of COPD (Bischoff 
et al., 2011, Sedeno et al., 2009). The use of mHealth interventions has the potential to improve 
the uptake of COPD action plans.  
Although there are effective and inexpensive treatments for COPD, adherence rates are 
amongst the lowest of all chronic diseases, leading to avoidable adverse medical outcomes, costs, 
and reduced quality of life. Nonadherence in COPD is documented in the uptake of all therapies, 
including oxygen supplementation, physical rehabilitation, and medications; it contributes to 
rising rates of hospitalizations, deaths, and healthcare costs (Bender, 2014).  Additional strategies 
are needed to overcome non-adherence and barriers to optimal treatment. 
5.1.2 mHealth for Chronic Obstructive Pulmonary Disease Management  
The current literature suggests the potential for smartphone integration in the 
management of COPD. mHealth could play a significant role in the management of modifiable 
risk factors. The application of a multifactorial intervention (COPD information, dose reminders, 
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audio-visual material, motivational aspects, and training in inhalation techniques) resulted in an 
improvement in therapeutic adherence in patients with COPD (Leiva-Fernandez et al., 2014). 
Wang et al. (2014) stated that a mobile-phone-based system can provide an efficient home 
endurance exercise training program with improved exercise capacity, strengthened limb 
muscles, and decreased systemic inflammation in patients with COPD. Another study indicated 
that the smartphone-based collection of COPD symptom diaries enabled patients to identify 
exacerbations symptoms early on in the exacerbation, providing the opportunity for early 
intervention (Johnston et al., 2012). Bender stated that COPD adherence may benefit from 
communication and advice delivered through mobile technology, along with a larger program of 
education, monitoring, and support (Bender, 2014).  
Medical devices, such as spirometers and pulse oximeters, can obtain objective data that 
cannot be collected by smartphones alone. Recent advancements in technology allow for 
seamless integration between smartphones and medical devices. Various studies have paired 
medical devices, such as electronic vests, heart rate monitors, pulse oximeters, and 
accelerometers, with smartphone technology to assist in COPD management and detect 
exacerbations  (Beattie et al., 2014; Barberan-Garcia et al.., 2014; Kelly et al., 2015; Kocsis et 
al., 2015; Nabhani-Gebara et al., 2014; Spina et al., 2015; Taylor et al., 2015; Tabak et al., 2014). 
However, these studies were focused on the technical effectiveness of these methods, and there 
was limited involvement of patients during the design of these interventions. In addition, the 
studies gave limited attention to patient perceptions, usability, and satisfaction. 
5.1.3 Importance of Human-Centered Design  
The International Organization for Standardization (ISO) 9241-210 standard defines 
human-centered design (HCD) as “an approach to systems design and development that aims to 
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make interactive systems more usable by focusing on the use of the system and applying human 
factors/ergonomics and usability knowledge and techniques” (ISO, 2010). The ISO uses the term 
HCD instead of user-centred design (UCD) to “address impacts on a number of stakeholders, not 
just those typically considered as users”(ISO, 2010). However, in practice, these terms are often 
used synonymously.  
Harnessing smartphone applications (apps) as a means of delivering behavioral 
interventions for health is receiving increasing interest from academics and clinicians; however, 
research on the development and evaluation of such apps is in the relatively early stages 
(Dennison et al., 2013). Many of the barriers to using telehealth can be avoided with better 
planning and collaboration (Taylor et al., 2015). Testing mHealth interventions with patients has 
revealed preferences and concerns unique to the tested population (Nelson et al., 2016; Sarkar et 
al., 2016; Steele Gray et al., 2016). When developing an mHealth intervention, Hopkins et al. 
(2016) encouraged including insights from key users to potentially improve the process and the 
outcome of the intervention. 
Triantafyllidis et al. (2015) used an iterative approach to refine a tablet computer-based 
home monitoring system for heart failure patients. However, there was limited uptake of the 
system due to usage difficulties and low levels of patient satisfaction. The authors recommended 
patient-centred approaches for the sustainable delivery of remote health monitoring services. 
Patient-centred care recognizes the complex, subjective, and changing nature of patients’ health 
status (Upshur & Tracy, 2008); in addition, it links multiple episodes of care offered by diverse 
providers into continuous, integrated care trajectories unique to particular patients. Developing a 
COPD mHealth intervention with insights from HCPs and patients with COPD will potentially 
improve the process and outcome of the mHealth intervention.  
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5.1.4 Human-Centered Design in Chronic Obstructive Pulmonary Disease  
Although mHealth has gained popularity in recent years, patient and HCP perspectives 
toward using mHealth for COPD management are relatively unexplored (Korpershoek et al., 
2018). The United Kingdom has recommended that apps be “prescribed” as part of the care for 
long-term conditions (Department of Health, 2012). Unfortunately, few published studies 
address which specific features of mHealth interventions are beneficial for patients with COPD 
(Sobnath et al., 2017). A recent meta-analysis on the remote monitoring of patients with COPD 
concluded that some interventions may prove promising in changing clinical outcomes in the 
future, but there are still large gaps in the evidence base, including the limited number of 
effectiveness trials (Noah et al., 2018). Noah et al. (2018) recommend that adding a qualitative 
component would give researchers insight into which elements best engage and motivate patients 
and HCPs.  
By obtaining the perspectives of nurses, physicians, pharmacists, and patients, we hope to 
understand their requirements for an mHealth intervention. Gaining a better understanding of 
how patients and HCPs interact with mHealth interventions will assist in developing evidence-
based interventions that have the potential to change behavior over long periods of time (Noah et 
al., 2018). Lessons learned will be offered as a guide for research and technology developers 
working with patients with COPD and their HCPs. 
5.2 Methods  
5.2.1 Purpose  
To explore and develop an understanding of the perceptions of patients with COPD and 
their HCPs regarding the appropriate mHealth features and compatible medical devices for 
COPD management. The study was also intended to intended to generate insights into the 
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potential frequency of the features to ensure that patients and HCPs remain engaged with and 
responsive to the mHealth intervention. 
5.2.2 Study Design  
We used a descriptive qualitative research design that was grounded in pragmatism 
(Merriam & Tisdell, 2015; Patton, 2015). Using a qualitative methodology allowed us to achieve 
an in-depth, contextualized picture of what a diverse sample of patients with COPD and their 
HCPs, in this case, nurses, pharmacists, and physicians, think and feel about the possibility of 
using mHealth in COPD management. This has pragmatic value, as mHealth is an emerging 
option for delivering health care.  
5.2.3 Recruitment and Study Setting  
HCPs involved in the treatment of patients with COPD were eligible to participate. The 
primary investigator (PI) contacted the Newfoundland and Labrador Medical Association, the 
Association of Registered Nurses of Newfoundland and Labrador, and the Pharmacists’ 
Association of Newfoundland and Labrador. These organizations were asked to forward a 
recruitment email to their mailing lists or post it on their websites. Interested HCPs contacted the 
PI via email or telephone, who then scheduled appointments to complete the consent forms and 
conduct the interviews.  
Patients were recruited during routine visits to their respirologists at outpatient 
respirology clinics in the Eastern Health Regional Health Authority of the province of 
Newfoundland and Labrador, Canada. Participants were eligible for the study if they met the 
following inclusion criteria:  
1. a COPD diagnosis (self-report), 
2. aged ≥30 years at study enrollment, 
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3. able to answer questionnaires in English, and  
4. able to provide informed consent.  
Based on the demographic information collected from patients, a purposeful sampling 
strategy was used to identify key informants that could provide rich and diverse interview data. 
We used purposeful typical case sampling to gather information that would reflect typical cases 
of mHealth use (Patton, 2015; Creswell, 2016). We also used a criterion-based selection (Patton, 
2015) so that we could categorize participant characteristics such as age, familiarity with 
mHealth, healthcare profession, and years of experience. In addition, as the interviews 
progressed, some participants were recruited by snowball or chain sampling, where participants 
suggested other possible HCPs (Patton, 2015, Emerson, 2015). Snowball or chain sampling was 
used to ask a few information-rich participants for additional contacts to provide confirming or 
different perspectives, allowing for richer data (Patton, 2015).  
We first contacted nurses, and after interviewing eight nurses, we reached saturation, as 
we were not gathering new information. However, we continued interviewing until 10 nurses 
were interviewed. This was to strengthen the validity of inferences (Maxwell, 2013). We used 
the same sampling strategy for the remaining professions and patients, with similar saturation 
points, as we continued to interview ten participants for each profession and for patients. Our 
final sample size was comparable with similar qualitative studies (Damhus et al., 2018; 
Korpershoek et al., 2018; MacDonald et al., 2018). 
Participants were recruited from April 2018 to August 2018. Our sample consisted of 10 
patients and 30 HCPs: 10 nurses, 10 pharmacists, and 10 physicians. The study took place in St. 
John’s, Canada. We conducted some interviews at Memorial University and others at the 
162 
 
participants’ offices or homes. After completing the interviews, patients were offered a $30 gift 
card.  
5.2.4 Ethical Considerations   
Ethical approval for this study was obtained from the Newfoundland and Labrador Health 
Research Ethics Authority (HREB -2017-194). Before agreeing to participate, all subjects were 
informed about the nature of the research project, the possible risks and benefits, and their rights 
as research subjects. All participants completed a written consent form. They were also given a 
copy of the consent form. 
5.2.5 Data Collection   
We conducted individual semistructured interviews to gain an understanding of the 
everyday lived experiences of HCPs and patients in relation to using mHealth (Brinkman & 
Kvale, 2015; Rubin & Rubin, 2012). Using semistructured interviews allowed the interviewer to 
begin with a broad question to direct the focus of the interview and then to provide an 
opportunity for the HCPs and patients to bring forth their thoughts and feelings about phenomena 
they thought were important (Brinkman & Kvale, 2015; Rubin & Rubin, 2012). The interview 
prompts are available in Appendix 1 (for HCPs) and Appendix 3 (for patients). To facilitate 
discussions, the interviews were conversational in nature, and items were not asked verbatim or 
in the order presented. As the study progressed, emerging issues were explored with subsequent 
participants to refine the themes. The prompts were informed by findings from the literature and 
input from the authors, who have diverse backgrounds including mHealth, pharmacy, nursing, 
medicine, respirology, family medicine, education, and qualitative research. 
The interviews were recorded to enable transparent and accurate transcription. Interview 
lengths ranged from 20 to 60 min. Topics included the following: demographics, mHealth usage, 
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perceptions toward challenges of mHealth adoption, factors facilitating mHealth adoption, and 
preferences regarding features of the mHealth intervention for COPD management. Topics also 
included discussions about smartphone-compatible medical devices (accelerometers, portable 
spirometers, and pulse oximeters). Owing to a large amount of data, preferences regarding the 
barriers and facilitators of mHealth adoption for COPD management were presented in different 
articles (Alwashmi et al. 2019a; Alwashmi et al., 2019b). HCP data consisted of more than 13 
hours of interview time with approximately 300 pages of transcription. Patient data consisted of 
about four hours of interview time with approximately 100 pages of transcription. 
5.2.6 Data Analysis   
The interviews were transcribed verbatim and compared against the digital recordings to 
ensure the accuracy of the content. Identifying information (names) were removed to protect 
anonymity. We used NVivo (version 12; QSR International) to organize the data and examine 
the words, including frequency counts, as in classical content analysis (Leech & Onwuegbuzie, 
2008). All data were analyzed, but we only coded data that were relevant for answering the 
research questions, as recommended by Saldana, 2015; Wolcott, 2009; and Yin, 2011. An audit 
trail was created to keep track of all analytic decisions (Guest et al., 2012). 
After using NVivo, we used first cycle coding with nurses’ data that were both structural 
and holistic (Saldaña, 2016), meaning that we used the interview prompts and the literature to 
guide some of the coding. One researcher analyzed the transcripts and developed a set of themes 
and subthemes and then obtained input from a second researcher. In the second cycle of coding, 
the two researchers independently coded the nurses’ data using pattern coding to develop themes 
(Saldaña, 2016). They then discussed commonalities and differences in their coding and theme 
development until a consensus was reached. The analysis of the nurses’ data was mainly 
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inductive and iterative throughout, as we went back and forth among the data, the coding, and 
the themes (Miles et al., 2014).  
After the nursing analysis was finished, we completed the same two cycles of analysis for 
the pharmacist, physician, and patient data. These analyses included inductive and deductive 
analysis. However, the analysis was more deductive in nature, as themes had already been 
developed from the nursing data. Furthermore, some new themes emerged when analyzing data 
from patients and other HCPs. The iterative process continued as these analyses were conducted 
to find commonalities, differences, and new patterns in thinking in relation to the nurses’ data. 
Once these four sets of analysis were complete, the two researchers discussed common and 
different trends among the three HCP groups and patient group to develop final themes that 
encompassed all the HCPs and patients. 
5.3 Results  
The results are organized in three sections. The first section describes the demographics 
of the sample. Then, the features of the patient interface will be highlighted in the second 
section. Lastly, the third section describes the features of the healthcare professionals’ interface.   
5.3.1 Demographics 
The sample included HCPs who worked with patients with COPD in various settings, 
including respirology clinics, cancer clinics, critical care, long-term care, and community health. 
Some HCPs founded a medical technology company or had a software programming 
background. About half the HCPs had experience with an mHealth intervention to manage 
COPD. Participant demographics are outlined in Table 5.1.  
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Table 5.1: Participant demographics.  
 Sample size Age mean (SD) Years of experience 
mean (SD) 
Nurses 5 47.3 (6) 19.6 (9) 
mHealth* Nurses  5 40.6 (10) 15.8 (10) 
Physicians 5 37 (9) 8.4 (8.7) 
mHealth* Physicians  5 41.2 (12) 14.4 (11) 
Pharmacists  7 35.7 (11) 11.4 (10) 
mHealth* Pharmacists  3 27.5 (4) 3.6 (2) 
mHealth: experience in using an mHealth intervention. 
SD: Standard Deviation 
 
Ten patients with COPD participated in face-to-face interviews. The mean age was 67.6 
(±7.58) years, and the range was from 51–80 years. There were four females and six males. 
Based on self-report, the mean number of years living with COPD was 8.4 (±4.45) years, and the 
range was from 3–15 years.  
5.3.2 Patient Interface 
The mHealth interface is defined as the way in which information is made available to 
users on the screen (Combley, 2011). We developed themes under two categories: patient 
interface and HCP interface. Table 5.2 summarizes the main features recommended for the 
patient interface. We have also included details and examples to illustrate the HCPs’ and 
patients’ thoughts and beliefs.  
The patient interface allows patients to access features of the mHealth intervention. The 
authors recommend using a smartphone to access these features. In addition, a tablet or a laptop 
can also be used. This section explains how patients and HCPs think these features would be 
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beneficial in the management of COPD. The following themes give examples of how patients 
and HCPs can work as a team in a complementary fashion to improve patient health. 
 
Table 5.2: Themes with specific examples regarding the features of the patient’s interface.  
Theme Specific examples for each theme 
The educational component is 
valuable.  
A source of reliable information is important. 
 
Topics include information about the disease, medication, 
inhaler techniques, and breathing exercises.  
 
The educational content can be delivered via messages, 
videos, or walkthroughs.   
It is important to collect baseline 
information. 
 
 
 
 
 
 
It is important to collect subjective 
health data.  
 
 
 
 
 
 
 
It is beneficial to collect objective 
health data. 
 
 
 
 
 
 
 
 
 
It is necessary to understand the patient and evaluate the 
COPD management progress. 
 
Information should include demographics, health data, 
psychosocial data, primary care physician, and emergency 
contact.   
 
 
It is necessary to understand the level of COPD 
management and guide pharmacological therapy.  
 
Information should include shortness of breath, cough, 
and sputum. 
 
Data about medication adherence, exacerbations, and 
hospitalizations are important.  
 
Objective data for monitoring COPD are helpful. 
 
It could reduce the reliance on healthcare resources. 
 
Medical devices could potentially include a portable 
spirometer, pulse oximeter and a medication adherence 
monitor.   
 
Additional devices can be added, especially if the patient 
has a comorbidity.  
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Providing a COPD Action Plan is 
recommended. 
 
 
 
 
Allowing patients to track their 
COPD management progress 
would be helpful.  
 
Providing access to family 
members or caregivers would be 
beneficial. 
 
 
Consider tailoring the features 
based on the patient’s unique 
needs. 
 
 
 
 
 
Reminding patients to manage 
their COPD is a benefit.  
 
 
 
Rewarding patients for managing 
their COPD is a possibility. 
 
 
 
There were a few features 
mentioned by a minority of HCPs 
and patients. 
 
 
 
 
It has the potential to empower patients to be a part of 
their management plan and reduce hospitalizations. 
 
It could use the subjective and objective data to 
personalize COPD management.  
 
The ability to track the progress of the subjective and 
objective data.   
 
 
Family members or caregivers can assist in the delivery of 
the mHealth intervention.    
 
 
Differences in COPD severity level and presence of a 
comorbidity can affect the features required by patients.  
 
Personalizing the features include changing the frequency 
of objective and subjective data collection.  
 
 
Reminders include taking medications, refilling 
prescriptions, and attending hospital appointments. 
 
 
Using positive reinforcement messages or reward 
programs can be motivational.  
 
 
Features include:  
Using artificial intelligence. 
Consider visually impaired patients.   
Ability to share the records with any HCP. 
Ability to access medical records. 
Including a smoking cessation program. 
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5.3.2.1 The educational component is valuable  
Pharmacists, nurses, and physicians agreed that mHealth can have a role in educating 
patients with COPD. One pharmacist remarked, “... COPD is something they’ll have for life. So 
especially when they’re getting diagnosed that this is introduced as a tool for education, for 
making sure that it doesn’t get worse”. Similarly, a physician felt confident that patients would 
“learn more about their own disease and if they know more about their disease, then, like, 
generally speaking, they’re more invested in their care”. A pharmacist raised a point that getting 
educational information through an app is better than “having to Google the information and 
coming across misinformation”.  
HCPs had strong thoughts regarding the educational content of the mHealth intervention. 
The majority of HCPs agreed that it should include information about the administration 
technique of inhaled medications. This physician statement represents the thoughts of several 
HCPs: “Because if I’m giving them the best drugs but they’re only getting 25% of the drug 
because they’re not using the device properly then that may be some of the reason they’re having 
a poor quality of life”. More generally, a pharmacist put forward the importance of patients being 
able “to better understand their condition and the importance of their medications... And 
understanding the disease process and how the importance of each medication in preventing it or 
treating it”. More specifically, a pharmacist recommended including breathing exercises. And, to 
summarize the content, one pharmacist remarked that the educational content should include “the 
patient information sheet that a patient would get upon counselling”. 
To deliver educational content, HCPs talked about several methods. Some HCPs 
recommended daily sessions, while others recommended monthly sessions. These educational 
sessions can be delivered via messages, videos, or walkthroughs, as in this pharmacist’s 
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comment: “So if there’s some sort of demonstrative capabilities where you could just click on it 
and have someone walk you through the technique. I mean the pharmacist is doing that but then 
a month later if they say oh I forgot it, you know, how did they tell me to do it again the 
reminders help”. Additionally, some HCPs recommended making a library of the content 
available so patients could access it at any time.  
One nurse explained how to provide educational sessions:  
Each day when they do their health session, they get one to two what we call education 
slides within their health session and it's just three to four sentences about COPD. So, it 
could be just some signs and symptoms, it could be a tip of the day to help keep them 
healthier at home, that sort of thing. Also, on the iPad there's encrypted in there some 
videos specifically for... there's more for COPD. It's a two- to three-minute video on 
COPD to help them understand their disease process a bit better. There's also videos on 
shortness of breath and there's a good video on showing them how to properly take deep 
breaths in and how... in order to help them decrease their shortness of breath, videos on 
how to use their inhalers properly along with even what we call very important too, just 
the signs and symptoms and the importance of keeping your blood pressure under 
control, so it will tell them symptoms of high blood pressure and what can cause low 
blood pressure, heart rate high and low along with oxygen... what a low oxygen reading 
could mean for them and the seriousness of breath. what can happen with a low oxygen 
reading.  
In addition, the mHealth intervention could be used to deliver “new research or new, you know, 
something has come about that they should know”.  
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Patients also thought that the mHealth intervention could be used to provide educational 
materials. All patients who were enrolled in an mHealth intervention for COPD management 
mentioned that they read some of the content provided. One patient remarked that he particularly 
enjoyed the educational tips that were presented as a notification: “They had certain hints on 
how, it might be on congestive heart failure or it might be on something else, but they’re all 
helpful. You learn things from them”. However, one patient had contradictory views about using 
mHealth to provide educational materials, as in “I have got so much information home now on 
COPD that I have not looked at”.  
5.3.2.2 It is important to collect baseline information 
Collecting baseline information is vital to understanding the patient and evaluating the 
COPD management progress. This nurse’s statement represents a commonly expressed thought: 
“I think the most important piece of that is to halt before you just go out and put a device in a 
patient’s home is to understand what their normal is”.  
When enrolling a new participant in the mHealth intervention, nurses supported the idea 
of collecting baseline data including: name, date of birth, address, who they live with, support 
systems, gender, and age. The nurse highlighted the importance of collecting “ baseline 
information about their overall health condition. Definitely, we would want to know if they’re a 
smoker or not, where they’re from, do they have any medical histories, family history”. HCPs 
also recommend identifying the primary care physician (PCP): “once a month we will send out 
their PCP a monthly report of the biometric readings”. Emergency contact information is also 
important: “if we still did not reach the patient and we felt that the result was potentially life-
threatening, we need three contact people who we can call. And if we cannot reach either of 
them then we call the police to go in and do a well check just to be sure”. 
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Nurses stated that it is important to collect information on the psychosocial aspects of the 
patient: 
What they’re dealing with at home, where they live, what their environment is. In terms of 
whether or not they can afford their medication. Whether or not they eat healthy, whether 
or not they get out of their home, you know. Do they live in an area where they’re safe to 
get out and go for a walk or, you know, do they live in an area where there’s no 
sidewalks or something that might inhibit them from getting out? Are they in a basement 
apartment? Do they have a bunch of grandchildren? Do they have no-one?” These 
aspects also include if “people smoking around them? Do they smoke themselves? Is that 
what you are getting at? Do they live in a basement apartment or top floor of a house? 
Those sort of things, physical environment?.  
5.3.2.3 It is important to collect subjective data 
Collecting subjective data from patients via surveys was recommended by the majority of 
HCPs. The aim is to have a record of various symptoms to understand the level of COPD 
management. These symptoms include shortness of breath, cough, and sputum. Depending on 
the answers to these questions about symptoms, one nurse advocated to include “branching 
questions to see what colour the sputum is and things like that”. HCPs also expressed interest in 
collecting data regarding medication adherence and medication side effects; for example, a 
pharmacist stated that “Adherence is the most important data point for everything with COPD”. 
Collecting the number of exacerbations and hospitalizations was also mentioned by HCPs, as in 
the physician’s statement, “I know there’s the CAT questionnaire on COPD. You can see when 
there are more dyspnoeic offs. And they can also log when they have exacerbations, so when 
they come to the hospital”. This was reiterated by another physician: “Number of 
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hospitalizations related to their COPD, number of times that they’re using prednisone per year, 
number of times that they’re having flu-like symptoms or any pneumonia or chest infections”. 
One nurse noted the importance of taking physical activity into consideration when assessing 
patients with COPD, as in “Things like activities of daily living. So, sometimes my patients 
would describe, relatively well, COPD management but it was because of not moving at all”. A 
minority of HCPs mentioned collecting data regarding smoking status, oxygen usage, and 
depression scores.  
When asked about the frequency of the survey, HCPs had conflicting opinions. Some 
HCPs thought a daily questionnaire would be feasible. A nurse with experience in mHealth 
interventions stated that a daily questionnaire did not affect the compliance rate, as in, “whole 
session, from biometrics to symptom question and answers will take five to ten minutes... I 
would say it would be probably about 90% to 92% compliance rate for patients who will 
complete their sessions”. This was also agreed upon by the patients who were part of the 
mHealth intervention. In addition, patients who were not enrolled in the mHealth intervention 
were open to completing a daily questionnaire, as in “If I get a notification that I need to answer 
some questions, it’s going to take me five or ten minutes, I’ve got no problem with that”. 
Alternatively, the majority of HCPs surmised that daily surveys are not feasible, as in “I think 
that would make them a little turned off from the app if they had to fill out a survey every day”. 
Two patients were not supportive of completing a survey on a daily basis: “I am pretty sure I 
would get pissed off with it and say...I am not doing it.”  Some HCPs suggested that the 
frequency of the questionnaire should depend on the COPD severity, as in: “I don’t know the 
exact timeframe, but for someone who is stable and well, I think that it could be very, you know, 
patients could lose their sense of self-control because they’re just having to do this daily thing 
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and it’s a bit tedious, but I think that for the acute patients, definitely daily, and patients should 
be able to recognize when they need to do that”. This was reiterated by a nurse: “divide it into 
different sections depending on how complicated their health condition is”. 
One pharmacist felt confident that the mHealth intervention could play a role in guiding 
pharmacological therapy: “If there’s no improvement, then what’s the point of keeping them on 
the drug? ...The patient can provide that information to the doctor... They can even just view it 
and then send a prescription into the pharmacy and the patient can go get it”. 
5.3.2.4 It is beneficial to collect objective health data 
It is common among mHealth interventions to use Bluetooth technology for pairing 
medical devices with smartphones. This is a user-friendly method that allows the transfer of 
results from the medical device to the smartphone and eventually to the healthcare provider 
platform:  
Everything is done through Bluetooth and so they're provided with a blood pressure cuff 
and pulse oximeter to check their oxygen readings and they're also given weight scales 
and, again, all this is Bluetooth-compatible and patients have to have cellular connection 
or Wi-Fi in order to be in the programme, because that's how it's all transmitted into the 
individual nurse's monitors. 
These devices allow patients and HCPs to obtain objective data for monitoring COPD. 
This was observed by a nurse who uses an mHealth intervention: “it validates that the condition 
is certainly stabilised and not worsening. And I think, if nothing else, it is peace of mind for the 
patients and so on”. Additionally, pairing medical devices could reduce the reliance on 
healthcare resources, as stated by a pharmacist: “I think that would be particularly valuable if 
you’re getting meaningful medical data that doesn’t necessarily require healthcare resource to be 
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tied up. You don’t have to send the client to a clinic to have these sorts of examinations or tests 
completed if they can do at home at their own convenience. I think that’s a win-win for 
everyone”. HCPs voiced their opinions regarding the use of a portable spirometer, pulse 
oximeter and a medication adherence monitor in COPD management.   
 When asked about the use of a pulse spirometer to monitor COPD, most HCPs thought 
that it is important to measure oxygen saturation. A pharmacist, echoing other HCPs, indicated 
that it would “definitely be a good idea because getting that like reinforcement of having that 
number come up, they might be like, okay, I’m not doing so well right Now”. In terms of the 
frequency of measuring oxygen saturation, many physicians mentioned that measuring it daily 
would be a general role, but one physician recommended tailoring it to the severity of the 
diseases: “I guess, it depends as well based on the severity of their disease but, I guess, on a daily 
basis again for somebody who’s quite short of breath and has low O2 stats, then less often for 
people who are better”.  
Four patients who were enrolled in an mHealth intervention to manage their COPD used 
a portable spirometer on a daily basis. Support for this practiced was voiced by others, as in this 
patient statement: “everyone has to have an oximeter. And I’m very surprised that an awful lot of 
COPD patients don’t”. It was also mentioned by another patient: “What I found so good with 
that was testing your oxygen, how much oxygen you got, you know, because that was really 
helpful. Because if you wait until you have a hard time breathing, that’s not good”. These 
patients were supportive of testing their blood oxygen levels daily.   
When asked about the use of a spirometer to monitor COPD, HCPs had contradictory 
views about its use for monitoring purposes. A few HCPs thought that it is important to measure 
the lung volume. The following physician statement supports the inclusion of a portable 
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spirometer as part of the mHealth intervention: “After acute exacerbation, I think that you 
should, the recommendation is that you should get repeat PFTs, like, 12 to 16 weeks post-
discharge. And I don’t think that that’s being done currently...if patients had spirometers at 
home, that this could alleviate some of that repeat PFTs for people so that they can monitor their 
severity of their COPD”. This was also supported by a patient: “my doctor generally orders it, 
but it’s not more than once a year and sometimes I haven't had it for a year and a half, maybe two 
years. I told you I’ve been diagnosed about six years and I’ve probably had four”. 
Alternatively, other HCPs did not recommend adding a portable spirometer to the 
mHealth intervention. One reason given was that patients may have trouble interpreting the 
results. A pharmacist noted, “I don’t know if everyone is going to be able to interpret the results 
properly. But that’s not to say that they could just bring them to their physician”. A nurse stated 
that “if the spirometry is going to go back to a respirologist then definitely. But if it’s going back 
to a staff nurse then perhaps the nurse would rather see other biometrics”. Physicians suggested 
that patients will not be able to perform spirometry independently, as observed by a respirologist: 
“There’s no coaching. And that’s prone to error, right off the bat, right, so sure, it might be 
helpful in terms of long-term trends, but I’m not sure it’s that useful”. Another physician 
questioned the ability of patients with COPD to perform spirometry:  
I feel like that would be more of a technique issue, so not all the patients have the best 
technique and then that’s one thing, Also, there’s a timing issue as well with the inhalers, 
so sometimes patients take inhalers right before they do it and can throw off the data a 
little bit and then sometimes patients don’t take it. So, I think that’s, it’ll be more 
challenging to do that, personally”. Some HCPs thought that patients will not be 
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interested in using the spirometer, and a pharmacist mentioned: “The average patient is 
not going to see the value of it and they’re not going to do it.  
In terms of the frequency of a spirometry test, there were varying opinions among HCPs. 
One pharmacist recommended performing it daily: “technically they should be doing it daily. I 
mean, when a patient had asthma we normally recommend doing it daily because with asthma 
there’s also actions that need to be taken with using spirometry”. This was also mentioned by a 
physician who was hesitant about the frequency of testing: “Yes...Once a day... Maybe, I don’t 
know... Somebody who is very mild and the spirometry results have been really good, maybe 
once a week. People who are more severe would probably do it more often on a daily basis”. On 
the other hand, a respirologist said, “I’m not sure if it’s worth the money to do something like 
that on a daily basis”. Other HCPs recommended using a spirometer every few weeks or months: 
“if it’s only a small procedure, it’s not invasive, there is no reason they can’t do it every few 
months, because if I remember right, the FEV tends to not change massively in a short period”. 
One physician expressed interest in tailoring the frequency to the individual based on defined 
criteria: “If you had strict clinical criteria as to when the FEV1 would be done, as opposed to 
okay do it once a month or whatever it is, you know, because it’s a clinical decision, it’s not a 
time based decision”.  
A physician talked about conducting a study to determine the ideal frequency for 
measuring lung volumes: “I think the only way to know that is if you had the device and you 
actually studied that...So to me it would be to correlate that with the measurements and then 
changing their breathlessness or their sputum or other things to try to figure out is there clinical 
things that we could ask that would give us that information without having the technology. But 
as technology gets cheaper and more available then yes, for sure, I mean it’s no different than if 
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you look at the insulin pumps and having the instantaneous monitoring now which we never had 
before and being able to give insulin in a much more physiological basis. So I think it could be 
helpful”. A few patients were interested in trying a portable spirometer but were not sure of how 
often they would have to perform the test, as in “Yes, probably once a week I’d get used to the 
hard blowing”. A patient shared her opinion: “ I could learn to use it. I don’t think I need it as 
long as I’m doing what I’m doing now”. 
Many HCPs thought that the use of a medication adherence monitor could be effective 
for COPD management, as one pharmacist said, “That will be really good for Ventolin because 
then you can actually see how much they’re actually using”. This was reiterated by a nurse: “Oh 
yes, I think that would be very useful, because sometimes, and I hate to say it, you can’t really 
believe the patients”. One physician suggested using a camera to promote medication adherence: 
“Right now I mean most times I prescribe inhalers I don’t actually watch patients take the 
inhaler. But if you’re able to say well take a little video of yourself and I’ll look at the video of 
you using the puffer this evening. That ability to actually measure compliance based on the 
ability that if you have remote monitoring you could observe the patient using their device”. 
Furthermore, a pharmacist suggested adding a device to an inhaler to assess the inhalation 
technique: “You can go to YouTube and you can see how to use an inhaler and they’re very, 
very good and I don’t think that the app would necessarily be able to do that unless it was 
somehow linked to the device and somehow knew whether you were doing it incorrectly”. Many 
patients were also interested in using a medication adherence device, as in “That absolutely 
amazes me. You mentioned, like, this counter and that for your puffer. That’s a very good idea. 
And also, this pulmonary function test. You have to know, especially in this day and age, the 
178 
 
reason, I guess, you’re coming out with these programs, is that there’s only so many doctors to 
go around”. 
Some HCPs recommended using other devices, especially if the patient has a 
comorbidity. These devices could be used to measure weight, respiratory rate, blood pressure, 
blood glucose levels. A nurse with mHealth experience shared, “If you were doing the oxygen, 
vital signs, the whole blood pressure and pulse and respiratory rate wouldn’t go astray either”. 
One pharmacist with experience in mHealth suggested that pharmacies can offer medical devices 
to be used by patients that can send data from the medical device to the patient’s phone. 
Patients who were enrolled in an mHealth intervention to manage their COPD used a 
blood pressure monitor and a scale. Additionally, patients with cardiovascular comorbidity used 
a blood pressure monitor: “When I had a problem with blood pressure about four or five years 
ago I used to have to use it quite a lot because used to have to keep a record for my family 
doctor. So since I got it under control now, some days when I feel a bit flushed in my face well 
I’ll check it and make sure that it’s not gone up anymore”. Two patients used a glucometer to 
manage their diabetes comorbidity. An accelerometer, Fitbit, was used by one patient, as in: 
I kind of slow down a bit and I started feeling more with my joint pain. And I said what I 
need, I think it’s better for me to track what I do every day going to make me feel better. 
So they recommended the watch so I just start from there... Normally every day...I check 
my sleep and check how I stressed and how much I eat, how much calories I burn in a 
day, how much I walk and my heart rate. It’s amazing. 
5.3.2.5 Providing a COPD Action Plan is recommended 
The majority of the HCPs supported the idea of including an action plan as part of the 
mHealth intervention. One nurse was already using the COPD Action Plan in her practice, as in:  
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we do promote something called COPD action plan... the whole premise of it is so they 
could have antibiotics and steroids on hand at their pharmacy in case they start to have a 
flare up. We educate them on when they should use this and the whole premise is to treat 
early so as they don't get to the point that they do end up having to go to an emergency 
room or be admitted. So based on that assessment the outcomes of individual cases that 
we handle is either to recommend that the patient take an extra inhaler, to use a 
nebuliser treatment, to increase the frequency. We may reach out to their physicians if we 
feel a change in their care plan is required. To get new orders for new treatment orders 
or, if it sounds to be a very acute situation that is not relieved with any home care 
measures, then we either refer to their physician, emergency department or, in some 
cases if they are in acute respiratory distress, we actually arrange an ambulance to come 
on site and visit. 
Several HCPs surmised that including an action plan had the potential to empower 
patients and reduce hospitalizations. One physician reinforced this notion and thought the action 
plan “would give patients the power to then be a part of their management plan, which is better 
when patients are empowered because they feel in control of their health. And then also would 
give them, you know, a couple of strategies before they need to go to the emergency department 
and, you know, people with COPD, it is hard for them to go out and walk to their car or take 
transportation to the emergency department. It can take an awful lot of effort, so it saves a patient 
as well as the healthcare system some resources as well”. A pharmacist stated that patients would 
not lose the action plan, which is common among paper-based action plans: “if they could 
customize like a COPD action plan or something like that in the app where they’re not going to 
lose it would also be beneficial to patients.”  
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Most importantly, HCPs agreed that the action plan could use subjective and objective 
data to personalize COPD management. A physician provided the following example:  
there could be an algorithm within the program to say, are you more short of breath, yes, 
are you having increased sputum production, yes, what is your oxygen saturation level, 
87, what is your temperature, 37.4, and based on this information, then the application 
could say, you know, increase your short-acting bronchodilator, increase your short-
acting agent just based on that.  
Three patients mentioned that they have a COPD action plan. In terms of using an 
mHealth intervention to deliver an action plan, one patient remarked, “I would be open to using 
my phone to help manage my COPD based on what that entails. If it’s a few questions in terms 
of information gathering to help sort of develop a micro-specific COPD treatment regimen, I 
could absolutely see the benefit in that. If it would be for generic information gathering, I 
probably wouldn’t be so open to that”. 
5.3.2.6 Allowing patients to track their COPD management progress would be helpful 
Some HCPs suggested providing patients with the ability to track their COPD 
management progress. A nurse thought that patients should be able to “see their signs and 
symptoms. Is this normal? Is this abnormal? Can I manage this myself with what I have got at 
home or should I go to the emergency department?” Some pharmacists suggested summarizing 
the signs and symptoms to share with HCPs, as in “I’d bring up my app and it would give me a 
simple one-page snapshot of how I’m doing. And then, from there, I could click on different 
areas and, you know, get some tips or whatever. It needs to be very simple…because if they went 
to their physician or to us and they hold the phone and say, here, let’s have a look”. 
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Many patients were interested in tracking their progress, as in “It’s a critical factor. It’s 
my health. But beyond all of this, I would really like to understand why I have COPD...I would 
definitely want to track my progress or regress accordingly and if the app would allow me to do 
that.” One patient kept a web-based record of his vital signs and medication adherence: “I can go 
back five and a half years and tell you, on the third of May, that I took my pills at eight 
seventeen AM in the morning”. 
5.3.2.7 Providing access to family members or caregivers would be beneficial 
Many HCPs mentioned that granting caregivers, family members or homecare workers 
access to assist in the mHealth intervention would be beneficial. A physician stated, “I guess 
they do often have children, grandchildren, homecare providers, people who can help or have it 
on their own phone when they’re with them”. When sharing information with family members, a 
physician was concerned about the importance of ensuring privacy and confidentiality: “the only 
issue that you’ll come across there is the, you know, release of information because patients, you 
know, if they’re competent they don’t want their family members to see their information and 
that could be an issue”. The majority of patients mentioned that a family member assisted them 
in the management of their COPD, as in “I’ve got a little organizer I put my pills in there for the 
week…And if I don’t, my wife gives me a smack in the back of the head”. 
5.3.2.8 Consider tailoring the features based on the patient’s unique needs 
A recurring theme among HCPs and patients was tailoring the mHealth intervention to 
each patient. Differences in COPD severity level and the presence of a comorbidity can affect the 
features required by patients. Personalizing the features includes changing the frequency of 
objective and subjective data collection. For example, a physician commented, “The question is 
do you want it to be individualized to the patient...You don’t want to overwhelm patients with 
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collecting all this information, right, it needs to be something that is beneficial to them and not 
just something else that they’re having to do”. A nurse describing her monitoring approach with 
patients enrolled in an mHealth intervention to manage COPD: “It would be patient-specific for 
sure. Somebody who is well and didn’t do a session for a couple of days, maybe we’d let it slide. 
But somebody who you know had been unwell for a few days and if they didn’t do their health 
session, say by mid-morning, maybe you’d might call them and say, are you okay? What’s going 
on?”  
Although this mHealth intervention is focused on COPD, many HCPs illustrated the 
importance of considering COPD comorbidities. A nurse gave this example: “Often it was either 
coronary artery disease, diabetes, hypertension. That’s the group that you tend to see most 
often”. This thought was reinforced by others, as in this physician statement: “nobody has one 
condition, right, particularly if you’re looking in your, sort of, 65 plus patients, right, they’re all 
going to have probably, in Newfoundland anyway, a minimum of three comorbidities”. 
Furthermore, some nurses supported the idea of adding a glucometer or a blood pressure 
monitor, based on the comorbidity, to the mHealth intervention.  
The majority of patients who participated in the interview had a comorbidity. Among 
these comorbidities were diabetes, congestive heart failure, cancer, and arthritis. A patient stated, 
“I am a walking disease! I have got high blood pressure, I got high cholesterol, I have got a 
problem with my thyroid, I have got a problem with walking…I have got a problem with my 
eyesight and hearing”. 
5.3.2.9 Reminding patients to manage their COPD is a benefit 
Many HCPs rationalized that the mHealth intervention should remind patients to manage 
their COPD. Giving patients reminders to take their medication was most frequently suggested 
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by HCPs, especially pharmacists, as in, “Adherence (with medications) would be a big thing 
because patients are not great with that so if the app had reminders, and reminders of dealing 
with side effects; if they need to rinse their mouth out after, or little things like that”. One nurse 
reinforced this notion and thought the mHealth intervention could remind patients to manage 
their COPD based on objective data collected by medical devices:  
let’s say, your respiratory rate went above 28 or 30 or whatever, whatever parameters 
that the nurse could set. Then the patient would get some, kind of, notification to say, 
what am I doing or it’s time for me to sit or maybe some notification, have you taken your 
medications today. Little reminders maybe or something that could pick up on their heart 
rate. And I think that might be the way of the future.  
Lastly, one nurse talked about reminding patients about refilling prescriptions and their hospital 
appointments “so they know what is coming up that they are not going to miss appointments. 
They are going to have their appropriate test done, they are not going to miss appointments 
because it is already in the app. Here we have a high percentage. On average if you have got a 
clinic of 14 patients, sometimes two don’t come because they didn’t get notifications”. 
5.3.2.10 Rewarding patients for managing their COPD is a possibility 
A few HCPs suggested using a reward system to motivate patients to use mHealth for 
COPD management. One pharmacist with experience in mHealth commented, “rewarding people 
is the best way you can get people to appreciate an app...it might be rewarding just with positive 
reinforcement, which is if they do three weeks in a row of 90 percent adherence to therapy, they 
get a notification or something to say, great job, you’re doing really well”. Some HCPs 
elaborated on using rewards to encourage patients to stop smoking or “to reinforce adherence, 
proper administration of the medication and proper timing”. A pharmacist and a physician 
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recommended a motivational app to their patients “I’ve recommended a couple of patients try 
this Carrot app...for patients that are trying to lose weight, they could use and record their 
weights and probably to set goals”.   
5.3.2.11 There were a few features mentioned by a minority of HCPs and patients 
Additional features were mentioned by a small number of HCPs. For example, one 
physician pointed out the use of artificial intelligence in the mHealth intervention, as in “they 
always talk about how the AI’s going to be, sort of, embedded in our EHRs, and I get that and I 
know that that’s coming”. A pharmacist expressed interest in including a feature to include 
visually impaired patients: “It would help if it could talk to you because then it could be used for 
people with visual impairment”. One nurse with experience in conducting mHealth interventions 
recommended that program administrators should conduct monthly satisfaction questionnaires 
with patients and healthcare providers. The questions could include “Were you satisfied? Did 
you follow the nurse’s advice? What was the outcome? Are you experiencing any difficulties 
with the device?”  
One nurse suggested adding information about “interactions between their medications if 
they are going to get new medications, put it in and it would give them a high alert or a low 
alert”. Lastly, a physician had contradictory views about allowing the patient to access their 
laboratory test results, such as blood work: “if patients had access to their blood-work and to 
their reports, that could be set up so that you could only access your own personal stuff and that 
would then, maybe, be helpful, because the biggest problem is if something gets missed and if 
you have access to your own reports, that can help. The only negative of that is it causes anxiety 
because for a patient when you see something or you’re reading something and you really don’t 
know what it means”.  
185 
 
A pharmacist and a physician expressed interest in using the mHealth intervention to aid 
in smoking cessation. A pharmacist describing an mHealth intervention that she recommends to 
patients noted, “you put in your quitting day in it and it gave you some sorts of kind of rewards 
and sent you congratulations messages and that sort of thing. And you could go on and see how 
many Dollars you’ve saved by quitting smoking, different things that happen every day as you 
quit what happens in terms of improving your lung function and that sort of thing. Also when a 
patient was having a craving they could actually go onto the app and play a game that would 
distract them for a couple of minutes to allow the craving to pass”. 
Patients did not recommend many features. The following patient statement represents 
thoughts from several other patients: “Really, you know far more than I do in terms of what will 
make for a very functional set of parameters”. Some features suggested by patients were 
medication and sleep tracking: “Yes I think if I sort of keep track of what I think will be my 
approximate amount of sleep the night before, stress levels possibly. That could be all 
important”. 
5.3.3 Healthcare provider interface 
Nurses, pharmacists, and physicians would require an interface to engage with the 
patients. One pharmacist talked about including other HCPs, “potentially other workers in the 
healthcare system, social workers, you know, maybe physio. So I think everybody in the 
healthcare system has a role to play in it and hopefully by combining that you get a more robust 
outcome”. Table 5.3 summarizes the main features recommended to assist the HCP. 
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Table 5.3: Themes with specific examples regarding the features of the healthcare professionals’ 
interface. 
Theme Specific examples for each theme 
Allowing HCPs to track their 
patients’ management progress is 
important.   
 
 
 
Allowing HCPs to communicate 
with patients and other HCPs is 
beneficial.  
 
 
 
 
 
 
 
 
The educational component is 
valuable. 
 
Remunerating HCPs is a 
possibility. 
Tracking data, including vital signs and medication 
adherence, is important.  
 
Tips on how to present and access the data would be 
beneficial. 
 
 
Automating a monthly report to be shared with the 
primary care physician would be helpful. 
 
Ability to manage requisitions and prescriptions would be 
beneficial.  
 
Opt-in to receive information regarding specified criteria 
or variables could be helpful.   
 
 
Including current best practices and guidelines on COPD 
management would be useful. 
Delivering existing COPD adherence programs that are 
funded by a third party would be beneficial. 
  
5.3.3.1 Allowing HCPs to track their patients’ management progress is important  
All HCPs stressed on the importance of using HCP interface to access the data collected 
from patients. Many HCPs discussed the importance of viewing information related to the 
patients’ signs and symptoms. A nurse suggested having the ability to view “their vitals, their 
levels of activity... oxygen saturation, oxygen usage, those types of things”. Other important 
information that can be accessed from the HCP interface is data regarding medication adherence, 
as in the following pharmacist comment: “as a pharmacist, would be useful to explore to see if 
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there’s anything we can do to help overcome barriers or facilitate adherence”. Some pharmacists 
felt confident that viewing data longitudinally would be valuable in choosing the right therapy, 
as in “So I see the most value in the initiation or changing of therapy...If you can actually see 
over a period of time, well, is that helping or not, then you can make a decision whether it’s 
actually making a difference”. Furthermore, a physician gave this example: “What I would 
appreciate as a physician is seeing longitudinal progress of my patient... because I want to know, 
did we just have that one acute episode, was there, kind of, many acute episodes that never 
actually came into me”.  
The following physician statement represents thoughts from several other HCPs: “I want 
all the data if I’m a research scientist because I’m trying to prove something but as a clinician, I 
want the data that’s going to impact my patient care and quality of care”. This was supported by 
a pharmacist, as in “so it’s having the relevant data to make the right clinical decision rather than 
having all the data”. To deliver the right data to HCPs, they suggested summarizing the 
information, as in this physician’s comment:  
there should be a way in the app to maybe synthesize it down a little bit or else you’ll just 
have a lot of data points without much direction... so maybe highlight areas of concern 
and maybe highlight, like, the averages of, say, blood pressure or saturation levels, stuff 
like that.  
A few HCPs rationalized the use of trends and outliers, as in “I think in the short amount of time 
I think pharmacists and physicians learn to look for specific things right...you’re looking for 
some outliers and you’re looking for trends and patterns and things like that”. Some HCPs 
suggested using graphs to present these trends. And, a nurse commented on her patients who 
were enrolled in an mHealth intervention to manage COPD: “we would set parameters, say for 
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the oxygen saturation, if they were less than 88 it would be red on the screen. So, of course, 
those would be the people that you would triage and call sooner than the others to check in on 
them”. 
Nurses, pharmacists, and physicians suggested several ways to access the data collected 
by mHealth interventions. Some HCPs posited that they should be able to access the data through 
electronic medical records (EMR). A pharmacist proposed, “if there’s a possibility, even 
securely, to be able to take that information and put it in the EMR securely”. Another method of 
accessing mHealth data with HCPs is via the patient’s phone. A pharmacist with experience in 
mHealth observed, “I’ve had a couple of patients now who brought in their app and opened it up 
and I could look at their history and the results and I would go through it with them and it works 
great because I could tell them right there”.   
5.3.3.2 Allowing HCPs to communicate with patients and other HCPs is beneficial  
The HCP interface could be used to enhance communication between HCPs. When asked 
about the current practice regarding communication with physicians and specialists, one nurse 
who was monitoring patients through mHealth stated that patients identified their primary care 
physician during enrollment. Then, “once a month we will send out their PCP a monthly report 
of the biometric readings. If a patient is going to a GP or a respirologist and there's a concern that 
we have regarding their current health status with their COPD, we will do that letter and fax it to 
their appointments along with their biometric readings”. This thought was reinforced by others, 
as in this pharmacist’s statement, “if a pharmacist was kind of monitoring this and they were able 
to kind of do up like a consult letter kind of to send to the physician before the patient went to 
their physician, that would definitely be beneficial”. A nurse talked about streamlining patient 
requisitions via the HCP interface: “if we were able to have patient requisitions ahead of time... 
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that could cut out a visit and just a follow-up phone call for results, reports, treatment, if 
necessary”. 
Some HCPs put forward a feature that would allow them to opt in and receive a 
notification based on set criteria. A few HCPs stated that this could enable the healthcare 
provider to “receive the alerts if they (patients) are then outside pre-set parameters”. When 
setting parameters, one nurse with experience in mHealth stressed the importance of “Realistic 
parameters for readings so that our patients are not alerting constantly. And number two:.. when I 
receive an alert I have got clinical algorithms to manage it”. Some pharmacists recommended 
getting a notification for medication adherence, as in “getting a notification, like, for two weeks 
of missed therapy, would be very interesting to me”.  
To follow up on these notifications, a nurse commented on her patients who were 
enrolled in an mHealth intervention for COPD management  
We would phone them or they would phone us if need be. It would be patient-specific for 
sure. Somebody who is well, somewhat well, who didn’t do a session for a couple of days, 
you know, maybe we’d let it slide. But somebody who you know had been unwell for a 
few days and if they didn’t do their health session, say by mid-morning, maybe you’d 
might call them and say, are you okay? What’s going on?  
Similarly, a physician with experience in mHealth interventions noted, “ensure that whatever is 
going on with the patient there’s an ability for them to have someone to have access to reassure 
them if they get upset”. 
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5.3.3.3 The educational component is valuable  
A few pharmacists and physicians recommended including current best practices and 
guidelines on COPD management. A physician reported: “would need to have an educational 
component, guidelines, you know, to remind me, of the Primary Care Guidelines…”. 
5.3.3.4 Remunerating HCPs is a possibility  
The HCP interface can be used to deliver existing COPD adherence programs that are 
funded by the government or insurers. For example, pharmacists in NL get a time reimbursement 
if they complete the COPD adherence initial and follow-up consultations. One pharmacist 
indicated that the program is underused because of the time required to determine eligible 
patients and remember to follow up with them, as in  
This is paid intervention, but the uptake is next-to-nothing because it is so hard to 
manage... For us to try to remember all that and remember to go get a manual form on 
top of that, it’s tough...I need to manually remember within two weeks and go through 
these lists of questions. And then, within two months afterwards, which is even harder...I 
don’t remember what I had for breakfast, let alone in two months, to call a person and do 
this again.  
The pharmacist surmised that the uptake of the medication adherence program would be higher if 
it was automated via an mHealth intervention “there’s nothing like incentivizing a pharmacist to 
say, this is a good technology for you because it will make this programme very easy...if this 
were automated for a pharmacist, the likelihood of doing this type of a follow-up would be much 
higher”.  
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5.4 Discussion  
5.4.1 Principal Findings 
This qualitative study found that HCPs and patients had several recommendations 
regarding the content of an mHealth intervention to assist in the management of COPD. Potential 
users brought forward several components that could support them in the future. This interest 
and the numerous suggestions from HCPs and patients with COPD indicate the readiness for 
using mHealth for COPD management.  
To optimize the successful implementation of mHealth interventions, it is important to 
consider the perceived facilitators and barriers to mHealth adoption for COPD management that 
were published by our research group (Alwashmi et al., 2019a; Alwashmi et al., 2019b). The 
main facilitators to mHealth adoption are possible health benefits for patients, ease of use, 
educating patients and their HCPs, credibility, and reducing the cost to the healthcare system. 
Alternatively, the barriers to adoption are technical issues, privacy and confidentiality issues, 
lack of awareness, lack of interest, potentially limited uptake from the elderly, potential limited 
connection between patients and HCPs, and finances (Alwashmi et al., 2019a; Alwashmi et al., 
2019b). 
Our thoughts, based on the data, are that both HCPs and patients recommend tailoring the 
mHealth intervention based on the patient’s unique needs and preferences. The mHealth 
intervention could potentially enhance COPD management using several features; most 
importantly, by collecting relevant subjective and objective data then using them to tailor COPD 
management based on the patient’s unique needs. This collaborative and human-centered 
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approach is not feasible without having a HCP interface to communicate and monitor the 
patients.    
5.4.2 Comparison with Prior Work 
Our study provides a novel and meaningful contribution to the literature. A few prior 
studies have specifically examined the features of mHealth among potential users, but in this 
case, we included HCPs and patients with COPD. We included consideration regarding a HCP 
interface that has not been reported previously in the context of mHealth for COPD management. 
Additionally, we discussed the use of compatible medical devices for COPD management.  
Some of the features presented in this study confirm findings by previous research, such 
as the importance of education, self-monitoring, reminders, and communication between patients 
and HCPs (Kim & Lee, 2017; Korpershoek et al, 2018; Sobnath et al, 2017). In addition, we 
identify other potentially useful functions such as using various medical devices, including 
family members, and rewarding patients and HCPs. Previous researchers recommended 
including a larger sample of HCPs with more mHealth experience in future studies (Korpershoek 
et al., 2018).    
Collecting baseline information was recommended by many HCPs. This information is 
vital for tracking patients’ progress, and it can also be used to assist in monitoring patients to 
prevent exacerbations (Alwashmi et al., 2016). Addtionally, many researchers are utilizing 
smartphones for health research (Dorsey et al., 2017). Data collected via mHealth can be paired 
with other data sources from the patient’s medical records or genetic makeup to expand our 
understanding of the etiology of COPD. 
As suggested by Kim & Lee (2017), patients and HCPs should support the use of medical 
devices that automate data generation and transmission, as this could lead to increased 
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compliance with the mHealth intervention. We elaborate on the use and frequency of several 
devices relevant to COPD management, including spirometers, pulse oximeters and medication 
adherence devices. Nuvoair® and AioCare® are two examples of portable spirometers that could 
be beneficial for COPD monitoring. The use of a patch biosensor, VitalPatch®, for measuring 
vital signs continuously could be beneficial for continuous unobtrusive patient monitoring 
(Selvaraj et al., 2018).    
Advancements in mobile technology have improved how we track and enhance 
medication adherence. Both AiCure® and emocha mobile health® utilized artificial intelligence 
technology for facial recognition to determine if a patient takes and swallows medication 
(Holzman et al., 2018; Labovitz et al., 2017). Furthermore, a few companies such as propeller 
health®, Adherium®, and Cohero Health® are manufacturing medication adherence devices to 
provide an objective measure of adherence (Adams et al., 2017; Gregoriano et al., 2017; 
Hollenbach et al., 2017). These medication adherence devices have the potential to be used in 
assisting with improving the technique of inhaled medications (Kuipers et al., 2019). 
A recurrent need was that mHealth interventions can be used to deliver an action plan to 
assist in COPD management. However, Korpershoek et al. (2018) stated that providing medical 
advice through mobile devices can be unsafe due to the large heterogeneity in patients and 
symptoms. Recent studies have shown that a machine-learning approach has the potential to 
assist in the management of COPD (Orchard et al., 2018; Swaminathan et al., 2017). While the 
action plan could increase patient autonomy, it will need extensive research on its safety, 
efficacy, and implications for COPD management.  
Our findings are in agreement with Korpershoek et al. (2018), who stated that patients’ 
needs regarding COPD management vary widely. The need for personalization, stemming from 
194 
 
the individuality of patients, is an important finding. We expand on these findings by including 
data from both HCPs and patients about their preferences regarding the potential frequency of 
entering information, follow-up, and performing medical tests via compatible medical devices.  
Some HCPs recommended using the mHealth intervention to remind patients about their 
appointments. The mHealth intervention could be used to automate scheduling and to remind 
patients about their appointments. Furthermore, Leavens et al. (2019) stated that rideshare 
services via smartphones may represent a relatively low-cost means for increasing study 
retention. Similarly, these ridesharing services can be integrated into the mHealth intervention to 
avoid missed appointments. Other researchers also found that rewarding patients via self-
affirmations can successfully increase adherence to recommended health goals in the context of 
an mHealth app (Springer et al., 2018). 
Sobnath et al. (2017) systematically reviewed the literature and app stores to identify 
features that can be considered in the initial design of a COPD support tool to improve healthcare 
services and patient outcomes. Features such as a social networking tool, personalized education, 
feedback, e-coaching, and psychological motivation to enhance behavioral change were found to 
be missing in many of the downloaded apps (Sobnath et al., 2017). A recent systematic review 
highlighted the effectiveness of mHealth apps that use CBT principles (Rathbone et al., 2017). 
Another important feature for a COPD support tool is the self-management of physical activity. 
Improvement of physical activity levels can result in better physical functioning, less dyspnea, 
higher quality of life, and lower risks for exacerbation-related hospitalization and mortality 
(Sobnath et al., 2017).  
  To stimulate information exchange between patients and HCPs, we included features of 
a HCP interface. Our findings echo some of the HCP interface features reported by Sobnath et al. 
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(2017), which include monitoring medication adherence and other features such as device 
tracking, patient training, managing clinic visits, and providing advice on lifestyle management. 
Korpershoek et al. (2018) found that both patients and their HCPs have doubts regarding 
information exchange between patients and HCPs through mobile devices. However, they did 
not expand on these doubts. We included qualitative quotes to expand on these insights. 
5.4.3 Strengths and Limitations 
This study has several strengths. First, this research is based on a diverse sample of 
participants. It includes various perspectives by presenting the views of patients, nurses, 
pharmacists, and physicians, including a respirologist. This human-centered approach ensures 
that the needs and challenges of different people involved in the management of COPD can be 
considered before developing an mHealth intervention. Second, some participants had 
experience in using an mHealth intervention to manage COPD, which further increases the 
richness of the data. Third, all the interviews were conducted in a similar manner to ensure 
consistency during the data collection and analysis. Finally, mHealth is particularly important in 
geographic locations with a relatively large proportion of rural residents such as Newfoundland 
and Labrador. mHealth may enhance care provider access throughout sparsely populated rural 
areas. Newfoundland and Labrador have a substantial remote and rural population; therefore, our 
results may be more applicable to rural areas. 
There were also several limitations. First, not all participants had experience with using 
mHealth. Thus, the perceptions of these participants were not based on actual interventions with 
patients. Second, we used only one data collection method, thus data collection was not 
triangulated. Conducting focus groups with some of the participants following the individual 
interviews could have yielded richer information, as participants would have been given the 
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opportunity to compare their thoughts and confirm or expand upon each other’s ideas. This 
would be a recommendation for a future study. 
5.4.4 Implications for practice and recommendations for future research  
The findings of this study provide valuable insights regarding the features of an mHealth 
intervention for COPD management. These findings may help various stakeholders who are 
planning to use mHealth interventions for COPD management. 
Future studies would benefit from conducting focus groups with some of the participants 
following the individual interviews. Focus groups could yield richer information, as participants 
would be given the opportunity to compare their thoughts and confirm or expand upon each 
other’s ideas. Furthermore, including the perspectives of allied HCPs, such as physiotherapists, 
social workers, and occupational therapists, would be beneficial to understand the perspectives of 
administrators (e.g., information technology managers) who may be able to identify some of the 
challenges with using mHealth for COPD management. After developing a prototype of these 
human-centered components, the authors recommend using a mixed methods framework for 
usability testing (Alwashmi et al., 2019c). 
Future mHealth studies should explore the utility of the mHealth intervention in reducing 
exacerbations, reducing hospitalizations and improving the quality of life for patients with 
COPD. Specifically, additional research is required to investigate the effectiveness and safety of 
the mHealth intervention in COPD management. Guidelines are required to tailor components of 
the mHealth intervention and frequency of contact, and reminders are required. Lastly, cost-
effectiveness analysis is required to assess the impact of mHealth interventions on healthcare 
resources.  
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5.5 Conclusions  
Advances in smartphones, wearables, and other smart devices align well with the 
developing interests of using mHealth to assist in the management of COPD. Although there is 
interest in applying mHealth for COPD management, little attention has been paid to human-
centered design features by future users of mHealth. The findings of this study suggest that 
COPD patients and their HCPs are receptive to using an mHealth intervention with multiple 
evidence-based components to manage COPD. These components include the use of subjective 
and objective data to tailor COPD management based on the patient’s unique needs. These 
findings are important, as they elaborate on the process of data flow from patients and their 
HCPs using both a patient and a HCP interface. These human-centered features may aid in the 
successful implementation of mHealth interventions for COPD management. We recommend 
that those who develop mHealth interventions for COPD should consider the components 
highlighted in this study. Lessons from this study may also be applied to other chronic diseases.  
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Chapter 6: The Iterative Convergent Design for Mobile Health Usability 
Testing: Mixed Methods Approach 
Preface 
Health care professional and patients stressed the importance of usability to improve the 
uptake of mHealth interventions. This chapter provides a new mixed-methods design to enhance 
the usability of an mHealth intervention. A version of this chapter has been published in the 
Journal of Medical Internet Research (JMIR) - mHealth and uHealth: Alwashmi, M. F., 
Hawboldt, J., Davis, E., & Fetters, M. D. (2019). The iterative convergent design for mobile 
health usability testing: mixed-methods approach. JMIR mHealth and uHealth, 7(4), e11656. I 
completed the first draft and revised it according to the suggestions of co-authors and reviewers. 
Dr. Michael Fetters, who is the co-Editor of the Journal of Mixed Methods Research, suggested 
the general research topic and provided feedback on the manuscript. He also helped revise the 
original manuscript to make the argument clearer. Dr. John Hawboldt and Dr. Erin Davis 
reviewed the manuscript and provided revision suggestions.  
Abstract 
Although patients express an interest in using mobile health (mHealth) interventions to 
manage their health and chronic conditions, many current mHealth interventions are difficult to 
use. Usability testing is critical for the success of novel mHealth interventions. Researchers 
recognize the utility of using qualitative and quantitative approaches for usability testing, but 
many mHealth researchers lack the awareness of integration approaches from advances in mixed 
methods research that can add value to mHealth technology. 
As efficient usability testing proceeds iteratively, we introduce a novel mixed methods 
design developed specifically for mHealth researchers. The iterative convergent mixed methods 
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design involves simultaneous qualitative and quantitative data collection and analysis that 
continues cyclically through multiple rounds of mixed methods data collection and analysis until 
the mHealth technology under evaluation is found to work to the satisfaction of the researcher. In 
cyclical iterations, early development is more qualitatively driven but progressively becomes 
more quantitatively driven. Using this design, mHealth researchers can leverage mixed methods 
integration procedures in the research question, data collection, data analysis, interpretation, and 
dissemination dimensions. 
This study demonstrates how the iterative convergent mixed methods design provides a 
novel framework for generating unique insights into multifaceted phenomena impacting mHealth 
usability. Understanding these practices can help developers and researchers leverage the 
strengths of an integrated mixed methods design.  
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6.1 Introduction  
Published studies indicate that mobile health (mHealth) interventions are beneficial for 
patients across various diseases and age groups (Joe & Demiris, 2013; Juen et al., 2015; Zhang et 
al., 2013; Alwashmi et al., 2016). Academics and clinicians have an increasing interest in 
harnessing these mHealth interventions to improve health outcomes. Although patients express 
an interest in using mHealth to manage their health and chronic conditions, many current 
mHealth interventions are difficult to use (Sarkar et al., 2016). Hence, developers of mHealth 
need efficient and effective approaches for development, but usability research methodology 
remains in a relatively nascent stage of development (Carayon et al., 2015). Usability testing is 
critical for the success of novel mHealth interventions. Although researchers recognize the utility 
of using qualitative and quantitative approaches for usability testing, many mHealth researchers 
lack the awareness of integration approaches from advances in mixed methods research (MMR) 
(Fetters & Molina-Azorin, 2017) that can add value to mHealth technology. 
This paper advances the existing literature about the combined use of qualitative and 
quantitative research for mHealth by advancing a specific, integrated approach to mixed methods 
design appropriate to mHealth. When using qualitative and quantitative procedures without 
integration, researchers miss the opportunity for added value. Mixed methods methodologists 
express this as 1+1=2, as the quantitative and qualitative procedures are conducted as 2 
independent studies with no particular synergy (Fetters, 2018). By using integrated procedures 
identified in the field of MMR, researchers can aspire for and achieve added value, as expressed 
by 1+1=3 (Fetters, 2018; Fetters & Freshwater, 2015). 
The purpose of this paper is to articulate and illustrate the features of an iterative 
convergent mixed methods design. As efficient usability testing proceeds iteratively, we 
introduce a novel mixed methods design developed specifically for mHealth researchers. It offers 
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a novel framework to generate unique insights into multifaceted phenomena related to mHealth 
usability. Understanding these practices can help developers and researchers leverage the 
strengths of an integrated mixed methods design. 
6.1.1 Background 
6.1.1.1 Mobile Health 
Effective health care strategies are required to ensure the right patient receives the right 
treatment at the right time. Advancements in mobile phones and tablets have led to the 
emergence of mHealth. The Global Observatory for eHealth of the World Health Organization 
defines mHealth as “medical and public health practice supported by mobile devices, such as 
mobile phones, patient monitoring devices, personal digital assistants, and other wireless 
devices” (World Health Organization, 2011). Recent advances allow seamless integration 
between smartphones and medical devices. This integration enables smartphones to store and 
analyze objective measurements such as heart rate, lung volume, and medication adherence. 
Advancements in machine learning and artificial intelligence have the potential to use these 
measurements, in combination with data collected via smartphones, to improve our 
understanding of disease etiology (Fogel & Kvedar, 2018; Watson, n.d.). 
The significance of mHealth is highlighted by its ability to deliver timely care over 
distance to manage diseases. It is particularly important for rural areas with limited access to 
health care (Källander et al., 2013; Aranda-Jan et al., 2014). Moreover, mHealth strategies can 
enhance treatment outcomes while mitigating health care costs (Vashist et al., 2015; Hayes et al., 
2014). Hayes et al. (2014) illustrated why mHealth could reduce physician visits, resource 
consumption, and emergency room visits. The literature continues to evolve on applications of 
mHealth. For example, several published studies indicate that mHealth interventions are 
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beneficial for patients across various diseases and age groups (Joe & Demiris, 2013; Juen et al., 
2015; Zhang et al., 2013; Alwashmi et al., 2016). However, research on the development and 
usability methodology of such interventions remains in a relatively early stage. 
6.1.1.2 Human-Centered Design 
The International Organization for Standardization (ISO) 9241-210 standard defines 
human-centered design (HCD) as “an approach to systems design and development that aims to 
make interactive systems more usable by focusing on the use of the system and applying human 
factors/ergonomics and usability knowledge and techniques” (ISO, 2010). The ISO uses the term 
HCD instead of user-centered design as it” addresses impacts on a number of stakeholders, not 
just those typically considered as users” (ISO, 2010). However, in practice, these terms are often 
used synonymously. 
HCD has 4 defined activity phases: (1) identify the user and specify the context of use, 
(2) specify the user requirements, (3) produce design solutions, and (4) evaluate design solutions 
against requirements. The process model of HCD as defined in ISO 9241-210 is illustrated in 
Figure 6.1. 
Researchers advocate for involving patients during development who are going to use the 
mHealth intervention to meet the patient’s needs and facilitate successful uptake. Testing 
mHealth interventions with patients reveals preferences and concerns unique to the tested 
population (Carayon et al., 2015; Nelson et al., 2016; Gray et al., 2016). Developing an mHealth 
intervention with insights from stakeholders will potentially improve the process and outcome of 
mHealth interventions. The main goal of HCD is to increase the usability of mHealth technology. 
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This study offers an in-depth account of the HCD’s fourth activity phase, evaluate design 
solutions against requirements. This clarifies that this framework intends to focus on usability 
testing as one component of the more extensive design process. 
 
Figure 6.1: Human-centered design activity phases. 
6.1.1.3 Usability 
The ISO defines usability as the extent to which a product can be used by specified users 
to achieve specified goals with effectiveness, efficiency, and satisfaction in a specified context of 
use (ISo, 2018). Although this definition was published in 1998, it has been updated in 2018 
without any changes to the core concepts. The definition is widespread and generalizable 
(Goldberg et al., 2011; Bevan et al., 2015). 
mHealth involves the interaction between multiple user groups through a system. As a 
result, the usability aspect is vital for the effective, efficient, and satisfactory use of mHealth 
interventions. Although patients express an interest in using mHealth to manage their health and 
chronic conditions, many mHealth interventions are not easy to use (Horton, 2008; Sarkar et 
al.,2016). Difficulty in using an mHealth intervention may limit the user retention rate. A high 
dropout rate is one of the most significant barriers to mHealth adoption (Mayberry et al., 2017; 
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Dorsey et al., 2017). The majority of mHealth app publishers (83%) have less than 10,000 users 
who have used the app at least once a month (Research2Guidance, 2018). These numbers are 
discouraging as according to a 2018 estimate, the average mHealth app costs $425,000 to 
develop (Research2Guidance, 2018). By putting a more significant emphasis on usability, 
iterative improvements can reduce costs and enhance the long-term use and adoption of mHealth 
interventions (Usability.gov, n.d. a; Ribeiro et al., 2016; Smith et al., 2015).  
Researchers recommend frequent and iterative usability testing to respond to users’ 
preferences, technical issues, and shortcomings (Hatink et al., 2016; Triantafyllidis et al., 2015; 
Nelson et al., 2016). It is also important to ensure that errors in understanding or using the 
intervention are addressed before testing the intervention in an efficacy trial (Lyles et al., 2014). 
A systematic review investigated the usability evaluation processes described in 22 studies 
related to mHealth applications (Zapata et al., 2015). The results suggest that the adoption of 
automated mechanisms could improve usability and stress the importance of adapting health 
applications to users’ need (Zapata et al., 2015). Including insights from key users of mHealth 
has the potential to improve the process and the outcome of the intervention (Hopkins et al., 
2016). 
Contemporary iterative development methods, such as prototyping, reduce the challenges 
that evolve during the development lifecycle (Krug, 2014). Prototyping is defined as creating a 
simulation of the final mHealth technology that is used for testing before launch. Furthermore, 
researchers suggest including patients who are going to use the mHealth interventions to assist in 
the development of the intervention (Sarkar et al., 2016; Nelso et al., 2016; Gray et al., 2016; 
Zapata et al., 2015). 
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The ISO 9241-11 established usability standards (ISO, 2018). These standards provide a 
measure of patients’ experienced usability. It focuses on effectiveness, efficiency, and 
satisfaction (ISO, 2018). It is easier to quantify effectiveness and efficiency compared with 
satisfaction. Brooke developed the System Usability Scale (SUS) (Brooke, 1996) and noted that 
“if there is an area in which it is possible to make more generalized assessments of usability, 
which could bear cross-system comparison, it is the area of subjective assessments of usability” 
(Brooke, 1996). Thus, the SUS was developed to quantify satisfaction (users’ subjective 
reactions to using the system) (Brooke, 1996) . The SUS is an affordable and effective tool for 
assessing the usability of products (Brooke, 1996). It contains 10 statements that are answered on 
a 5-point Likert scale. Although this scale was developed in 1996, it is relevant and applicable to 
current research because it is short and easy to use. Many contemporary mHealth studies have 
been successful in combining both ISO and SUS to assess usability (Farinango et al., 2018; 
Gunter et al., 2016; Georgsson & Staggers, 2016). Table 6.1 describes the ISO 9241-11 usability 
constructs. 
Table 6.1: Usability constructs and descriptions. 
Constructsa Metrics Description 
Effectiveness 
  
  
  
  
Time to learn and use Time to read the 
scenarios and to begin 
performing tasks 
Data entry time Time to enter the data 
necessary for the execution 
of a task 
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Tasks time Time to accomplish 
given tasks 
Response time Time of having the 
response to the requested 
information 
Time to install Installation time of 
applications or its update 
Efficiency 
  
Number of errors Number of errors made 
while reading scenarios and 
during the task execution 
Completion rate The percentage of 
participants who correctly 
complete and achieve the 
goal of each task 
Satisfaction Usability score The System Usability 
Questionnaire 
aadapted from Moumane et al. (2016). 
6.1.1.4 Mixed Methods Research 
MMR is gaining popularity and acceptance across disciplines and the world (Creswell, 
2016). It draws from multiple scientific traditions and disciplinary backgrounds. MMR is defined 
as “the type of research in which a researcher or team of researchers combines elements of 
qualitative and quantitative research approaches for the broad purposes of breadth and depth of 
understanding and corroboration” (Johnson et al., 2007). MMR combines both closed-ended 
response data (quantitative) and open-ended personal data (qualitative) (Creswell, 2016). 
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Although quantitative research historically has predominated in health sciences research, 
many contemporary phenomena in health care are difficult, if not impossible, to measure using 
quantitative methods alone (Curry & Nunez-Smith, 2015). The goal of qualitative research is to 
produce a deep understanding of a phenomenon. It can also be used to generate a hypothesis 
regarding a phenomenon, its precursors, and its consequences (Curry et al., 2009). When the 
study phenomenon of interest is multifaceted and complex, a mixed methods approach is 
appropriate (Curry & Nunez-Smith, 2015). The National Institutes of Health best practices 
guidelines and many mixed methods researchers advise distinguishing the quantitative purpose, 
the qualitative research questions, and the mixed methods questions (Creswell et al., 2011). 
Consequently, MMR can capitalize on the strengths of both methods, the depth of qualitative 
research and the breadth of quantitative research. The resulting mixed data can be integrated to 
balance the strengths and limitations of either method to provide a more comprehensive 
understanding under potentially complementary sources of evidence (Curry & Nunez-Smith, 
2015). 
Understanding the principles and practices of integration is essential for leveraging the 
strengths of MMR. Fetters and Molina-Azorin (2017) defined integration as the linking of 
qualitative and quantitative approaches and dimensions together to create a new whole or a more 
holistic understanding than achieved by either alone. Fetters et al. examined vital integration 
principles and practices in MMR (Fetters et al., 2013). They provide approaches to integrating 
both research procedures and data in the design, methods, interpretation, and reporting 
dimensions of research (Fetters et al., 2013). Table 6.2 provides the relevant dimensions of 
MMR integration and illustrates how researchers can integrate those dimensions. These 
dimensions are relevant to mHealth, and additional information about MMR dimensions is 
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explained elsewhere (Fetters & Molina-Azorin, 2017). Through increasingly sophisticated 
approaches, MMR is viewed as an opportunity to address the highly complex, compelling, and 
even wicked research problems facing researchers in the health and social sciences (Metrens, 
2014). Investigation of novel mHealth technologies is an important example of a highly complex 
research challenge that can benefit from a systematic mixed methods approach.  
Table 6.2: Relevant dimensions of the mixed methods research integration. 
Integration dimensionsa Mixed methods researchers integrate by 
Rationale dimension Citing a rationale for conducting an 
integrated mixed methods research study 
(e.g., offsetting strengths and weaknesses, 
comparing, complementing or expanding, 
developing or building, and promoting 
social justice) 
Study purpose, aims, and research 
questions dimension 
Composing an overarching mixed methods 
research purpose and stating qualitative, 
quantitative, and mixed methods aims or 
multiple mixed methods aims with 
quantitative aims and qualitative questions 
Research design dimension Scaffolding the work in core (e.g., 
convergent, exploratory sequential, and 
explanatory sequential), advanced (e.g., 
intervention, case study, evaluation, and 
participatory), or emergent designs. 
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Sampling dimension Sampling through the type, through the 
relationship of the sources of the 
qualitative and quantitative data (e.g., 
identical sample, nested sample, separate 
samples, and multilevel samples), and 
through the timing (e.g., same or different 
periods for collection of the qualitative and 
quantitative data) 
Data collection dimension Collecting both types of data with an intent 
relative to the mixed methods research 
procedures (e.g., comparing, matching, 
diffracting, expanding, constructing a case, 
connecting, building, generating and 
validating a model, or embedding). 
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Data analysis dimension Analyzing both types of data using 
intramethod analytics (e.g., analyzing each 
type of data within the respective 
qualitative and quantitative methods and 
core integration analytics), using 1 or more 
core mixed methods analysis approach 
(e.g., by following a thread, spiraling, and 
back-and-forth exchanges), or employing 
advanced mixed methods analysis (e.g., 
qualitative to quantitative data 
transformation, quantitative to qualitative 
data transformation, creating joint displays, 
social network analysis, qualitative 
comparative analysis, repertory grid/other 
scale development techniques, geographic 
information systems mapping techniques, 
and iterative and longitudinal queries of 
the data). 
Interpretation dimension Interpreting the meaning of mixed findings 
(e.g., where there are related data and 
drawing metainferences or conclusions 
based on interpreting the qualitative and 
quantitative findings) and examining for 
the fit of the 2 types of data (e.g., 
confirmation, complementarity, expansion, 
or discordance). When the results conflict 
with each other, using procedures for 
handling the latter including reconciliation, 
initiation, bracketing, and exclusion. 
aadapted from Fetters and Molina-Azorin (2017). 
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6.1.1.5 Importance of Mixed Methods in Usability Testing 
Usability is a complex phenomenon. It is challenging to investigate usability 
comprehensively using only quantitative methods or qualitative methods in isolation, so-called 
monomethod approaches (Carayon et al., 2015). The alternative to using a monomethod 
approach is using diverse methods to generate a complete picture and reveal hidden patterns and 
novel relationships between variables and concepts (Curry & Nunez-Smith, 2015). To identify 
and resolve usability issues, various researchers emphasize the importance of using multiple 
methods and sources of data (Nitsch et al., 2016; Nelson et al., 2016). Although many studies 
collect both quantitative and qualitative data to test usability(Sage et al., 2017; Beatty et al., 
2018; Alnasser et al., 2018), mHealth researchers could benefit from advances being made for 
integration in mixed methods studies (Fetters et al., 2013; Creswell & Clark, 2018).  
Despite the recognized and intuitive value of using mixed methods for mHealth usability 
testing, mixed methodologists have yet to articulate specific designs that guide the development 
and testing of mHealth interventions. A core MMR study design that is attractive for usability 
testing is the convergent design (Creswell & Clark, 2018). Also called by some authors as a 
concurrent parallel study (Tashakkori et al., 1998) or, historically, a concurrent triangulation 
design (Creswell et al., 2003), the convergent mixed methods design features the collection and 
analysis of both types of data and then merging of the data for the final interpretation (Creswell, 
2015). 
6.1.1.6 The Iterative Convergent Mixed Methods Design 
Owing to the iterative nature of usability testing, we propose a new variation of the 
convergent design specifically for mHealth, namely, the iterative convergent mixed methods 
design. We define an iterative convergent mixed methods design as an approach involving 
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simultaneous qualitative and quantitative data collection and analysis that continues cyclically 
through multiple rounds of mixed methods data collection and analysis until the mHealth 
technology under evaluation is found to work to the satisfaction of the researcher. In cyclical 
iterations, early development is more qualitatively driven but progressively becomes more 
quantitatively driven; see Figure 6.2 (Hesse-Biber & Johnson, 2015). Thus, the iterative 
convergent mixed methods design involves simultaneously collecting and analyzing qualitative 
and quantitative data and, as critically important, taking into consideration the iterative nature of 
mHealth technology development.  
In the following, we articulate the features of an iterative convergent mixed methods 
design appropriate for mHealth intervention development and usability testing that incorporates 
an iterative process and is conducted according to the user’s health care and usability needs. 
Leveraging a specific mixed methods design can help fully integrate the 2 forms of data to 
enhance the understanding of the usability of mHealth interventions.  
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Figure 6.2: Evolution in an iterative convergent mixed methods design from qualitatively driven 
to quantitatively driven. 
6.2 Methodology  
Fetters et al recommend considering the design, data collection procedures, 
interpretation, and analysis for achieving integration in a mixed methods study (fetters et al., 
2013). The iterative convergent design includes integration in various dimensions: the research 
aim/question, data collection, data analysis, and data interpretation. As illustrated in Figure 6.3, 
the results of each iteration inform further development of mHealth technology. These 
integration dimensions, as applied to usability testing, are discussed in more detail below.  
6.2.1 Step 1: Integration in the Research Aim/Question Dimension 
An iterative convergent mixed methods design should have an MMR aim as well as 
specific quantitative research aims and qualitative research questions. 
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6.2.1.1 Mixed Methods Aim 
The mixed methods aim is to illustrate, explore, and measure how to improve the 
usability of an mHealth intervention. A mixed methods aim should imply both qualitative and 
quantitative data collection methods. For example, illustrate and explore imply qualitative data 
collection, whereas measure implies qualitative data collection (Fetters & Molina-Azorin, 2017). 
6.2.1.2 Quantitative Research Aims 
Appropriate quantitative research aims include measuring effectiveness, efficiency, and 
satisfaction, as illustrated in Table 6.3. These constructs provide a measure of patients’ 
experienced usability. Effectiveness, efficiency, and satisfaction can be compared across 
iterations to identify the most usable mHealth technology. 
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Table 6.3 Matching of the construct’s quantitative variables and qualitative questions in a joint 
display depicting mixed methods of data collection. 
  
Construct Quantitative variables Qualitative questions 
Effectiveness Time to learn and use How did you learn to use the 
app? How can we reduce the 
time it takes to learn the app? 
What was your experience 
using the app? How can we 
reduce the time it takes to use 
the app? 
Data entry time How can we reduce the time it 
takes to enter the data? 
Tasks time How can we reduce the time it 
takes to complete the task? 
Response time How do you feel about the app 
response time? 
Time to install What are your thoughts about 
the time it took to install the 
app? The time it took to pair 
the medical device, if 
applicable? 
Efficiency Number of errors What can we do to help users 
avoid the same error? 
Completion rate What can we do to enhance the 
completion rate? 
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Satisfaction Usability score How often would you use the 
app? Why? Why not?; How do 
you feel about the complexity 
of the app?; How can we 
simplify it?; Do you have any 
recommendations to make the 
wording and interface easier to 
use? ; Would you need the 
support of a technical person 
to be able to use this system? 
How would you contact them: 
phone, email, or messaging? ; 
How did you find the 
integration of various 
functions in this app? How can 
we make it better?; How did 
you feel about the consistency 
of the app?; How can we 
simplify it?; Did you have any 
troubles when using the app? 
Where? How can we fix it? ; 
Did you feel confident when 
using the app? How can we 
make you more confident?; 
Did the app capture issues of 
importance to you?; Are there 
other ways to gather similar 
information? 
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6.2.1.2 Qualitative Research Questions  
As illustrated in Table 6.3, appropriate qualitative research questions include clarifying 
and characterizing our understanding of mHealth intervention usability. Qualitative inquiry is 
particularly valuable for understanding how and why a phenomenon occurs, a theory explaining 
a phenomenon, or the nature of someone’s experience (Teherani et al., 2015). In usability testing, 
specific applications can include how and why participants make certain choices when using a 
prototype or their overall assessment of the utility. Usability testing may require or suggest a 
theory for its utility. The quality of the user’s experience is critical for an mHealth developer 
who is creating a desirable user-friendly system. 
A recent study by Beatty et al. (2018) illustrates the mixed methods process as they 
collected both quantitative and qualitative data to determine the usability of a mobile app for 
technology-facilitated home cardiac rehabilitation. Quantitative data included the SUS and task 
completion rate, whereas the qualitative data included questions about the functionality of the 
mobile app (Beatty et al., 2018). 
6.2.2 Step 2: Integration in the Data Collection Dimension 
During usability testing, users will be asked to provide feedback optionally on paper and, 
later, on working prototypes. Testing usability with 5 participants will generally be sufficient for 
identifying significant issues for each version (Nielsen, 2018). During each session, participants 
will be given specific tasks. Both quantitative and qualitative data will be collected during and 
after the completion of the tasks. Researchers have 3 key strategies for integration during data 
collection: matching, diffracting, and expanding.  
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6.2.2.1 Matching  
The matching integration strategy involves intentionally asking qualitative questions that 
address the scales or constructs of quantitative instruments such that both instruments will 
elucidate data about the same concepts or domains (Fetters & Molina-Azorin, 2017). For 
example, the constructs of both the ISO standards and SUS used during quantitative data 
collection can be matched with similar or related qualitative questions to generate related 
quantitative and qualitative data, as illustrated in Table 6.3. A mixed methods data collection 
joint display includes the major constructs of inquiry in the first column. The latter 2 columns 
include the quantitative data, for example, scales or items, and the qualitative data, for example, 
qualitative questions or observation types. For example, Beatty et al. (2018) used matching by 
integrating the task completion time (quantitative) with asking “I noticed that the _____ feature 
took you longer than some of the others. Tell me more about that?” (qualitative). They also 
expanded on the SUS by asking open-ended questions regarding the user’s experience with the 
mHealth intervention.  
The qualitative questions in this table include both general and specific questions. 
Depending on the development needs, more general questions may be used initially, whereas 
later, more specific questions may be asked. When data become available, the same table 
structure can be populated with the findings; see Step 4: Integration in the Data Interpretation 
Dimension. The ordering of the columns is flexible according to specific project procedures.  
6.2.2.2 Diffracting  
The diffracting integration strategy involves intentionally asking qualitative questions 
that will address different aspects of the quantitative data, in the case of mHealth, the usability 
measure (Uprichard & Dawney, 2019). The intent is to obtain different cuts of data that will 
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reveal information about different aspects of the usability that will not be addressed with the 
quantitative scales or items that are being collected (Uprichard & Dawney, 2019). Hence, for the 
ISO measures of effectiveness, efficiency, and satisfaction, qualitative questions might explore 
other facets, for example, animations, color patterns, sounds, and font size. 
Diffracting can be used to address external factors to the user; such as the ease of 
connecting to the internet or connecting medical devices via Bluetooth. It is also important to 
develop an mHealth intervention that is energy efficient. mHealth interventions that require 
frequent charging of the smartphone or medical device are not recommended. Finally, developers 
should ensure that adequate resources are available to address medical and technical difficulties 
related to the mHealth intervention.  
6.2.2.3 Expanding  
The expanding integration strategy occurs when the findings from the 2 sources of data 
diverge and expand upon the phenomenon of interest by addressing both different aspects of a 
single phenomenon as well as a central phenomenon of interest (Fetters et al., 2013). Expansion 
involves intentionally asking qualitative questions that will be the same as the quantitative scales, 
while also measuring and asking qualitative questions that will address different aspects of 
usability. In essence, it reflects a hybrid strategy of using both matching, an area of overlap, and 
diffracting by looking at different aspects or facets of mHealth during the collection of data. 
Each of these integration strategies could be used effectively in usability testing. 
6.2.2.4 Quantitative Data Collection 
Current prototyping platforms, such as InVision and Adobe XD, integrate with Lookback 
to enable recording of the user’s interaction with a smartphone. These allow recording of the 
participant’s voice, nonverbal reactions, and mobile phone screen display. The researcher asks 
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participants to complete a set of tasks and assess effectiveness, efficiency, and satisfaction. The 
researcher records the time to learn and use mHealth technology, data entry time, task 
completion time, response time, and time to install the mHealth technology. The researcher also 
records the number of errors and task completion rate. After completing the tasks, the researcher 
administers the SUS to assess the user’s satisfaction with the mHealth technology. 
6.2.2.5 Qualitative Data Collection 
The methods appropriate for assessment generally involve semistructured interviews 
during or after the participant’s use of the prototype. Researchers can utilize cognitive testing, 
also called cognitive interviewing (Willis & Artino, 2013; Wharton et al., 1994; Lapka et al., 
2008). The researcher asks participants to use the system while continuously thinking out loud as 
they move through the user interface (Nielsen, 2012). Thinking aloud questions include “Tell me 
what you are thinking,” “What are you looking at?”, or “What’s on your mind?”. The goal is for 
the users to make their thoughts transparent to the researcher. Verbal probing is another 
alternative for eliciting additional information about mHealth technology. It is a more active 
form of data collection in which the cognitive interviewer administers a series of probe questions 
specifically designed to elicit detailed information beyond that which is typically provided by 
respondents (Willis & Artino, 2013).  
Another alternative to these approaches involves a postuse debrief where the interviewer 
observes the user going through the mHealth intervention, notes decisions made, and, after use, 
enquires about decisions made along each step of the way. The strength of this approach is that 
the user can go through the version naturally without disruption as a real user would. However, 
the downside is the risk that the user may forget what specific thoughts or motivations influenced 
their decisions during real-time use. Postuse debrief questions may include (1) whether the tool 
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captured issues of importance to the user, (2) whether the tool was easy to use and understand 
regarding question wording and interface, and (3) whether there were other ways the system 
could be improved.  
A different option involves the collection of observations to record information about 
behavior. This can be done in real time through the collection of notes while observing or 
through recordings of the user’s interactions and using video elicitation interviews (Henry & 
Fetters, 2012). Video elicitation interviews question the user about their experiences and choices 
at certain points while interacting, for example, specific choices made and reasons for leaving a 
screen or returning to it. Tobii Pro can allow the researcher to track eye movements that convey 
behavioral patterns of use while interfacing with the mHealth technology. 
Semistructured interviews and cognitive interviewing are suitable in the early stages of 
development. The goal is to identify bugs in the system, that is, anything that is dysfunctional or 
suboptimal. In later stages, verbal probing and video elicitation interviews are recommended to 
obtain specific data about the engineered changes.  
6.2.3 Step 3: Integration in the Data Analysis Dimension 
There are 2 approaches for an integrated analysis: an interactive analysis strategy or an 
independent intramethod analysis (Moseholm & Fetters, 2017).  
6.2.3.1 Interactive Analysis Strategy  
The interactive analysis strategy (Moseholm & Fetters, 2017), also called a crossover-
tracks analysis (Teddlie & Tashakkori, 2009), means that the researcher considers the qualitative 
and quantitative findings, in real time, as the data are collected and analyzed. That is, the data are 
openly, actively, and interactively considered in the context of each other. Metaphorically, the 
data are talking to each other.  
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6.2.3.2 Independent Intramethod Strategy 
The independent intramethod strategy, also called a parallel-tracks analysis (Teddlie & 
Tashakkori, 2009), means that the researcher uses an intramethod (ie, within method) qualitative 
data analysis strategy separately or independently to the quantitative data analysis strategy. First, 
each type of data is examined using a strategy appropriate for the type of data, for example, 
statistical analysis of quantitative data and thematic analysis of the qualitative data. After the 
separate/independent analysis, the findings are then integrated to draw an overarching 
interpretation, so-called metainferences in MMR methodology (Teddlie & Tashakkori, 2009).  
For an iterative convergent design, the research can and likely will use both strategies 
depending on the stage of testing. The interactive analysis strategy is preferred, especially during 
early prototype testing when the number of users will invariably be smaller and there is an 
urgency for identifying major issues. As statistical analyses will not be feasible or necessary, this 
approach allows rapidly assessing user rankings of certain features, for example, using the SUS 
as well as their qualitative experiences with the system. 
In later cycles of testing, the analysis may shift to a more independent intramethod 
analysis strategy. As a higher number of users engage and real-time automated digital user data 
emerge, the interactive analysis approach may become more challenging to conduct. Moreover, 
the independent intramethod analysis may be preferred when the scale of testing expands such 
that blinded quantitative data collection becomes more important. Doing so can enable the 
researcher to avoid validity threats to the data quality that could occur by changing the data 
collection approach or by sharing patterns with users in real time. For example, Kron et al. 
(2017) linked the qualitative findings from learners’ reflections on their experiences after 
completing the qualitative and quantitative analyses.  
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6.2.3.3 Combined Independent and Interactive Data Analysis 
The third option can involve an iteration of both interactive and independent data 
analyses, that is, user survey and interview data conducted in real time can be looked at 
interactively, whereas automated data collection that accumulates as the number of users 
expands may be brought into the results of the interactive analysis after being examined 
independently. The exact approach may vary and evolve according to development needs.  
6.2.3.4 The Fit of the Two Types of Data When Considered Together  
Comparing both the qualitative and quantitative findings allows researchers to examine 
the similarities, differences, or contradictions. This comparison also allows researchers to obtain 
an expanded understanding of when the qualitative and quantitative findings from the analyses 
are merged for an interpretation. Similarities occur when there is convergence or confirmation 
between the qualitative and quantitative findings. Differences occur when the 2 types of data 
illustrate different, nonconflicting interpretations, so-called complementarity (Greene et al., 
1989). There is an expanded understanding, namely, expansion, when qualitative and 
quantitative finding provides a broader understanding of a central commonality (Fetters & 
Molina-Azorin, 2017; Fetters et al., 2013). Contradictions occur when there is discordance or 
divergence between the findings of the qualitative and quantitative data. To handle discordance, 
Fetters et al recommend gathering additional data, reanalyzing existing databases to resolve 
differences, seeking explanations from theory, or challenging the validity of the constructs 
(Fetters & Molina-Azorin, 2017; Fetters et al., 2013).  
6.2.4 Step 4: Integration in the Data Interpretation Dimension 
A key challenge in mixed methods studies is how to merge the qualitative and 
quantitative data. A very promising approach of growing popularity among mixed methods 
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researchers is the creation of a joint display (Guetterman et al., 2015). Table 6.4 provides an 
example of presenting matched quantitative and qualitative data through a joint display. This 
joint display is derived from a randomized multisite mixed methods trial designed to compare a 
medical student’s attitudes and experiences regarding the intervention, a virtual human-computer 
simulation program teaching communication skills, or a control, a computer-based learning 
module focused on teaching communication skills (Kron et al., 2017). The data collection for 
this project included usability-focused questioning .  
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Table 6.4: A joint display adapted from Kron et al’s MPathic-VR mixed methods trial 
comparing a virtual human simulation and a computer-based communications module that 
illustrates medical students’ attitudes and experiences in both trial arms. 
  
Domains MPathic-VR Computer Based Learning Interpretation 
of mixed 
methods 
findings 
Attitudina
l item, 
mean (SD) 
Qualitative 
reflection; 
illustrative 
quotes 
Attitudina
l item, 
mean (SD) 
Qualitative 
reflection; 
illustrative 
quotes 
Verbal 
communicatio
n 
5.02 (1.62) “How to 
introduce 
myself without 
making 
assumptions 
about the 
cultural 
background of 
the patient and 
the family” 
3.89 (1.67) “This 
educational 
module was 
useful for 
clarifying the 
use of SBAR 
and addressing 
ways that all 
members of a 
health care 
team can 
improve 
patient care 
through better 
communicatio
n skills” 
Intervention 
arm comments 
suggest deeper 
understanding 
of the content 
than teaching 
using 
memorization 
and mnemonics 
as in the 
control, a 
difference 
confirmed by 
higher 
attitudinal 
scores 
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Nonverbal 
communicatio
n 
4.11 (1.85) “Effective 
communicatio
n involves 
non-verbal 
facial 
expression like 
smiling and 
head nodding” 
2.77 (1.45) None Intervention 
arm comments 
address the 
value of 
learning 
nonverbal 
communication
, the difference 
confirmed by 
attitudinal 
scores 
Training was 
engaging 
5.43 (1.55) “Reviewing 
the video 
review was a 
great way to 
see my facial 
expressions 
and it allowed 
me to improve 
on these skills 
the second 
time around” 
3.69 (1.62) “This 
experience can 
be improved 
by 
incorporating 
more active 
participation. 
For example, 
there could 
have been a 
scenario in 
which we 
would have to 
select the 
appropriate 
hand-off 
information 
per SBAR 
guideline” 
Intervention 
arm comments 
reflect 
engagement 
through the 
after-action 
review, 
whereas the 
control 
comments 
suggested the 
need for 
interaction, the 
difference 
confirmed by 
higher 
attitudinal 
scores 
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Effectiveness 
in learning to 
handle 
emotionally 
charged 
situations 
5.13 (1.48) “I tend to try 
to smile more 
often than not 
in emotionally 
charged 
situations and 
that may result 
in conveying 
the wrong 
message” 
2.34 (1.35) “I anticipate 
that high-stress 
situations 
where time is 
exceedingly 
crucial 
requires 
modification 
to the methods 
presented.” 
Intervention 
arm comments 
indicate 
awareness of 
communication 
in emotionally 
charged 
situations, yet 
control 
comments 
indicate the 
need for 
additional 
training, a 
difference 
confirmed in 
attitudinal 
scores 
 
Joint displays allow researchers to integrate data through visual means to draw out new 
insights beyond the information gained from the separate quantitative and qualitative results 
(Fetters et al., 2013; Guetterman et al., 2015). Joint displays are commonly built by organizing 
quantitative and qualitative findings of a related construct or topic in a table. When matching has 
been used during data collection, this process follows naturally. In the case of mHealth, the joint 
display might include the usability constructs, user’s perceptions, and an image or even a video 
representing the task (Usability.gov, n.d.b). For example, SUS and ISO metrics can be used to 
populate the numerical score in the quantitative column. In addition, themes and representative 
quotations can be used to populate the qualitative column. In the final column, metainferences, 
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an interpretation in consideration of the qualitative and quantitative findings, are made about the 
findings when analyzed together. 
6.2.5 Step 5: Developer Updates the Mobile Health Intervention  
After merging the data and drawing interpretations about their cumulative meaning 
(making metainferences), an iterative convergent mixed methods design then involves the results 
being communicated to the developers who will include the recommendations in the new 
iteration of the intervention. Moreover, as the developers make changes, they may also have 
specific questions to be answered in the subsequent cycle of iterative convergent data collection. 
Thus, newly emerging questions are added into subsequent rounds of data collection. In general, 
both qualitative and quantitative data (task completion rate, task completion time, number of 
errors, completing rate, and the SUS questionnaire) should be compared with each iteration for 
new mHealth versions. 
6.2.6 Step 6: Iterative Evaluation 
As illustrated in Figure 6.3, after 1 cycle of iterative evaluation, the next step is to 
develop a new version that has incorporated the findings from the previous evaluation. For 
example, Beatty et al. (2018) compared the task completion success rate and SUS across 
iterations of the mHealth intervention. The procedure will be similar by going back to Step 2: 
Integration in the Data Collection Dimension. With the new iteration, there will be new questions 
to ask, sometimes more general and sometimes more specific, depending on what changes were 
made. Furthermore, a new iteration is also required when the researcher introduces a new feature 
or functionality to the mHealth intervention.  
On the basis of the results of the usability test, many changes may be required. The 
researcher should prioritize these changes while focusing on the user’s needs. Generally, the 
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magnitude of data collection and intensity will change. In the early rounds of development, the 
qualitative component of the mixed methods evaluation will weigh more heavily for identifying 
the macrolevel changes (Figure 6.2). This is more of a qualitatively driven mixed methods 
approach (Moseholm & Fetters, 2017). In subsequent iterations, as the prototype moves from 
paper to digital prototype to product, changes may depend much more heavily on the quantitative 
automated analyses that can accumulate with increased numbers of users, a quantitatively driven 
approach. Hence, in later cycles, the quantitative data may help identify problems, whereas the 
qualitative data can be used to identify solutions.  
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Figure 6.3: The iterative convergent mixed methods research design. 
6.2.7 Reaching Closure in an Iterative Convergent Mixed Methods Design 
Many researchers use the concept of saturation when conducting usability testing (Press 
et al., 2015; Voncken-Brewster et al., 2013). Saturation represents the point at which the 
researcher stops collecting data based on the criterion of not finding new information relevant to 
the development of the mHealth application. Researchers also have the option for longitudinal 
evaluation by comparing user satisfaction with the new mHealth technology with the result of the 
239 
 
SUS across iterations. Similarly, qualitative data about specific features can be compared as well. 
After usability testing, the final prototype of the mHealth intervention can then be included in a 
pilot study for final refinement before launching it in a larger trial. During these subsequent 
phases, the iterative convergent mixed methods design will naturally continue, even into the trial.  
6.3 Discussion  
Here, we emphasize the need and process for mHealth researchers to use state-of-the-art 
mixed methods procedures. Previous single method usability studies were limited in their 
findings. Some studies have assessed usability using only qualitative data(Lodhia et al., 2016; 
Wang et al., 2018; Khurana et al., 2016). These studies can only elucidate an understanding of 
how and why participants make certain choices when using a prototype or their overall 
assessment of the utility. On the contrary, some studies have used quantitative data exclusively to 
assess usability (Schobel et al., 2018; Metelmann et al., 2018). These studies are limited to 
specific questions about usability and could miss valuable experiential information. 
6.3.1 Features of the Iterative Convergent Mixed Methods Design 
Despite the recognized value of using mixed methods for usability testing (Alnasser et 
al., 2018; Beatty et al., 2018; and Sage et al., 2017; Andargoli et al., 2017), researchers have 
lacked a specific design and clear procedures featuring an integrated approach that is focused on 
mHealth development. We believe, and the identified literature supports, that many researchers 
in the field are only using qualitative and quantitative procedures separately without a focus on 
the features of integration (Beatty et al., 2018; Alnasser et al., 2018; Farinango et al., 2018). This 
illustrates explicitly why mHealth intervention researchers need a better understanding of how to 
incorporate the latest advances in MMR methodology, which explicitly emphasizes integration, 
and has procedures for achieving it.  
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We suggest the following criteria for evaluating the quality of studies that have used the 
iterative convergent mixed methods design: 
1. The authors report on an empirical mHealth-related usability study. 
2. The authors use an integrated mixed methods approach, defined as the collection, 
analysis, and integration of quantitative and qualitative data (Creswell & Clark, 2018). 
3. The authors compare the results of various iterations of the mHealth intervention. 
 
The iterative convergent mixed methods design provides a clear framework for 
integrating quantitative and qualitative data to assess usability. As illustrated in Figure 6.3, there 
are multiple dimensions during testing, questions, data collection, analysis, and interpretation as 
well as subsequent data collection that characterize an iterative convergent mixed methods 
design.  
With this design, researchers will start with a mockup, prototype, or the actual mHealth 
intervention that is represented in the diagram by the circle named the mHealth technology 
version. In each round, the researcher will evaluate aspects of the version using both qualitative 
and quantitative research aims and, importantly, making overarching interpretations or 
metainferences based on the findings of both types of data that inform the next steps (Teddlie & 
Tashakkori, 2009). During data collection, the researcher can use matching, diffracting, or 
expanding as data are collected. Employing specific data collection approaches, the constructs 
explored quantitatively with scales can be explored with a similar line of qualitative questioning 
or inquiry. Once the data are brought together, they are compared so as to examine their 
confirmation, expansion, differing interpretations, or discordance (Fetters et al., 2013). As 
successive versions of the mHealth technology are produced, each version will involve both 
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qualitative and quantitative data collection brought together for an integrated analysis. Iterative 
qualitative and quantitative data collection can be compared with each iteration to create the 
most usable version of the mHealth technology.  
6.3.2 Limitations  
There are potential limitations to the current usability approach. Although the small 
sample size may resolve the majority of usability issues (Nielsen, 2018), usability testing with a 
small number of individuals will generally reveal major flaws or bugs in the system. As the 
mHealth intervention becomes refined and moves from the protocol stage to the actual use stage, 
access to quantitative data rapidly increases and becomes more of a focus.  
Usability testing can be conducted on the Web or in a laboratory setting. The value of 
Web-based testing is that users can participate from their natural context and use their own 
devices. It is also more cost-effective, and users can be in any location with an internet 
connection. In a laboratory setting, the researcher can probe users while they walk through their 
tasks, gather visual cues, assist stumped users, and ask new questions during the testing session.  
We acknowledge that there are other methods, including other mixed methods designs 
(Fetters et al., 2013), potentially applicable for usability and design research, for example, mixed 
methods interventions or trials. There are also other scales that can be used to quantify the 
satisfaction construct, such as the Post Study System Usability Questionnaire (Lewis, 1992). 
Addressing all of these methods and scales extends beyond the scope of our current focus. 
6.4 Conclusions   
A usable mHealth intervention with high user satisfaction can have a significantly 
positive effect on mHealth adoption, resulting in improved health outcomes and quality of life 
and reduced overall health care costs. Effective mHealth interventions are critically important for 
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empowering patients to manage their health and also potentially enable them to participate more 
actively in shared decision making with their health care providers. This study offers a novel 
framework to guide mHealth research that has the potential to generate unique insights into 
multifaceted phenomena related to usability. Understanding these practices can help developers 
and researchers leverage the strengths of an integrated mixed methods design.  
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Chapter	7:	Summary		
 
This chapter briefly summarizes the research and the findings. The implications of the 
research are then discussed, followed by recommendations for further research on developing 
mHealth interventions for COPD management.  
7.1 General Discussion  
The main goal of this program of research is to investigate how to apply the Human-
Centered Design process when developing an mHealth intervention for COPD management. A 
set of research questions was designed to facilitate this research. To examine this process, we 
produced five unique journal articles: 1) a systematic review and meta-analysis of the effect of 
mHealth interventions on exacerbations for patients with COPD; 2) a qualitative study to explore 
the perceptions of healthcare providers regarding an mHealth intervention for COPD 
management; 3) a mixed methods study to explore the perceptions of patients with COPD 
regarding an mHealth intervention for COPD management; 4) a qualitative study to identify the 
features of an mHealth intervention for COPD management; and 5) developing a mixed methods 
approach, the iterative convergent design, for mHealth usability testing.   
The first study (chapter 2) was conducted to determine if mHealth can be effective in 
reducing COPD exacerbations. It elaborated on how I answered the following research question: 
“Based on the existing literature, what is the association between mHealth interventions and the 
management of COPD exacerbations?” A systematic review and meta-analysis were performed 
to summarize and quantify the association between mHealth interventions and the management 
of COPD exacerbations. 
Although the current literature on the role of mHealth in reducing COPD exacerbations is 
limited, findings from my review suggest that mHealth interventions are potentially useful in 
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reducing the number of patients with a COPD exacerbation. Of the 245 unique citations 
screened, six studies were included in the qualitative synthesis. The qualitative synthesis 
included data regarding the study design, study procedure, intervention, population 
demographics, and number of patients having an exacerbation. All the articles were published 
after 2008. All of the studies were conducted on relatively small samples, less than 100 
participants each. The pooled random-effects odds ratio of patients having an exacerbation was 
0.20 in patients using a smartphone intervention (95% CI 0.07-0.62), a reduction of 80% for 
smartphone interventions compared with usual care. However, there was moderate heterogeneity 
across the included studies (I2=59%). These results should be interpreted with caution due to the 
heterogeneity among the studies. Another recommendation that emerged from the systematic 
review was the need for implementing a mixed methods research design to investigate the 
validity and clinical utility of smartphone interventions that could help to understand why a 
particular component is successful and how patients will use mHealth interventions for in the 
long term. 
My second study (chapter 3) examined some of the perceived barriers and facilitators of 
adopting an mHealth intervention to manage COPD, according to HCPs. This study was 
conducted to answer the following research question: What are the potential facilitators and 
barriers that might influence healthcare providers of patients with COPD regarding the use of 
mHealth in COPD management? To answer this, I developed a qualitative study. A total of 30 
nurses, physicians, and pharmacists participated. The main facilitators to mHealth adoption are 
possible health benefits for patients, ease of use, educating patients and their HCPs, credibility, 
and reducing the cost to the health care system. Alternatively, the barriers to adoption are 
technical issues, privacy and confidentiality issues, lack of awareness, potential limited uptake 
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from the elderly, potential limited connection between patients and HCPs, and finances. These 
facilitators and barriers may inform the successful development and implementation of mHealth 
interventions for COPD management.  
The third study (chapter 4) explored the perceptions of patients with COPD regarding the 
use of mHealth in COPD management. This resulted in the following research questions: What 
are the potential facilitators and barriers that might influence patients with COPD regarding the 
use of mHealth in COPD management? What are the demographics, use, and access to 
smartphones among patients with COPD? I developed an explanatory sequential mixed methods 
study to answer these questions.  
Patients with COPD completed a survey to assess how they use various types of mobile 
technology and to what extent they use mHealth. The quantitative component revealed that many 
COPD patients owned a mobile phone, but only about a quarter of the participants, 18/77 
(23.4%), owned a smartphone. The likelihood of owning a smartphone was not associated with 
age, sex, marital status, or geographical location, but patients with high educational status were 
more likely to own a smartphone. I collected qualitative data through interviews to further 
explicate the data collected from the surveys and provide a richer depiction of the data. The 
qualitative component found that COPD patients, in general, had a positive attitude toward 
mHealth adoption for COPD management, but several facilitators and barriers were identified. It 
is important to promote the facilitators and address the barriers to optimize the successful 
implementation of mHealth interventions. 
In comparison with the facilitators reported by HCPs, patients had four parallel 
facilitators: there are possible health benefits for patients, the software needs to be easy to use, 
patients need to be educated on the use of mHealth, and the credibility of mHealth should be 
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evident (Alwashmi et al., 2019a). The only facilitator that was not mentioned by patients is that 
mHealth should reduce the cost to the healthcare system. On the other hand, patients had five 
parallel barriers with the HCPs: there are technical issues with mHealth, lack of awareness is a 
challenge, there may be limited uptake from the elderly, there are possible financial barriers, and 
there may be privacy and confidentiality concerns (Alwashmi et al., 2019a). The possibility of 
mHealth limiting the personal connection between HCPs and patients was not mentioned as a 
barrier by patients. Furthermore, one new barrier emerged from interviewing patients: some 
patients were not interested in using mHealth interventions. Our findings, and the limited 
literature on the matter, emphasize the need for further research into the use of mHealth in 
COPD management.   
In the fourth study (chapter 5), I focused on the features of the mHealth intervention. This 
resulted in the following research question: How can an mHealth intervention for COPD 
management be developed that takes into account the needs and requirements of patients with 
COPD and their HCPs? A list of recommendations was made based on interviews with patients 
with COPD and their HCPs. The recommendations provide a set of considerations for delivering 
an mHealth intervention to assist in the management of COPD. This collaborative and human-
centered approach requires two different interfaces: one for patients and the other for HCPs. The 
mHealth intervention could potentially enhance COPD management using several features; most 
importantly, by collecting relevant subjective and objective data, then using it to tailor COPD 
management based on the patient’s unique needs.  
In the last article (chapter 6), a mixed methods framework, called the iterative convergent 
design, for usability testing is described. This framework was developed in response to a barrier 
that was identified by the majority of patients and HCPs — having difficulty in using the 
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mHealth intervention. The following research question was addressed: What is the most suitable 
MMR framework for generating unique insights into the usability of mHealth? This usability 
framework is a relevant way of determining usability and patient perceptions toward an mHealth 
intervention. The iterative convergent mixed methods design provides a clear framework for 
integrating quantitative and qualitative data to assess usability, which is critical to the success of 
an mHealth intervention.  
7.2 Applying human-centered design activity phases to mHealth development   
This thesis follows the ISO HCD activity phases discussed in section 1.1.2.1. Figure 1.4 
highlights the HCD and its associated thesis chapter. The first phase, understand and specify the 
context of use, was addressed in chapters 2–4. It consisted of identifying the user characteristics 
of both patients with COPD and their HCPs. Based on what we learned about how patients may 
use mHealth in COPD management, we were able to determine the usage requirements, which 
brings us to phase two.  
The second phase consists of specifying the user requirements and defining those 
requirements for the system, based on what the user needs to do within the context of use. This 
phase was addressed in chapter 5. It includes the features and requirements for users, both 
patients and HCPs. In phase two, actions a user should be able to perform while interacting with 
the interface were described.  
The third phase consists of producing design solutions to meet user requirements. Some 
design considerations were included in chapter 5. Ideally, a low-fidelity prototype would be 
developed after a few iterations that can be used for testing in the following phase.   
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In the final phase, the developed prototype can be used to evaluate the design solution 
from the user’s perspective via usability testing. A meta-inference I observed from interviewing 
patients and HCPs was the importance of a usable mHealth intervention that could enhance 
mHealth adoption. Chapter 6 includes a mixed methods framework specifically for mHealth 
usability testing. Both quantitative and qualitative data are vital to understanding the user’s needs 
and goals. MMR can capitalize on the strengths of both methods: the depth of qualitative 
research and the breadth of quantitative research. The resulting mixed data can be integrated to 
provide a more comprehensive understanding of a complex phenomenon, such as usability. After 
producing a usable mHealth intervention, the final version can be used in a pilot study, then a 
randomized controlled trial should be carried out to assess its effectiveness.   
 
Figure 1.4 Human-centered design activity phases and the associated thesis chapters. 
7.3 Study implications  
Globally, we are seeing a push towards more patient-centered care. mHealth 
interventions have the potential to empower patients to manage their own health and also 
potentially enable them to participate more actively in shared decision making with their health 
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care providers to optimize their COPD control and medication adherence. Given that COPD 
management is critical to positive health outcomes, a usable mHealth intervention with high user 
satisfaction and retention could have a significantly positive effect on health outcomes, quality of 
life, and reduced overall health care costs. The final, fully customized mHealth intervention will 
help to direct a future full-scale, randomized efficacy study to quantify these benefits. 
There were a few barriers identified by the patients and their HCPs. Most of these 
barriers have the potential to be resolved, as suggested by many of the participants. This program 
of research highlights the barriers to adoption that can be addressed by various stakeholders. 
Additionally, some of these barriers and facilitators to mHealth adoption can be generalized to 
other chronic diseases, such as asthma, heart failure, and diabetes.   
7.4 Areas for future research  
The use of mHealth to manage COPD is still an emerging field of research. Experts in the 
field continue to identify areas in need of more research, clarification or guidance. My research 
program, as described in this dissertation, has further identified several questions. These are 
grouped according to the study in which they were identified, and broader questions are listed at 
the end. 
I acknowledge that there are other frameworks potentially applicable for usability and 
design research, for example, Technology Acceptance Model (Davis et al., 1989) and 
Instructional Design (Reiser & Dempsey, 2012). There are also other theories that can be used to 
affect behaviour change, such as the self-efficacy theory (Bandura et al., 1977) and self-
determination theory (Deci & Ryan, 2012). Addressing all of these methods and scales extends 
beyond the scope of our current focus. 
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7.4.1 Systematic review and meta-analysis of the effect of mHealth interventions 
on patients with COPD 
Although the studies in this review have a small sample size and a relatively short follow-
up period, current literature supports the potential of smartphones in reducing COPD 
exacerbations. There is a need for more studies that evaluate mHealth interventions, including 
studies that use smartphones as the main intervention. This will assist in determining whether 
smartphones can be effective in the management of COPD. Another systematic review was 
published last year with similar findings (Yang et al., 2018). They concluded that mHealth may 
help to reduce hospital admissions or improve the health status of patients with COPD. Future 
studies should include participants with different stages of COPD severity and age spans to 
minimize the risk of bias and enhance the generalizability of the study results.  
7.4.2 Perceptions of healthcare providers regarding a Mobile Health intervention 
for COPD management 
More research needs to be conducted to explore the perceptions of HCPs regarding the 
use of mHealth in COPD management. This includes conducting focus groups with some of the 
participants following individual interviews. Additionally, including the perspectives of allied 
HCPs, such as physiotherapists, social workers, and occupational therapists, would be beneficial 
to understand the perspectives of administrators (e.g., information technology managers) who 
may be able to identify some of the challenges with using mHealth for COPD management. 
7.4.3 Perceptions of patients with COPD regarding a Mobile Health intervention 
for COPD management 
As highlighted above, more research needs to be done to explore the perceptions of 
patients regarding the use of mHealth in COPD management. This includes conducting focus 
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groups with some of the participants following individual interviews. We recruited patients who 
attended respirology clinics. Replicating the study with patients in a community setting or using 
digital recruitment methods (e.g. social media) could lead to different results, especially 
regarding the access to and use of mHealth.    
7.4.4 Features of a Mobile Health intervention for COPD management  
Similar to the previous studies, some recommendations include the use of a focus group, 
including the perspectives of allied HCPs and administrators, and obtaining perspectives from 
patients in a community setting.  
7.4.5 The Iterative Convergent Design for Mobile Health Usability Testing: 
Mixed Methods Approach 
This approach is geared towards enhancing the usability of mHealth interventions. Future 
studies could adopt this framework to potentially improve the effectiveness, efficiency and 
satisfaction of an mHealth intervention.  
7.4.6 General areas for future research  
While I have discussed recommendations for future research that were specific to each 
study, there are overarching goals that need to be addressed by future studies. This research 
makes contributions to the development of an mHealth intervention to manage COPD. However, 
the following points can be further improved in the future: 1) if further research is undertaken, 
the mHealth intervention should be developed fully; 2) usability testing should be conducted 
using the framework described in chapter 6; 3) additional trials will be required to provide data 
regarding the efficacy and cost-effectiveness of mHealth interventions in COPD management; 
and 4) a mixed methods framework could be developed to guide the process of producing design 
solutions of an mHealth intervention. It is also important to develop a framework that considers 
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the introduction of new features, or medical devices, during the assessment of the mHealth 
intervention trial.  
7. 5 Conclusion 
This program of research used diverse research methods, including quantitative, 
qualitative, and mixed methods studies to examine the process of developing mHealth to manage 
COPD. These studies resulted in information about the effectiveness of COPD on reducing 
exacerbations, though as discussed, these findings were small in magnitude and may not be of 
clinical importance. More importantly, this research identifies several facilitators and barriers to 
mHealth adoption for COPD management. It also includes features of the mHealth intervention 
for both patients and HCPs. The last study provides methodological guidance to successfully 
perform usability testing for mHealth interventions. This is a developing field of research and a 
promising one for understanding how to use contemporary technologies in chronic disease 
management.   
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Appendix 1- HCP Interview prompts 
A- Health Care Providers 
● Date and place 
● Age and experience from general practice 
● Job title 
 
General perceptions 
● Tell me a little bit about your experience with patients with COPD. 
● What are the likely treatment outcomes? 
● Do you know what mHealth is? 
 
Facilitators 
● Have you used mHealth before? (if no, go to barriers).  
● Tell me about a situation when you have tried to use mHealth in your practice.  
○ Why this episode? 
○ What did you use it for? 
○ What data did you collect? 
○ How often? 
● What motivated you as a healthcare provider to use mHealth? 
● What elements of the intervention do you think are most important? 
● Did you do any preparation before using mHealth to manage COPD? 
● What is necessary for you to obtain knowledge/experience and keep up to date 
about mHealth? 
 
Barriers 
● What is limiting you from using mHealth in your practice? 
● What difficulties have you experienced when using mHealth? 
● How did you solve it? 
● Were there any challenges? 
○  (financial, employees, technical)?  
● Did you experience changes in the contact/bond with the patient?  
● Do HCPs require education before use and how did that happen in the past? 
● Do patients require education before use and how did that happen in the past? 
 
mHealth in COPD Management 
● Do you see a role of mHealth in COPD management?  
○ how do you feel about apps used in COPD management? 
● Could you tell me about whether you would be interested in using it? 
● How do you perceive using mHealth to manage COPD? 
● What information do you want to collect from the patient?  
○ Education (how often) 
○ Survey (how often) 
○ Care plan 
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○ Compatible medical devices (e.g. spirometer, pulse oximeter, medication 
adherence device) 
● What else would you like it to do? 
● What would you change, take away or add? 
● What about any problems or concerns you can see with this? 
● How does mHealth affect the current COPD management process?  
● Did you have to do any practical changes in consultations to enable the 
intervention? (Time, follow-ups, other?) 
● How about viewing large amount of data, e.g. heart rate, spirometry, survey? 
● Does your patients see a role of mHealth in COPD management?  
● How does your patients perceive using mHealth to manage COPD? 
● Who do you think can be a candidate for this intervention? (What is it about the 
patient that makes them suitable or not?) 
 
Final questions 
● Would you recommend mHealth to a colleague? 
○ if so, what would you emphasize? 
● Would you like to add anything? 
● Would you like to elaborate on anything I asked?  
 
Thank you for participating in this study, your answers to these questions are very important to 
us , and we really appreciate you taking the time to complete this interview. Please contact me if 
you have any questions or would like to discuss this topic further. 	  
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Appendix 2 - Patient questionnaire  
A- Eligibility  
1. Have you been diagnosed by a physician as having Chronic Obstructive Pulmonary 
Disease (COPD), Emphysema, or Chronic Bronchitis? 
 
🖵 Yes 
🖵 No (If you have not been diagnosed by a physician as having COPD, emphysema, or 
chronic bronchitis then we’re sorry. You are not eligible to participate in this study. 
Please discard the questionnaire).  
2. How old are you?  
 
🖵 30- 34 years 
🖵 35 - 44 years 
🖵 45 - 54 years 
 🖵 55 - 64 years 
🖵 Age 65 or older 
 
B- Mobile Health Technology Ownership  
3. Do you own an iPad and/or tablet?  
 
🖵 Yes 
🖵 No 
4. Do you own a mobile/cell phone? 
 
🖵 Yes 
🖵 No (skip to question 6) 
5. Is the mobile/cell phone you use a smartphone?   
  
🖵 Yes 
🖵 No 
🖵 Don’t know 
6. Other than you, does someone in your household have a smartphone? 
 
🖵 Yes  🖵 No  
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🖵 Don’t know 🖵 Live alone 
7. Do you own any of the following health devices? Check all that apply 
 
🖵 Spirometer/ Peak flow meter 
🖵 Glucose meter/ sugar level monitor 
🖵 Blood pressure monitor 
🖵 Heart rate monitor 
 🖵 Activity counter (e.g. fitbit or apple watch) 
🖵 Scale 
🖵 Thermometer 
🖵 Insulin pump 
🖵 Other, please specify:____________________________________  
C- Mobile Health Technology Use  
8. What language do you use on your phone?  
🖵 English 
🖵 French 
🖵 Other, please specify:____________________________________  
9. Do you use any of the social media accounts listed below? Check all that apply 
 
🖵 Facebook 
🖵 Instagram 
 🖵 Twitter  
🖵  Snapchat 
🖵 I do not use social media accounts (skip to question 11) 
🖵 Other, please specify:____________________________________  
10. How often do you use your social media networks? 
 
🖵 Never 
🖵 A few times a month 
🖵 A few times a week 
🖵 About once a day 
🖵 More than once a day 
11. Would you be interested in using social media to share your health experience with 
other people with similar health issues?  
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🖵 Yes 
🖵 No 
 
12. Do you know what a smartphone “app” is? 
 
🖵 Yes 
🖵 No (Skip to question 21)  
13. Do you use apps on your smartphone?  
 
🖵 Yes 
🖵 No (Skip to question 21)  
🖵 Don’t know 
14. In the past 12 months, did you use health-related apps on your smartphone? 
 
🖵 Yes 
🖵 No 
🖵 Don’t know 
15. Would you be interested in using a smartphone app to improve your health?  
 
🖵 Yes 
🖵 No (skip to question 17) 
16. If you are interested in using a health-related app, how often do you think you would 
you use it to improve your health? 
 
🖵 Once a week 
🖵 Once a day  
🖵 2-3 times per day 
🖵 4-5 times per day 
🖵 6 or more times per day  
17. What particular health-related app feature do you think would be useful? Check all 
that apply 
 
🖵 Medication information 
🖵 Inhaler technique education 
 🖵 Medication Reminders  
🖵 Nutrition information  
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🖵 COPD action plan 
🖵 General information about disease 
🖵 Mental wellness techniques 
🖵 Other, please specify:____________________________________  
18. Would you be comfortable allowing a family member or friend to access health-related 
information that you shared in an app? 
 
🖵 Yes 
🖵 No 
19. Would you be comfortable allowing your family doctor or other healthcare 
professionals to have access to your health information that you shared in an app? 
 
🖵 Yes 
🖵 No 
20. Which of the following concerns do you have about the use of smartphone applications 
(apps)? Check all that apply 
 
 
🖵 They are not easy to use 
🖵 They take too much time to use 
🖵 I do not know if they are effective 
🖵 Apps use a lot of data 
 🖵 There is an extra fee to use the app 
🖵 Worried about personal information disclosure 
🖵 Not recommended by a healthcare provider 
🖵 None of the above 
🖵 Other, please specify:____________________________________  
21. Did you access the Internet from your phone during the past 12 months?  
 
🖵 Yes 
🖵 No 
🖵 Don’t know 
22. If you use the internet on your smartphone for health needs, which sites do you use? 
Check all that apply 
 
🖵 Google 
🖵 WebMD 
 🖵 Yahoo/Bing/Other search engines 
🖵 Mayo clinic/PubMed/NIH 
🖵 Wikipedia 
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🖵 YouTube 
🖵 Other, please specify:____________________________________  
 
 
 
 
 
23. Which of the following concerns do you have about smartphones? Check all that apply 
 
🖵 Cost of smartphones 
🖵 They are not easy to use 
 🖵 Reducing face to face interaction 
🖵 None of the above  
🖵 Other, please specify:____________________________________  
D- Demographics and Health Information  
24. What is your sex?  
🖵 Female 
🖵 Male 
25. What is your gender?  
🖵 Female 
🖵 Male 
🖵 Prefer not to answer  
🖵 Other, please specify:____________________________________  
 
26. What is your Marital Status?  
 
🖵 Married 
🖵 Common Law 
🖵 Single (never married) 
 🖵 Widowed, Separated, or Divorced 
🖵 Prefer not to answer 
27. What is your highest level of education?   
 
🖵 Less than high school 
🖵 High School Equivalency (GED) 
 🖵 Bachelor’s degree 
🖵 Master’s degree 
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🖵 High School  🖵 PhD/ MD/ JD 
🖵 Prefer not to answer 
🖵 Other, please specify:____________________________________  
28. Which of the following best describes where you currently live?  
🖵 Rural area, with a population less than 1,000 
🖵 Small population centre, with a population between 1,000 and 29,999 
🖵 Medium population centre, with a population between 30,000 and 99,999  
🖵 Large urban population centre, with a population of 100,000 or more. 
29. What best describes your employment ?  
 
🖵 Employed full time 
🖵 Employed part time 
🖵 Self-employed 
 🖵 Retired 
🖵 Student 
🖵 Unemployed  
30. What is the range that best describes your gross household income in the last year? 
 
🖵 Under $20,000 
🖵 $20,000-$39,000 
🖵 $40,000-$59,000 
🖵 $60,000–79,000 
 🖵 $80,000–150,000 
🖵 Over $150,000 
🖵 Don’t know 
🖵 Prefer not to answer 
31. What medical conditions do you have or have had in the past? Check all that apply 
 
🖵 Diabetes 
🖵 Lung disease 
🖵 Heart disease 
🖵 Kidney disease  
 🖵 Cancer 
🖵 Mental Health Issues 
🖵 Skeletal/ Muscular disease (e.g. Arthritis) 
🖵 Prefer not to answer 
🖵 Other, please specify:____________________________________  
32. How many medications do you take each day? This include medications you may buy 
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without a prescription 
 
🖵 None 
🖵 1-2  
🖵 3-4  
🖵 4-6  
🖵 More than 6 
🖵 Prefer to not answer 
🖵 Other, please specify:____________________________________   
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E- Future Research  
33. Are you willing to participate in a focus group to help develop an app for COPD 
management? 
 
🖵 Yes (Please answer question 36) 
🖵 No 
34. Are you willing to participate in an individual interview to help develop an app 
for COPD management? 
 
🖵 Yes (Please answer question 36) 
🖵 No 
35. Are you willing to be contacted for future research? 
 
🖵 Yes (Please answer question 36) 
🖵 No 
Thank you for participating in this study. Your answers to these questions are 
important to us, and we really appreciate you taking the time to complete this 
questionnaire.  
Insert the completed form in the 
BLUE box located at the clinic   
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36. If you answered yes to questions 33, 34 and/ or 35, please provide a phone 
number and/or email below to allow us to contact you. 
*Note that adding your contact information may present some privacy and confidentiality 
risks. There is always a small risk that data your answers to the questionnaire may be 
identified. We will use strict measures to protect your privacy.  
 
Name: 
 
Phone number:  
 
Email:  
 
Best time to call:  
 
 
Tear this page and insert it the 
RED box located at the clinic  
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Appendix 3 - Patient Interview prompts 
 
● Date  
● Years living with COPD 
General perceptions 
● Tell me a little bit about your experience with COPD?  
● How do you know if your COPD is getting worse?  
● How do you manage it? 
● Do you have other chronic diseases besides COPD?  
● How do you manage it along with your COPD? 
● How many medications do you take?  
● How do you remember when to take it? 
● Do you own any health devices (e.g., spirometer, blood pressure monitor)?  
● How often do you use it?  
● Does it connect to your smartphone?  
● What type of phone do you have?  
○ How did you learn how to use it?  
○ Do you live with someone who knows how to use it?  
○ Does your friends/ family use a smartphone?  
○ Do you know what a smartphone “app” is? 
○ Do you use apps on your smartphone? 
○ In the past 12 months, did you use health-related apps on your 
smartphone? 
○ Did you access the Internet from your phone during the past 12 months?  
Facilitators 
● Do you know what mHealth is? (using a phone to improve your health) 
● Have you used mhealth before? (if no, go to barriers).  
● Tell me about a situation when you have tried to use mhealth/ telehealth.  
○ Why this episode? 
○ What did you use it for? 
○ What data did you collect? 
○ How often? 
● What motivated you to use mhealth? 
● What elements of the intervention do you think are most important? 
● Did you do any preparation before using mHealth to manage COPD? 
● What is necessary for you to obtain knowledge/experience and keep up to date 
about mHealth? 
Barriers 
● What is limiting you from using a smartphone? 
● What is limiting you from using mHealth? 
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● What difficulties have you experienced when using mHealth? 
● How did you solve it? 
● Were there any challenges? 
○  (financial, employees, technical)?  
● Did you experience changes in the contact/bond with your healthcare provider?  
mHealth in COPD Management 
● Do you see a role of mHealth in COPD management?  
● How do you feel about apps used in COPD management? 
● What features do you want the app to include?   
○ Education (how often) 
○ Survey (how often) 
○ Care plan 
○ Compatible medical devices ((e.g. spirometer, pulse oximeter, medication 
adherence device) 
○ Health coach 
● What else would you like it to do? 
● How often do you think you would you use it to manage your COPD?  
● Could you tell me whether you would be interested in using it? 
● What about any problems or concerns you can see with this? 
● Would you be comfortable allowing a family member or friend to access health-
related information that you shared in an app? Why/ why not? 
● Would you be comfortable allowing your family doctor or other healthcare 
professionals to have access to your health information that you shared in an 
app?Why/ why not? 
● How does mHealth affect your current COPD management process?  
● How about viewing a large amount of data, e.g. heart rate, spirometry, survey? 
● Does your healthcare provider see a role of mHealth in COPD management?  
● How does your healthcare provider perceive using telehealth/ mHealth to 
manage COPD? 
Final questions 
● Would you like to add anything? 
● Would you like to elaborate on anything I asked?  
 
Thank you for participating in this study, your answers to these questions are very 
important to us, and we really appreciate you taking the time to complete this interview. 
Please contact me if you have any questions or would like to discuss this topic further. 
